An alkyl phenyl sulfide derivative represented by the general formula [I] or an agriculturally acceptable salt thereof, and a pest control agent containing the derivative or the salt as an active ingredient. [structure] [in the above formula, R 1 is, for example, a C 1 ˜C 6 alkyl group which is mono- or poly-substituted with halogen atom; R 2 is, for example, a halogen atom or a C 1 ˜C 6 alkyl group; R 3 is, for example, a hydrogen atom or a halogen atom; and R 4 is, for example, a hydrogen atom or a C 1 ˜C 12 alkyl group.] The derivative or the salt has an excellent pest control effect.

Description

60 parts

›TECHNICAL FIELD

The present invention relates to a novel alkyl phenyl sulfide derivative or an agriculturally acceptable salt thereof, as well as to a pest control agent containing the derivative or the salt thereof as an active ingredient.

›BACKGROUND ART

Alkyl phenyl sulfide derivatives having a pest control effect are described in patent literatures 1, 2, 3, 4, 5 and 6. However, the compounds described in the patent literatures 1, 2, 3 and 4 are restricted to alkyl phenyl sulfide derivatives having no substituent group on the alkylthio group; the compounds described in the patent literature 5 are restricted to alkyl phenyl sulfide derivatives having certain substituents on the phenyl ring; and the compounds described in the patent literature 6 are restricted to alkyl phenyl sulfide derivatives having a 2-bromoethylthio group as a substituent group. Thus, these patent literatures make no mention of an alkyl phenyl sulfide derivative having a substituent group other than bromine atom on the alkylthio group.

The follow-up experiment made on the compounds described in the above patent literatures revealed that, despite the description made therein, the compounds have an insufficient effect to spider mites, have no effect to spider mites which have acquired chemical resistance, and accordingly have no sufficient control effect.

Patent literature 1: JP-A-1975-29744

Patent literature 2: JP-A-1976-19121

Patent literature 3: JP-B-1982-35162

Patent literature 4: JP-A-1988-41451

Patent literature 5: JP-A-1992-312566

Patent literature 6: U.S. Pat. No. 3,388,167

›SUMMARY OF THE INVENTION · 1 of 2

Pest control agent applied to useful crops is desired to be a chemical agent which exhibits a sufficient pest control effect at a low dose when applied to soil or stem and leaf. Also, development of safer pest control agent is desired because requirements for safety of chemical substance and its influence to environment are becoming stronger. Further, in recent years, the use of pest control agents such as insecticide, miticide and the like over many years have invited the appearance of pests which have acquired resistance to such pest control agents, and complete control of pests have become difficult. Furthermore, the use of pest control agents having high toxicity to humans and livestock has become a problem from the safety to workers and others.

Under such circumstances, the task of the present invention is to solve the above-mentioned problems of conventional pest control agents and provide a pest control agent superior in safety, control effect, residual effect, etc.

Means to Solve the Problems

In order to develop a pest control agent having the above-mentioned desirable properties, the present inventors synthesized various alkyl phenyl sulfide derivatives and investigated their physiological activities earnestly. As a result, it was found that an alkyl phenyl sulfide derivative represented by the following general formulas [I] or [I′] (the derivative is hereinafter referred to as the present compound) has an excellent effect on various pests, particularly on spider mites represented by Tetranychus urticae, Tetranychus kanzawai, Panonychus citri , etc. A further research has led to the completion of the present invention.

The present invention is as follows.

(1) An alkyl phenyl sulfide derivative represented by the general formula [I] or an agriculturally acceptable salt thereof

[in the formula [I],

n is an integer of 0, 1 or 2,

R 1 is a C 1 -C 6 haloalkyl group (the group excludes 2-bromoethyl group), a C 2 -C 8 alkenyl group (the group excludes allyl group), a C 2 -C 8 haloalkenyl group, a C 2 -C 6 alkynyl group, a C 2 -C 6 haloalkynyl group, a branched C 4 -C 6 alkyl group (the group excludes isobutyl group), a C 3 -C 6 cycloalkyl C 1 -C 6 alkyl group or a C 3 -C 6 halocycloalkyl C 1 -C 6 alkyl group,

R 2 is a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group, a C 3 -C 6 cycloalkyl group, a C 3 -C 6 halocycloalkyl group, a C 1 -C 6 alkoxy group, a C 1 -C 6 haloalkoxy group, a cyano group or a nitro group,

R 3 is a hydrogen atom, a halogen atom, a C 1 -C 6 alkyl group or a C 1 -C 6 haloalkyl group,

R 4 is a C 1 -C 12 alkyl group (the group may be mono- or poly-substituted with R 5 ), a C 3 -C 6 cycloalkyl group (the group may be mono- or poly-substituted with R 5 ), a C 2 -C 8 alkenyl group (the group may be mono- or poly-substituted with R 5 ), a C 2 -C 6 alkynyl group (the group may be mono- or poly-substituted with R 5 ) or a benzoyl group (the group may be mono- or poly-substituted with R 6 ),

R 5 is a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group, a C 3 -C 6 cycloalkyl group (the group may be mono- or poly-substituted with R 6 ), a C 3 -C 6 halocycloalkyl group, a hydroxyl group, a C 1 -C 6 alkoxy group, a C 1 -C 6 haloalkoxy group, a C 3 -C 6 cycloalkoxy group, a C 3 -C 6 halocycloalkoxy group, a C 1 -C 6 alkoxy C 1 -C 6 alkoxy group, a C 1 -C 6 haloalkoxy C 1 -C 6 alkoxy group, a C 1 -C 6 haloalkoxy C 1 -C 6 haloalkoxy group, a C 1 -C 6 alkylsulfinyloxy group, a C 1 -C 6 haloalkylsulfinyloxy group, a C 3 -C 6 cycloalkylsulfinyloxy group, a C 3 -C 6 halocycloalkylsulfinyloxy group, a C 1 -C 6 alkylsulfonyloxy group, a C 1 -C 6 haloalkylsulfonyloxy group, a C 3 -C 6 cycloalkylsulfonyloxy group, a C 3 -C 6 halocycloalkylsulfonyloxy group, a thiol group, a C 1 -C 6 alkylthio group, a C 1 -C 6 haloalkylthio group, a C 2 -C 6 alkenylthio group, a C 2 -C 6 haloalkenylthio group, a C 3 -C 6 cycloalkylthio group, a C 3 -C 6 halocycloalkylthio group, a C 3 -C 6 cycloalkyl C 1 -C 6 alkylthio group, a C 3 -C 6 halocycloalkyl C 1 -C 6 alkylthio group, a tri(C 1 -C 6 alkyl)silyl C 1 -C 6 alkylthio group, a C 1 -C 6 alkylsulfinyl group, a C 1 -C 6 haloalkylsulfinyl group, a C 3 -C 6 cycloalkylsulfinyl group, a C 3 -C 6 halocycloalkylsulfinyl group, a C 1 -C 6 alkylsulfonyl group, a C 1 -C 6 haloalkylsulfonyl group, a C 3 -C 6 cycloalkylsulfonyl group, a C 3 -C 6 halocycloalkylsulfonyl group, a C 1 -C 6 alkylcarbonyl group, a C 1 -C 6 haloalkylcarbonyl group, a formyl group, a C 1 -C 6 alkylcarbonyloxy group, a C 1 -C 6 haloalkylcarbonyloxy group, a formyloxy group, an amino group, a C 1 -C 6 alkylcarbonylamino group (the amino group may be substituted with R 9 ), a C 1 -C 6 haloalkylcarbonylamino group (the amino group may be substituted with R 9 ), a phenylcarbonylamino group (the phenyl group may be mono- or poly-substituted with R 6 , the amino group may be substituted with R 9 ), a C 1 -C 6 alkoxycarbonylamino group (the amino group may be substituted with R 9 ), a C 1 -C 6 haloalkoxycarbonylamino group (the amino group may be substituted with R 9 ), a C 1 -C 6 alkylaminocarbonylamino group (the amino group may be substituted with R 9 ), a C 1 -C 6 haloalkylaminocarbonylamino group (the amino group may be substituted with R 9 ), a C 1 -C 6 alkylsulfonylamino group (the amino group may be substituted with R 9 ), a C 1 -C 6 haloalkylsulfonylamino group (the amino group may be substituted with R 9 ), a phenylsulfonylamino group (the phenyl group may be substituted with R 6 , the amino group may be substituted with R 9 ), a C 1 -C 6 alkylamino group (the amino group may be substituted with R 9 ), a C 1 -C 6 haloalkylamino group (the amino group may be substituted with R 9 ), a C 1 -C 6 alkylaminocarbonylthio group (the amino group may be substituted with R 9 ), a C 1 -C 6 haloalkylaminocarbonylthio group (the amino group may be substituted with R 9 ), a C 1 -C 6 alkylaminocarbonyl group (the amino group may be substituted with R 9 ), a C 1 -C 6 haloalkylaminocarbonyl group (the amino group may be substituted with R 9 ), a C 1 -C 6 alkoxycarbonyl group, a C 1 -C 6 haloalkoxycarbonyl group, a tri(C 1 -C 6 alkyl)silyl group, a phenyl group (the group may be mono- or poly-substituted with R 6 ), a pyridyloxyphenyl group (the pyridyl group may be mono- or poly-substituted with R 6 ), a phenoxy group (the group may be mono- or poly-substituted with R 6 ), a phenyl C 1 -C 6 alkoxy group (the phenyl group may be mono- or poly-substituted with R 6 ), a phenylcarbonyloxy group (the phenyl group may be mono- or poly-substituted with R 6 ), a phenylcarbonyl group (the phenyl group may be mono- or poly-substituted with R 6 ), a benzoyl group (the group may be mono- or poly-substituted with R 6 ), a benzoyloxy group (the group may be mono- or poly-substituted with R 6 ), a phenylthio group (the group may be mono- or poly-substituted with R 6 ), a phenylsulfonyl group (the group may be mono- or poly-substituted with R 6 ), a phenylsulfinyl group (the group may be mono- or poly-substituted with R 6 ), a phenyl C 1 -C 6 alkylthio group (the phenyl group may be mono- or poly-substituted with R 6 ), a phenyl C 1 -C 6 alkylsulfinyl group (the phenyl group may be mono- or poly-substituted with R 6 ), a phenyl C 1 -C 6 alkylsulfonyl group (the phenyl group may be mono- or poly-substituted with R 6 ), a —O—N═C(R 7 )(R 8 ) group, an adamantyl group, a pyrrolyl group (the group may be mono- or poly-substituted with R 6 ), a pyrazolyl group (the group may be mono- or poly-substituted with R 6 ), an imidazolyl group (the group may be mono- or poly-substituted with R 6 ), a triazolyl group (the group may be mono- or poly-substituted with R 6 ), an oxazolyl group (the group may be mono- or poly-substituted with R 6 ), an isoxazolyl group (the group may be mono- or poly-substituted with R 6 ), a thiazolyl group (the group may be mono- or poly-substituted with R 6 ), an isothiazolyl group (the group may be mono- or poly-substituted with R 6 ), a pyridyl group (the group may be mono- or poly-substituted with R 6 and the nitrogen atom of the group may be oxidized to form N-oxide), a pyrimidinyl group (the group may be mono- or poly-substituted with R 6 ), a pyridyloxy group (the group may be mono- or poly-substituted with R 6 ), a tetrahydrofuranyl group (the group may be mono- or poly-substituted with R 6 ), 1,3-dioxoisoindolinyl group (the group may be mono- or poly-substituted with R 6 ), a cyano group, a nitro group, a carboxyl group, a thiocyanato group or an aminoxy group,

›SUMMARY OF THE INVENTION · 2 of 2

R 6 is a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group, a C 3 -C 6 cycloalkyl group, a C 3 -C 6 halocycloalkyl group, a C 3 -C 6 cycloalkyl C 1 -C 6 alkyl group, a C 3 -C 6 halocycloalkyl C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a C 1 -C 6 haloalkoxy group, a C 1 -C 6 alkylthio group, a C 1 -C 6 haloalkylthio group, a C 1 -C 6 alkylsulfinyl group, a C 1 -C 6 haloalkylsulfinyl group, a C 1 -C 6 alkylsulfonyl group, a C 1 -C 6 haloalkylsulfonyl group, a C 1 -C 6 alkylthio C 1 -C 6 alkyl group, a C 1 -C 6 haloalkylthio C 1 -C 6 alkyl group, a C 1 -C 6 alkylsulfonyloxy group, a C 1 -C 6 haloalkylsulfonyloxy group, a phenyl group (the group may be mono- or poly-substituted with halogen atom, alkyl group or haloalkyl group), a phenyl C 1 -C 6 alkyl group, a phenyl C 1 -C 6 alkoxy group, a cyano group or a nitro group,

R 7 and R 8 may be the same or different, are each a hydrogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group, a C 3 -C 6 cycloalkyl group, a C 3 -C 6 halocycloalkyl group or a phenyl group (the group may be mono- or poly-substituted with R 6 ), and may form a 3- to 6-membered ring together with the carbon atom to which they bond, and

R 9 is a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group, a C 3 -C 6 cycloalkyl group, a C 3 -C 6 halocycloalkyl group, a C 1 -C 6 alkylcarbonyl group, a C 1 -C 6 haloalkylcarbonyl group, a C 1 -C 6 alkoxycarbonyl group, a C 1 -C 6 haloalkoxycarbonyl group, a C 1 -C 6 alkylaminocarbonyl group, a C 1 -C 6 haloalkylaminocarbonyl group or benzoyl group (the group may be mono- or poly-substituted with R 6 ].

(2) An alkyl phenyl sulfide derivative or an agriculturally acceptable salt thereof, set forth in (1), wherein R 1 in the general formula [I] is a 2,2-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 3,3,3-trifluoropropyl group, a pentafluoroethyl group, 1,2,2,2-tetrafluoroethyl group, 2-chloro-2,2-difluoroethyl group, a 2,2,3,3-tetrafluoropropyl group, a 2,2,3,3,3-pentafluoropropyl group, a 3,3-dichloroallyl group, a propargyl group, a cyclopropylmethyl group or a (2,2-difluorocyclopropyl)methyl group.

(3) An alkyl phenyl sulfide derivative or an agriculturally acceptable salt thereof, set forth in (1) or (2), wherein R 2 in the general formula [I] is a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group or a cyano group.

(4) An alkyl phenyl sulfide derivative or an agriculturally acceptable salt thereof, set forth in any of (1) to (3), wherein R 3 in the general formula [I] is a hydrogen atom, a halogen atom or a C 1 -C 6 alkyl group.

(5) A pest control agent which contains, as an active ingredient, an alkyl phenyl sulfide derivative or an agriculturally acceptable salt thereof, set forth in any of (1) to (4).

(6) An alkyl phenyl sulfide derivative represented by the general formula [I′] or a salt thereof

wherein n is an integer of 0, 1 or 2,

R 1′ is a C 1 -C 6 haloalkyl group (the group excludes 2-bromoethyl group), a C 2 -C 8 alkenyl group (the group excludes allyl group), a C 2 -C 8 haloalkenyl group, a C 2 -C 6 alkynyl group, a C 2 -C 6 haloalkynyl group, a branched C 4 -C 6 alkyl group (the group excludes isobutyl group), a C 3 -C 6 cycloalkyl C 1 -C 6 alkyl group or a C 3 -C 6 halocycloalkyl C 1 -C 6 alkyl group,

R 2′ is a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group, a C 3 -C 6 cycloalkyl group, a C 3 -C 6 halocycloalkyl group, a C 1 -C 6 alkoxy group, a C 1 -C 6 haloalkoxy group, a cyano group or a nitro group,

R 3′ is a hydrogen atom, a halogen atom, a C 1 -C 6 alkyl group or a C 1 -C 6 haloalkyl group.]

(7) An alkyl phenyl sulfide derivative or an agriculturally acceptable salt thereof, set forth in (6), wherein R 1′ in the general formula [I′] is a 2,2-difluoroethyl group, a 2,2,2-trifluoroethyl group, a 3,3,3-trifluoropropyl group, a pentafluoroethyl group, a 1,2,2,2-tetrafluoroethyl group, a 2-chloro-2,2-difluoroethyl group, a 2,2,3,3-tetrafluoropropyl group a 2,2,3,3,3-pentafluoropropyl group, a 3,3-dichloroallyl group, a propargyl group, a cyclopropylmethyl group or a (2,2-difluorocyclopropyl)methyl group.

(8) An alkyl phenyl sulfide derivative represented by the general formula [I′] or an agriculturally acceptable salt thereof, set forth in (6) or (7), wherein R 2′ in the general formula [I′] is a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 haloalkyl group or a cyano group.

(9) An alkyl phenyl sulfide derivative represented by the general formula [I′] or an agriculturally acceptable salt thereof, set forth in any of (6) to (8), wherein R 3′ in the general formula [I′] is a hydrogen atom, a halogen atom or a C 1 -C 6 alkyl group.

›Advantages of the Invention · 1 of 25

The pest control agent containing the present compound has an excellent effect to a wide range of pests such as Hemiptera, Lepidoptera, Coleoptera, Diptera, Hymenoptera, Orthoptera, Order Isoptera, Thysanoptera, spider mites, plant parasitic nematodes and the like and can control even pests which have acquired chemical resistance.

In particular, the pest control agent containing the present compound has an excellent effect to spider mites as pest, represented by Tetranychus urticae, Tetranychus kanzawai, Panonychus citri , etc., and has a sufficient effect even to spider mites which have acquired chemical resistance.

The symbols and terms used in this Specification are explained.

In the present invention, pest control agent means insecticide, miticide, nematicide, etc., used in agricultural and horticultural field, animals (e.g. livestock and pets), household, or infectious disease control.

In the present invention, halogen atom indicates fluorine atom, chlorine atom, bromine atom or iodine atom.

In the present invention, expression such as C 1 -C 6 indicates that the substituent group after the expression has 1 to 6 carbon atoms in this case.

In the present invention, C 1 -C 6 alkyl group indicates a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, unless otherwise specified. There can be mentioned, for example, groups such as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1-ethylpropyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, neopentyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl.

In the present invention, C 1 -C 6 haloalkyl group indicates a straight chain or branched chain haloalkyl group having 1 to 6 carbon atoms, substituted with 1 to 13 same or different halogen atoms, unless otherwise specified. There can be mentioned, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, bromomethyl, dibromomethyl, tribromomethyl, iodomethyl, chlorodifluoromethyl, dichlorofluoromethyl, 1-fluoroethyl, 2-fluoroethyl, 1,1-difluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1,1,2,2-tetrafluoroethyl, pentafluoroethyl, 1-chloroethyl, 2-chloroethyl, 1,1-dichloroethyl, 2,2-dichloroethyl, 2,2,2-trichloroethyl, 1,1,2,2-tetrachloroethyl, pentachloroethyl, 1-bromoethyl, 2-bromoethyl, 2,2,2-tribromoethyl, 1-iodoethyl, 2-iodoethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2-trichloroethyl, 1-fluoropropyl, 2-fluoropropyl, 3-fluoropropyl, 1,1-difluoropropyl, 2,2-difluoropropyl, 3,3-difluoropropyl, 3,3,3-trifluoropropyl, 2,2,3,3,3-pentafluoropropyl, heptafluoropropyl, 1-fluoropropane-2-yl, 2-fluoropropane-2-yl, 1,1-difluoropropane-2-yl, 1,2-difluoropropane-2-yl, 1,3-difluoropropane-2-yl, 1,2,3-trifluoropropane-2-yl, 1,1,3,3-tetrafluoropropane-2-yl, 1,1,1,3,3,3-hexafluoropropane-2-yl, heptafluoropropane-2-yl, 1-chloropropyl, 2-chloropropyl, 3-chloropropyl, 1,1-dichloropropyl, 2,2-dichloropropyl, 3,3-dichloropropyl, 3,3,3-trichloropropyl, 2,2,3,3,3-pentachloropropyl, heptachloropropyl, 1-chloropropane-2-yl, 2-chloropropane-2-yl, 1,1-dichloropropane-2-yl, 1,2-dichloropropane-2-yl, 1,3-dichloropropane-2-yl, 1,2,3-trichloropropane-2-yl, 1,1,3,3-tetrachloropropane-2-yl, 1,1,1,3,3,3-hexachloropropane-2-yl, heptachloropropane-2-yl, 1-bromopropyl, 2-bromopropyl, 3-bromopropyl, 1-bromopropane-2-yl, 2-bromopropane-2-yl, 1-iodopropyl, 2-iodopropyl, 3-iodopropyl, 1-iodopropane-2-yl, 2-iodopropane-2-yl, 1-fluorobutyl, 2-fluorobutyl, 3-fluorobutyl, 4-fluorobutyl, 4,4-difluorobutyl, 4,4,4-trifluorobutyl, 3,3,4,4,4-pentafluorobutyl, 2,2,3,3,4,4,4-heptafluorobutyl, nonafluorobutyl, 1,1,1-trifluorobutane-2-yl 4,4,4-trifluorobutane-2-yl, 3,3,4,4,4-pentafluorobutane-2-yl, nonafluorobutane-2-yl, 1,1,1,3,3,3-hexafluoro-2-(trifluoromethyl)propane-2-yl, 1-chlorobutyl, 2-chlorobutyl, 3-chlorobutyl, 4-chlorobutyl, 4,4-dichlorobutyl, 4,4,4-trichlorobutyl, nonachlorobutyl, 1,1,1-trichlorobutane-2-yl 4,4,4-trichlorobutane-2-yl, nonachlorobutane-2-yl, 1-bromobutyl, 2-bromobutyl, 3-bromobutyl, 4-bromobutyl, 1-iodobutyl, 2-iodobutyl, 3-iodobutyl, 4-iodobutyl, 4-chloro-1,1,2,2,3,3,4,4-octafluorobutyl, 4-bromo-1,1,2,2,3,3,4,4-octafluorobutyl, 1-fluoropentyl, 2-fluoropentyl, 3-fluoropentyl, 4-fluoropentyl, 5-fluoropentyl, 5,5,5-trifluoropentyl, 4,4,5,5,5-pentafluoropentyl, 3,3,4,4,5,5,5-heptafluoropentyl, 2,2,3,3,4,4,5,5,5-nonafluoropentyl, undecafluoropentyl, 1-chloropentyl, 2-chloropentyl, 3-chloropentyl, 4-chloropentyl, 5-chloropentyl, 5,5,5-trichloropentyl, 4,4,5,5,5-pentachloropentyl, 3,3,4,4,5,5,5-heptachloropentyl, 2,2,3,3,4,4,5,5,5-nonachloropentyl, undecachloropentyl, 1-bromopentyl, 2-bromopentyl, 3-bromopentyl, 4-bromopentyl, 5-bromopentyl, 5-iodopentyl, 1-fluorohexyl, 2-fluorohexyl, 3-fluorohexyl, 4-fluorohexyl, 5-fluorohexyl, 6-fluorohexyl, 6,6,6-trifluorohexyl, 5,5,6,6,6-pentafluorohexyl, 4,4,5,5,6,6,6-heptafluorohexyl, 3,3,4,4,5,5,6,6,6-nonafluorohexyl, 2,2,3,3,4,4,5,5,6,6,6-undecafluorohexyl, tridecafluorohexyl, 1-chlorohexyl, 2-chlorohexyl, 3-chlorohexyl, 4-chlorohexyl, 5-chlorohexyl, 6-chlorohexyl, 5-bromohexyl, 6-bromohexyl, 5-iodohexyl and 6-iodohexyl.

In the present invention, C 1 -C 12 alkyl group indicates a straight chain or branched chain alkyl group having 1 to 12 carbon atoms, unless otherwise specified. There can be mentioned, in addition to the above-mentioned C 1 -C 6 carbon atoms, for example, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, 4,4-dimethylpentyl, 5-methylhexyl, 5,5-dimethylhexyl, 3,5,5-trimethylhexyl, 6-methylheptyl, 6,6-dimethylheptyl, 3,6,6-trimethylheptyl, 7-methyloctyl, 7,7-dimethyloctyl, 8-methylnonyl, 8,8-dimethylnonyl, 9-methyldecyl, 9,9-dimethyldecyl and 10-methylundecyl.

›Advantages of the Invention · 2 of 25

In the present invention, branched chain C 4 -C 6 alkyl group indicates a branched chain alkyl group having 4 to 6 carbon atoms, unless otherwise specified. There can be mentioned, for example, groups such as sec-butyl, isobutyl, tert-butyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1-ethylpropyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, neopentyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-ethylbutyl, 2-ethylbutyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl.

In the present invention, C 3 -C 6 cycloalkyl group indicates a cycloalkyl group having 3 to 6 carbon atoms, unless otherwise specified. There can be mentioned, for example, groups such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.

In the present invention, C 3 -C 6 halocycloalkyl group indicates a cycloalkyl group having 3 to 6 carbon atoms, substituted with 1 to 11 same or different halogen atoms, unless otherwise specified. There can be mentioned, for example, groups such as 1-fluorocyclopropyl, 2-fluorocyclopropyl, 2,2-difluorocyclopropyl, 2,2,3,3-tetrafluorocyclopropyl, 1-chlorocyclopropyl, 2-chlorocyclopropyl, 2,2-dichlorocyclopropyl, 2,2,3,3-tetrachlorocyclopropyl, 2,2-dibromocyclopropyl, 2,2-diiodocyclopropyl, 1-fluorocyclobutyl, 2-fluorocyclobutyl, 3-fluorocyclobutyl, 3,3-difluorocyclobutyl, heptafluorocyclobutyl, 2-chlorocyclobutyl, 3-chlorocyclobutyl, 3,3-dichlorocyclobutyl, 3,3-dibromocyclobutyl, 3,3-diiodocyclobutyl, 1-fluorocyclopentyl, 2-fluorocyclopentyl, 3-fluorocyclopentyl, 2,2-difluorocyclopentyl, 3,3-difluorocyclopentyl, nonafluorocyclopentyl, 2,2-dichlorocyclopentyl, 3,3-dichlorocyclopentyl, 2,2-dibromocyclopentyl, 3,3-dibromocyclopentyl, 2,2-diiodocyclopentyl, 3,3-diiodocyclopentyl, 1-fluorocyclohexyl, 2-fluorocyclohexyl, 3-fluorocyclohexyl, 4-fluorocyclohexyl, 2,2-difluorocyclohexyl, 3,3-difluorocyclohexyl, 4,4-difluorocyclohexyl, 1-chlorocyclohexyl, 2-chlorocyclohexyl, 3-chlorocyclohexyl, 4-chlorocyclohexyl, 2,2-dichlorocyclohexyl, 3,3-dichlorocyclohexyl, 4,4-dichlorocyclohexyl, 3,3-dibromocyclohexyl, 4,4-dibromocyclohexyl, 3,3-diiodocyclohexyl and 4,4-diiodocyclohexyl.

In the present invention, C 2 -C 8 alkenyl group indicates a straight chain or branched chain alkenyl group having 2 to 8 carbon atoms, unless otherwise specified. There can be mentioned, for example, groups such as vinyl, 1-propenyl, isopropenyl, 2-propenyl, 1-butenyl, 1-methyl-1-propenyl, 2-butenyl, 1-methyl-2-propenyl, 3-butenyl, 2-methyl-1-propenyl, 2-methyl-2-propenyl, 1,3-butadienyl, 1-pentenyl, 1-ethyl-2-propenyl, 2-pentenyl, 1-methyl-1-butenyl, 3-pentenyl, 1-methyl-2-butenyl, 4-pentenyl, 1-methyl-3-butenyl, 3-methyl-1-butenyl, 1,2-dimethyl-2-propenyl, 1,1-dimethyl-2-propenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1,2-dimethyl-1-propenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,3-pentadienyl, 2,3-butadien-1-yl, 1-vinyl-2-propenyl, 1-hexenyl, 1-propyl-2-propenyl, 2-hexenyl, 1-methyl-1-pentenyl, 1-ethyl-2-butenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-4-pentenyl, 1-ethyl-3-butenyl, 1-(isobutyl)vinyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-2-propenyl, 1-(isopropyl)-2-propenyl, 2-methyl-2-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1,3-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1,5-hexadienyl, 1-vinyl-3-butenyl, 2,4-hexadienyl, 2-octenyl and 3,7-dimethyl-6-octenyl.

In the present invention, C 2 -C 8 haloalkenyl group indicates a haloalkenyl group having 2 to 8 carbon atoms, substituted with 1 to 15 same or different halogen atoms, unless otherwise specified. There can be mentioned, for example, groups such as 1-fluorovinyl, 2-fluorovinyl, 1,2-difluorovinyl, 2,2-difluorovinyl, trifluorovinyl, 1-chlorovinyl, 2-chlorovinyl, dichlorovinyl, trichlorovinyl, dibromovinyl, diiodovinyl, 1-fluoro-2-propenyl, 2-fluoro-2-propenyl, 3-fluoro-2-propenyl, 2,3-difluoro-2-propenyl, 3,3-difluoro-2-propenyl, 3,3-difluoro-1-propenyl, 2,3,3-trifluoro-2-propenyl, 3,3,3-trifluoro-1-propenyl, 1,2,3,3,3-pentafluoro-1-propenyl, 1-chloro-2-propenyl, 2-chloro-2-propenyl, 3-chloro-2-propenyl, 2,3-dichloro-2-propenyl, 3,3-dichloro-2-propenyl, 3,3-dichloro-1-propenyl, 2,3,3-trichloro-2-propenyl, 3,3,3-trichloro-1-propenyl, 3-bromo-2-propenyl, 3,3-dibromo-2-propenyl, 3,3-diiodo-2-propenyl, 2,2-difluoro-1-propen-2-yl, 3,3,3-trifluoro-1-propen-2-yl, 3,3,3-trichloro-1-propen-2-yl, 4-fluoro-3-butenyl, 4,4-difluoro-3-butenyl, 4,4-difluoro-3-buten-2-yl, 4,4,4-trifluoro-2-butenyl, 3,4,4-trifluoro-3-butenyl, 2-trifluoromethyl-2-propenyl, 2-trifluoromethyl-3,3-difluoro-2-propenyl, 4,4,4-trifluoro-3-chloro-2-butenyl, 4,4-dichloro-3-butenyl, 4,4,4-trichloro-2-butenyl, 2-trichloromethyl-2-propenyl, 5,5-difluoro-4-pentenyl, 4,5,5-trifluoro-4-pentenyl, 5,5,5-trifluoro-3-pentenyl, 4,4,4-trifluoro-3-methyl-2-butenyl, 4,4,4-trifluoro-3-trifluoromethyl-2-butenyl, 5,5-dichloro-4-pentenyl, 4,4,4-trichloro-3-methyl-2-butenyl, 6,6-difluoro-5-hexenyl, 5,6,6-trifluoro-5-pentenyl, 6,6,6-trifluoro-4-pentenyl, 5,5,5-trifluoro-4-methyl-3-pentenyl, 5,5,5-trifluoro-4-trifluoromethyl-3-pentenyl, 6,6-dichloro-5-hexenyl and 5,5,5-trichloro-4-methyl-3-pentenyl.

In the present invention, C 2 -C 6 alkynyl group indicates a straight chain or branched chain alkynyl group having 2 to 6 carbon atoms, unless otherwise specified. There can be mentioned, for example, groups such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 1-methyl-2-propynyl, 2-butynyl, 3-butynyl, 1-pentynyl, 1-ethyl-2-propynyl, 2-pentynyl, 3-pentynyl, 1-methyl-2-butynyl, 4-pentynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 1-hexynyl, 1-(n-propyl)-2-propynyl, 2-hexynyl, 1-ethyl-2-butynyl, 3-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 4-methyl-1-pentynyl, 3-methyl-1-pentynyl, 5-hexynyl, 1-ethyl-3-butynyl, 1-ethyl-1-methyl-2-propynyl, 1-(isopropyl)-2-propynyl, 1,1-dimethyl-2-butynyl and 2,2-dimethyl-3-butynyl.

›Advantages of the Invention · 3 of 25

In the present invention, C 2 -C 6 haloalkynyl group indicates a straight chain or branched chain haloalkynyl group having 2 to 6 carbon atoms, substituted with 1 to 9 same or different halogen atoms, unless otherwise specified. There can be mentioned, for example, groups such as fluoroethynyl, chloroethynyl, bromoethynyl, iodoethynyl, 3-fluoro-2-propynyl, 3-chloro-2-propynyl, 3-bromo-2-propynyl, 3-iodo-2-propynyl, 4-fluoro-3-butynyl, 4-chloro-3-butynyl, 4-bromo-3-butynyl, 4-iodo-3-butynyl, 4,4-difluoro-2-butynyl, 4,4-dichloro-2-butynyl, 4,4,4-trifluoro-2-butynyl, 4,4,4-trichloro-2-butynyl, 3-fluoro-1-methyl-2-propynyl, 3-chloro-1-methyl-2-propynyl, 5-fluoro-4-pentynyl, 5-chloro-4-pentynyl, 5,5,5-trifluoro-3-pentynyl, 5,5,5-trichloro-3-pentynyl, 4-fluoro-2-methyl-3-butynyl, 4-chloro-2-methyl-3-butynyl, 6-fluoro-5-hexynyl, 6-chloro-5-hexynyl, 6,6,6-trifluoro-4-hexynyl, 6,6,6-trichloro-4-hexynyl, 5-fluoro-3-methyl-4-pentynyl and 5-chloro-3-methyl-4-pentynyl.

In the present invention, C 3 -C 6 cycloalkyl C 1 -C 6 alkyl group indicates a (C 3 -C 6 cycloalkyl)-(C 1 -C 6 alkyl) group wherein the cycloalkyl and alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as cyclopropylmethyl, 2-cyclopropylethyl, 3-cyclopropylpropyl, 4-cyclopropylbutyl, 5-cyclopropylpentyl, 6-cyclopropylhexyl, cyclobutylmethyl, cyclopentylmethyl and cyclohexylmethyl.

In the present invention, C 3 -C 6 halocycloalkyl C 1 -C 6 alkyl group indicates a (C 3 -C 6 halocycloalkyl)-(C 1 -C 6 alkyl) group wherein the halocycloalkyl and alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 1-fluorocyclopropylmethyl, 2-fluorocyclopropylmethyl, 2,2-difluorocyclopropylmethyl, 2-chlorocyclopropylmethyl, 2,2-dichlorocyclopropylmethyl, 2,2-dibromocyclopropylmethyl, 2,2-diiodorocyclopropylmethyl, 2-(2,2-difluorocyclopropyl)ethyl, 2-(2,2-dichlorocyclopropyl)ethyl, 3-(2,2-difluorocyclopropyl)propyl, 4-(2,2-difluorocyclopropyl)butyl, 5-(2,2-dichlorocyclopropyl)pentyl, 5-(2,2-difluorocyclopropyl)pentyl, 6-(2,2-difluorocyclopropyl)hexyl, 2,2-difluorocyclobutylmethyl, 2,2-dichlorocyclobutylmethyl, 3,3-difluorocyclopentylmethyl, 3,3-dichlorocyclopentylmethyl, 4,4-difluorocyclohexylmethyl and 4,4-dichlorocyclohexylmethyl.

In the present invention, C 1 -C 6 alkoxy group indicates a (C 1 -C 6 alkyl)-O— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, n-pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1-ethylpropoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy and n-hexyloxy.

In the present invention, C 1 -C 6 haloalkoxy group indicates a (C 1 -C 6 haloalkyl)-O— group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as difluoromethoxy, trifluoromethoxy, trichloromethoxy, tribromomethoxy, 2,2,2-trifluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy, 3,3,3-trifluoropropoxy, heptafluoro-2-propoxy, tri(trifluoromethyl)methoxy, 3,3,3-trichloropropoxy and heptafluoropropoxy.

In the present invention, C 3 -C 6 cycloalkoxy group indicates a (C 3 -C 6 cycloalkyl)-O— group wherein the cycloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as cyclopropoxy, cyclobutoxy, cyclopentyloxy and cyclohexyloxy.

In the present invention, C 3 -C 6 halocycloalkoxy group indicates a (C 3 -C 6 halocycloalkyl)-O— group wherein the halocycloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2,2-difluorocyclopropoxy, 2,2-dichlorocyclopropoxy, 3,3-difluorocyclobutoxy, 3,3-dichlorocyclobutoxy, 3-fluorocyclopentyloxy, 3,3-difluorocyclopentyloxy, nonafluorocyclopentyloxy, 3,3-dichlorocyclopentyloxy, 4,4-difluorocyclohexyloxy, and 4,4-dichlorocyclohexyloxy.

In the present invention, C 1 -C 6 alkoxy C 1 -C 6 alkoxy group indicates a (C 1 -C 6 alkoxy)-(C 1 -C 6 alkoxy)- group wherein the alkoxy has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2-methoxyethoxy, 3-methoxypropoxy, 2-ethoxyisopropoxy, 2-isopropoxybutoxy, 5-ethoxypentyloxy, 6-ethoxyhexyloxy, 2-(tert-butoxy)ethoxy, 2-methoxyisopentyloxy and 2-isopropoxyisobutoxy.

In the present invention, C 1 -C 6 haloalkoxy C 1 -C 6 alkoxy group indicates a (C 1 -C 6 haloalkoxy)-(C 1 -C 6 alkoxy)- group wherein the haloalkoxy and alkoxy has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2-difluoromethoxyethoxy, 2-trifluoromethoxyethoxy, 3-trifluoromethoxypropoxy and 2-(2,2,2-trifluoroethoxy)ethoxy.

In the present invention, C 1 -C 6 haloalkoxy C 1 -C 6 haloalkoxy group indicates a (C 1 -C 6 haloalkoxy)-(C 1 -C 6 haloalkoxy)- group wherein the haloalkoxy has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2-(difluoromethoxy)-1,1,2,2-tetrafluoroethoxy, 2-(trifluoromethoxy)-1,1,2,2-tetrafluoroethoxy, 1,1,2,3,3,3-hexafluoro-2-(hexafluoropropoxy)propoxy, and 2-(2,2,2-trifluoroethoxy)-1,1,2,2-tetrafluoroethoxy.

In the present invention, C 1 -C 6 alkylsulfinyloxy group indicates a (C 1 -C 6 alkyl)-SO—O— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methylsulfinyloxy, ethylsulfinyloxy, n-propylsulfinyloxy and isopropylsulfinyloxy.

In the present invention, C 1 -C 6 haloalkylsulfinyloxy group indicates a (C 1 -C 6 haloalkyl)-SO—O— group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as difluoromethylsulfinyloxy, trifluoromethylsulfinyloxy, 2,2,2-trifluoroethylsulfinyloxy, pentafluoroethylsulfinyloxy, heptafluoropropylsulfinyloxy, trichloromethylsulfinyloxy and heptafluoro-2-propylsulfinyloxy.

›Advantages of the Invention · 4 of 25

In the present invention, C 3 -C 6 cycloalkylsulfinyloxy group indicates a (C 3 -C 6 cycloalkyl)-SO—O— group wherein the cycloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as cyclopropylsulfinyloxy, cyclobutylsulfinyloxy, cyclopentylsulfinyloxy and cyclohexylsulfinyloxy.

In the present invention, C 3 -C 6 halocycloalkylsulfinyloxy group indicates a (C 3 -C 6 halocycloalkyl)-SO—O— group wherein the halocycloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2,2-difluorocyclopropylsulfinyloxy, 2,2-dichlorocyclopropylsulfinyloxy, 3,3-difluorocyclobutylsulfinyloxy, 3,3-difluorocyclopentylsulfinyloxy and 4,4-difluorocyclohexylsulfinyloxy.

In the present invention, C 1 -C 6 alkylsulfonyloxy group indicates a (C 1 -C 6 alkyl)-SO 2 —O— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methylsulfonyloxy, ethylsulfonyloxy, n-propylsulfonyloxy and isopropylsulfonyloxy.

In the present invention, C 1 -C 6 haloalkylsulfonyloxy group indicates a (C 1 -C 6 haloalkyl)-SO 2 —O— group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as difluoromethylsulfonyloxy, trifluoromethylsulfonyloxy, trichloromethylsulfonyloxy, 2,2,2-trifluoroethylsulfonyloxy, 2,2,2-trichloroethylsulfonyloxy, 3,3,3-trifluoropropylsulfonyloxy, heptafluoro-2-propylsulfonyloxy and perfluorobutylsulfonyloxy.

In the present invention, C 3 -C 6 cycloalkylsulfonyloxy group indicates a (C 3 -C 6 cycloalkyl)-SO 2 —O— group wherein the cycloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as cyclopropylsulfonyloxy, cyclobutylsulfonyloxy, cyclopentylsulfonyloxy and cyclohexylsulfonyloxy.

In the present invention, C 3 -C 6 halocycloalkylsulfonyloxy group indicates a (C 3 -C 6 halocycloalkyl)-SO 2 —O— group wherein the halocycloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2,2-difluorocyclopropylsulfonyloxy, 2,2-dichlorocyclopropylsulfonyloxy, 3,3-difluorocyclobutylsulfonyloxy, 3,3-cyclopentylsulfonyloxy and 4,4-difluorocyclohexylsulfonyloxy.

In the present invention, C 1 -C 6 alkylthio group indicates a (C 1 -C 6 alkyl)-S— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio, tert-butylthio and neo-pentylthio.

In the present invention, C 1 -C 6 haloalkylthio group indicates a (C 1 -C 6 haloalkyl)-S— group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as fluoromethylthio, difluoromethylthio, trifluoromethylthio, trichloromethylthio, 2,2,2-trifluoroethylthio, pentafluoroethylthio, 2,2,2-trichloroethylthio, 3,3,3-trifluoropropylthio, heptafluoropropylthio, 1,1,1,3,3,3-hexafluoropropane-2-yl-thio, heptafluoropropane-2-yl-thio, 4,4,4-trifluorobutylthio and 2,2,2-trichloroethylthio.

In the present invention, C 2 -C 6 alkenylthio group indicates a (C 2 -C 6 alkenyl)-S— group wherein the alkenyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as vinylthio, 1-propenylthio, isopropenylthio, 2-propenylthio, 2-butenylthio, 3-butenylthio, 2-pentenylthio, 3-pentenylthio, 4-pentenylthio, 2-methyl-2-butenylthio, 2,4-pentadienylthio, 2-hexenylthio, 3-hexenylthio, 4-hexenylthio, 5-hexenylthio and 2,4-hexadienylthio.

In the present invention, C 2 -C 6 haloalkenylthio group indicates a (C 2 -C 6 haloalkenyl)-S— group wherein the haloalkenyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2,2-difluorovinylthio, 2,2-dichlorovinylthio, 3,3-difluoro-2-propenylthio, 2,3,3-trifluoro-2-propenylthio, 3-chloro-2-propenylthio, 3,3-dichloro-2-propenylthio, 3-bromo-2-propenylthio, 4,4-difluoro-3-butenylthio, 4,4-difluoro-3-butene-2-ylthio, 3,4,4-trifluoro-3-butenylthio, 4,4,4-trifluoro-3-chloro-2-butenylthio, 4,4-dichloro-3-butenylthio, 4,5,5-trifluoro-4-pentenylthio, 5,5,5-trifluoro-3-pentenylthio, 4,4,4-trifluoro-3-trifluoromethyl-2-butenylthio, 6,6-difluoro-5-hexenylthio, 5,6,6-trifluoro-5-hexenylthio and 6,6-dichloro-5-hexenylthio.

In the present invention, C 3 -C 6 cycloalkylthio group indicates a (C 3 -C 6 cycloalkyl)-S— group wherein the cycloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as cyclopropylthio, cyclobutylthio, cyclopentylthio and cyclohexylthio.

In the present invention, C 3 -C 6 halocycloalkylthio group indicates a (C 3 -C 6 halocycloalkyl)-S— group wherein the halocycloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2,2-difluorocyclopropylthio, 2,2-dichlorocyclopropylthio, 3,3-difluorocyclobutylthio, 3,3-difluorocyclopentylthio and 4,4-difluorocyclohexylthio.

In the present invention, C 3 -C 6 cycloalkyl C 1 -C 6 alkylthio group indicates a (C 3 -C 6 cycloalkyl)-(C 1 -C 6 alkyl)-S— group wherein the cycloalkyl and alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as cyclopropylmethylthio, 2-cyclopropylethylthio, 3-cyclopropylpropylthio, 4-cyclopropylbutylthio, 5-cyclopropylpentylthio, cyclobutylmethylthio, cyclopentylmethylthio and cyclohexylmethylthio.

In the present invention, C 3 -C 6 halocycloalkyl C 1 -C 6 alkylthio group indicates a (C 3 -C 6 halocycloalkyl)-(C 1 -C 6 alkyl)-S— group wherein the halocycloalkyl and alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2,2-difluorocyclopropylmethylthio, 2,2-dichlorocyclopropylmethylthio, 2-(2,2-difluorocyclopropyl)ethylthio, 2-(2,2-dichlorocyclopropyl)ethylthio, 2,2-difluorocyclobutylmethylthio and 4,4-difluorocyclohexylmethylthio.

›Advantages of the Invention · 5 of 25

In the present invention, tri(C 1 -C 6 alkyl)silyl-C 1 -C 6 alkylthio group indicates a (C 1 -C 6 alkyl) 3 -Si—(C 1 -C 6 alkyl)-S— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as trimethylsilylmethylthio, triethylsilylmethylthio, trimethylsilylethylthio, tertbutyldimethylsilylmethylthio, and trimethylsilylpropylthio.

In the present invention, C 1 -C 6 alkylsulfinyl group indicates a (C 1 -C 6 alkyl)-SO— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methylsulfinyl, ethylsulfinyl, n-propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl, isobutylsulfinyl, sec-butylsulfinyl and tert-butylsulfinyl.

In the present invention, C 1 -C 6 haloalkylsulfinyl group indicates a (C 1 -C 6 haloalkyl)-SO— group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as difluoromethylsulfinyl, trifluoromethylsulfinyl, 2,2,2-trifluoroethylsulfinyl, 2,2,2-trichloroethylsulfinyl, pentafluoroethylsulfinyl, heptafluoropropylsulfinyl, trichloromethylsulfinyl and heptafluoro-2-propylsulfinyl.

In the present invention, C 3 -C 6 cycloalkylsulfinyl group indicates a (C 3 -C 6 cycloalkyl)-SO— group wherein the cycloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as cyclopropylsulfinyl, cyclobutylsulfinyl, cyclopentylsulfinyl and cyclohexylsulfinyl.

In the present invention, C 3 -C 6 halocycloalkylsulfinyl group indicates a (C 3 -C 6 halocycloalkyl)-SO— group wherein the halocycloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2,2-difluorocyclopropylsulfinyl, 2,2-dichlorocyclopropylsulfinyl, 3,3-difluorocyclobutylsulfinyl, 3,3-difluorocyclopentylsulfinyl and 4,4-difluorocyclohexylsulfinyl.

In the present invention, C 1 -C 6 alkylsulfonyl group indicates a (C 1 -C 6 alkyl)-SO 2 — group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methylsulfonyl, ethylsulfonyl, n-propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl and tert-butylsulfonyl.

In the present invention, C 1 -C 6 haloalkylsulfonyl group indicates a (C 1 -C 6 haloalkyl)-SO 2 — group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as difluoromethylsulfonyl, trifluoromethylsulfonyl, trichloromethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, 3,3,3-trifluoropropylsulfonyl and heptafluoro-2-propylsulfonyl.

In the present invention, C 3 -C 6 cycloalkylsulfonyl group indicates a (C 3 -C 6 cycloalkyl)-SO 2 — group wherein the cycloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as cyclopropylsulfonyl, cyclobutylsulfonyl, cyclopentylsulfonyl and cyclohexylsulfonyl.

In the present invention, C 3 -C 6 halocycloalkylsulfonyl group indicates a (C 3 -C 6 halocycloalkyl)-SO 2 — group wherein the halocycloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2,2-difluorocyclopropylsulfonyl, 2,2-dichlorocyclopropylsulfonyl, 3,3-difluorocyclobutylsulfonyl, 3,3-difluorocyclopentylsulfonyl and 4,4-difluorocyclohexylsulfonyl.

In the present invention, C 1 -C 6 alkylthio C 1 -C 6 alkyl group indicates a (C 1 -C 6 alkyl)-S—(C 1 -C 6 alkyl) group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methylthiomethyl, 2-(methylthio)ethyl, 3-(methylthio)propyl, 4-(methylthio)butyl, ethylthiomethyl, propylthiomethyl, butylthiomethyl and pentylthiomethyl.

In the present invention, C 1 -C 6 haloalkylthio C 1 -C 6 alkyl group indicates a (C 2 -C 6 haloalkyl)-S—(C 1 -C 6 alkyl) group wherein the alkyl and haloalkyl have the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as trifluoromethylthiomethyl, difluoromethylthiomethyl, 2,2,2-trifluoroethylthiomethyl, 2,2,2-trichloroethylthiomethyl, 2-(trifluoromethylthio)ethyl, 2-(difluoromethylthio)ethyl, 2-(2,2,2-trifluoroethylthio)ethyl, 3-(trifluoromethylthio)propyl, 3-(difluoromethylthio)propyl and 3-(2,2,2-trifluoroethylthio)propyl.

In the present invention, C 1 -C 6 alkylcarbonyl group indicates a (C 1 -C 6 alkyl)-C(═O)— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as acetyl, propionyl, isopropionyl and pivaloyl.

In the present invention, C 1 -C 6 haloalkylcarbonyl group indicates a (C 1 -C 6 haloalkyl)-C(═O)— group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as fluoroacetyl, difluoroacetyl, trifluoroacetyl, chloroacetyl, trichloroacetyl, tribromoacetyl, 3,3,3-trifluoropropionyl, 3,3-difluoropropionyl and 4,4,4-trifluorobutyryl.

In the present invention, C 1 -C 6 alkylcarbonyloxy group indicates a (C 1 -C 6 alkyl)-C(═O)—O— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as acetoxy and propionyloxy.

In the present invention, C 1 -C 6 haloalkylcarbonyloxy group indicates a (C 1 -C 6 haloalkyl)-C(═O)—O— group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as fluoroacetoxy, difluoroacetoxy, trifluoroacetoxy, chloroacetoxy, trichloroacetoxy, tribromoacetoxy, 3,3,3-trifluoropropionyloxy, 3,3-difluoropropionyloxy and 4,4,4-trifluorobutyryloxy.

In the present invention, C 1 -C 6 alkoxycarbonyl group indicates a (C 1 -C 6 alkoxy)-C(═O)— group wherein the alkoxy has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl and tert-butoxycarbonyl.

›Advantages of the Invention · 6 of 25

In the present invention, C 1 -C 6 haloalkoxycarbonyl group indicates a (C 1 -C 6 haloalkoxy)-C(═O)— group wherein the haloalkoxy has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2-fluoroethoxycarbonyl, 2,2,2-trifluoroethoxycarbonyl, 2,2,2-trichloroethoxycarbonyl, pentafluoroethoxycarbonyl, 3,3,3-trifluoropropoxycarbonyl and heptafluoro-2-propoxycarbonyl.

In the present invention, C 1 -C 6 alkylamino group indicates a (C 1 -C 6 alkyl)-NH— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methylamino, ethylamino and n-propylamino.

In the present invention, C 1 -C 6 haloalkylamino group indicates a (C 1 -C 6 haloalkyl)-NH— group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2-fluoroethylamino, 2,2-difluoroethylamino, 2,2,2-trifluoroethylamino, 2,2,2-trichloroethylamino, pentafluoroethylamino, 3,3,3-trifluoropropylamino and 1,1,1,3,3,3-hexafluoro-2-propylamino.

In the present invention, C 1 -C 6 alkylcarbonylamino group indicates a (C 1 -C 6 alkyl)-C(═O)—NH— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as acetylamino, propionylamino, butyrylamino, isobutyrylamino and tert-butylcarbonylamino.

In the present invention, C 1 -C 6 haloalkylcarbonylamino group indicates a (C 1 -C 6 haloalkyl)-C(═O)—NH— group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as fluoroacetylamino, difluoroacetylamino, trifluoroacetylamino, chloroacetylamino, trichloroacetylamino, tribromoacetylamino, 3,3,3-trifluoropropionylamino, pentafluoropropionylamino, 3,3-difluoropropionylamino and 3,3,3-trifluoro-2-methyl-2-trifluoromethylpropionylamino.

In the present invention, C 1 -C 6 alkoxycarbonylamino group indicates a (C 1 -C 6 alkoxy)-C(═O)—NH— group wherein the alkoxy has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methoxycarbonylamino, ethoxycarbonylamino, npropoxycarbonylamino and isopropoxycarbonylamino.

In the present invention, C 1 -C 6 haloalkoxycarbonylamino group indicates a (C 1 -C 6 haloalkoxy)-C(═O)—NH— group wherein the haloalkoxy has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2-fluoroethoxycarbonylamino, 2,2,2-trifluoroethoxycarbonylamino, 2,2,2-trichloroethoxycarbonylamino, pentafluoroethoxycarbonylamino, 3,3,3-trifluoropropoxycarbonylamino, and heptafluoro-2-propoxycarbonylamino.

In the present invention, C 1 -C 6 alkylaminocarbonylamino group indicates a (C 1 -C 6 alkyl)-NH—C(═O)—NH— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methylaminocarbonylamino, ethylaminocarbonylamino, n-propylaminocarbonylamino, isopropylaminocarbonylamino, tert-butylaminocarbonylamino, and tertpentylaminocarbonylamino.

In the present invention, C 1 -C 6 haloalkylaminocarbonylamino group indicates a (C 1 -C 6 haloalkyl)-NH—C(═O)—NH— group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2-fluoroethylaminocarbonylamino, 2,2,2-trifluoroethylaminocarbonylamino, 2,2,2-trichloroethylaminocarbonylamino, pentafluoroethylaminocarbonylamino and 1,1,1,3,3,3-hexafluoro-2-propylaminocarbonylamino.

In the present invention, C 1 -C 6 alkylsulfonylamino group indicates a (C 1 -C 6 alkyl)-SO 2 —NH— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methylsulfonylamino, ethylsulfonylamino, n-propylsulfonylamino, isopropylsulfonylamino and tertbutylsulfonylamino.

In the present invention, C 1 -C 6 haloalkylsulfonylamino group indicates a (C 1 -C 6 haloalkyl)-SO 2 —NH— group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as fluoromethylsulfonylamino, difluoromethylsulfonylamino, tri fluoromethylsulfonylamino, chloromethylsulfonylamino, trichloromethylsulfonylamino, 2,2,2-trifluoroethylsulfonylamino, 2,2-difluoroethylsulfonylamino and 3,3,3-trifluoropropylsulfonylamino.

In the present invention, C 1 -C 6 alkylaminocarbonylthio group indicates a (C 1 -C 6 alkyl)-NH—C(O═)—S— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methylaminocarbonylthio, ethylaminocarbonylthio, propylaminocarbonylthio, isopropylaminocarbonylthio and dimethylaminocarbonylthio.

In the present invention, C 1 -C 6 haloalkylaminocarbonylthio group indicates a (C 1 -C 6 haloalkyl)-NH—C(O═)—S— group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2-fluoroethylaminocarbonylthio, 2,2,2-trifluoroethylaminocarbonylthio, 2,2,2-trichloroethylaminocarbonylthio, pentafluoroethylaminocarbonylthio and 1,1,1,3,3,3-hexafluoro-2-propylaminocarbonylthio.

In the present invention, C 1 -C 6 alkylaminocarbonyl group indicates a (C 1 -C 6 alkyl)-NH—C(═O)— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as methylaminocarbonyl, ethylaminocarbonyl, propylaminocarbonyl and isopropylaminocarbonyl.

In the present invention, C 1 -C 6 haloalkylaminocarbonyl group indicates a (C 1 -C 6 haloalkyl)-NH—C(═O)— group wherein the haloalkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as 2-fluoroethylaminocarbonyl, 2,2,2-trifluoroethylaminocarbonyl, 2,2,2-trichloroethylaminocarbonyl, pentafluoroethylaminocarbonyl and 1,1,1,3,3,3-hexafluoro-2-propylaminocarbonyl.

›Advantages of the Invention · 7 of 25

In the present invention, tri(C 1 -C 6 alkyl)silyl group indicates a (C 1 -C 6 alkyl) 3 -Si— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as trimethylsilyl, triethylsilyl, triisopropylsilyl, dimethylisopropylsilyl and tert-butyldimethylsilyl.

In the present invention, phenyl C 1 -C 6 alkyl group indicates a phenyl-(C 1 -C 6 alkyl)- group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as benzyl, 1-phenylethyl, 2-phenylethyl, 1-phenylpropyl, 2-phenylbutyl and 1-phenylpentyl.

In the present invention, phenyl C 1 -C 6 alkoxy group indicates a phenyl-(C 1 -C 6 alkoxy)- group wherein the alkoxy has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as phenylmethoxy, 1-phenylethoxy, 2-phenylethoxy, 1-phenylpropoxy, 2-phenylbutoxy and 1-phenylpentoxy.

In the present invention, phenyl C 1 -C 6 alkylthio group indicates a phenyl-(C 1 -C 6 alkyl)-S— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as phenylmethylthio, 1-phenylethylthio, 2-phenylethylthio, 1-phenylpropylthio, 2-phenylbutylthio and 1-phenylpentylthio.

In the present invention, phenyl C 1 -C 6 alkylsulfinyl group indicates a phenyl-(C 1 -C 6 alkyl)-SO— group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as phenylmethylsulfinyl, 1-phenylethylsulfinyl, 2-phenylethylsulfinyl, 1-phenylpropylsulfinyl, 2-phenylbutylsulfinyl and 1-phenylpentylsulfinyl.

In the present invention, phenyl C 1 -C 6 alkylsulfonyl group indicates a phenyl-(C 1 -C 6 alkyl)-SO 2 — group wherein the alkyl has the above-mentioned meaning, unless otherwise specified. There can be mentioned, for example, groups such as phenylmethylsulfonyl, 1-phenylethylsulfonyl, 2-phenylethylsulfonyl, 1-phenylpropylsulfonyl, 2-phenylbutylsulfonyl and 1-phenylpentylsulfonyl.

In the present invention, agriculturally acceptable salt refers, when the present compound represented by the general formula [I] and general formula [I′] contains, in its structure, hydroxyl group, carboxyl group, amino group, etc., to a salt of the present compound with a metal or an organic base, or with a mineral acid or an organic acid. As the metal, there can be mentioned an alkali metal such as sodium, potassium or the like, or an alkaline earth metal such as magnesium, calcium or the like. As the organic base, there can be mentioned triethylamine, diisopropylamine, etc. As the mineral acid, there can be mentioned hydrochloric acid, hydrobromic acid, sulfuric acid, etc. As the organic acid, there can be mentioned formic acid, acetic acid, methanesulfonic acid, 4-toluenesulfonic acid, trifluoromethanesulfonic acid, etc.

Next, representative examples of the compounds included in the alkyl phenyl sulfide derivative represented by the general formula [I] are shown in Table 1 to Table 41, and those represented by the general formula [I′] are shown in Table 42. However, the compounds included in the present derivative are not restricted thereto. Incidentally, the compound Nos. shown in Tables are used in later description.

Incidentally, the compounds included in the alkyl phenyl sulfide derivative of the present invention contain, in some cases, geometrical isomers of E form and Z form depending upon the kinds of substituent groups. The present invention includes the E forms, the Z forms and mixtures containing the E form and the Z form at any ratio. Also, the compounds included in the present invention contain, in some cases, optical isomers having 1 to 2 asymmetric carbon atoms or asymmetric sulfur atoms. The present invention includes all optical isomers, racemic modifications, and diastereomers.

The following expressions used in the Tables of the present specification indicate the following groups.

Me: methyl

Et: ethyl

tBu: tert-butyl

CF 3 : trifluoromethyl

Ph(4-CF 3 ): 4-trifluoromethylphenyl

Ph(2,5-(CF 3 )): 2,5-bis(trifluoromethyl)phenyl

Ph(3-F,4-CF 3 ): 3-fluoro-4-trifluoromethylphenyl

Ac: acetyl

nPropyl: n-propyl

Isopropyl: isopropyl

nButyl: n-butyl

nPentyl: n-pentyl

nHexyl: n-hexyl

nHeptyl: n-heptyl

nOctyl: n-octyl

nNonyl: n-nonyl

nDecyl: n-decyl

The present compound represented by the general formula [I] and general formula [I′] can be produced by the methods shown below, but the production methods of the present compound are not restricted thereto. Incidentally, for example, “the compound represented by the general formula [I-1]”, “the compound represented by formula [I-1]” and “the compound [I-1]”, mentioned below have the same meaning.

Of the present compounds, a compound represented by the general formula [I-1] can be produced, for example, by the following method.

(In the above formula, L 1 is halogen atom, C 1 -C 6 alkylsulfonyloxy group, trifluoromethanesulfonyloxy group, nonafluorobutylsulfonyloxy group, phenylsulfonyloxy group, 4-toluenesulfonyloxy group or SO 2 M; M is alkali metal or alkaline earth metal, and the alkali metal is preferably sodium or potassium; and R 1 , R 2 , R 3 and R 4 each have the same meaning as given above.)

Thus, the compound represented by the general formula [I-1] can be produced by reacting a compound represented by the general formula [II] with a compound represented by the general formula [III] in an appropriate solvent in the presence or absence of an appropriate base in the presence or absence of an appropriate radical initiator.

The amount of the compound [III] used in the present reaction is selected appropriately, and ordinarily in a range of 1.0 to 5.0 mols and is preferably 1.0 to 2.0 mols relative to 1 mol of the compound [II].

As the solvent usable in the present reaction, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; a halogenated hydrocarbon such as dichloromethane, chloroform, 1,2-dichloroethane or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; an alcohol such as methanol, ethanol, 2-propanol or the like; a nitrile such as acetonitrile, propionitrile or the like; an ester such as ethyl acetate, ethyl propionate or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; a pyridine such as pyridine, picoline or the like; water; and a mixture thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.3 to 5 liters relative to 1 mol of the compound [II].

›Advantages of the Invention · 8 of 25

As the base usable in the present reaction, there can be mentioned, for example, an inorganic base such as alkali metal hydroxide (e.g. sodium hydroxide or potassium hydroxide), alkaline earth metal hydroxide (e.g. calcium hydroxide or magnesium hydroxide), alkali metal carbonate (e.g. sodium carbonate or potassium carbonate), alkali metal bicarbonate (e.g. sodium hydrogencarbonate or potassium hydrogencarbonate) or the like; a metal hydride (e.g. sodium hydride or potassium hydride); a metal alcoholate (e.g. sodium methoxide, sodium ethoxide or potassium tert-butoxide); and an organic base (e.g. triethylamine, N,N-dimethylaniline, pyridine, 4-N,N-dimethylaminopyridine or 1, 8-diazabicyclo[5.4.0]-7-undecene). Incidentally, the use amount of the base is appropriately selected in a range of 0 to 5.0 mols and is preferably 0 to 1.2 mols relative to 1 mol of the compound [II].

As the radical initiator usable in the present reaction, there can be mentioned, for example, sulfurous acid, sodium sulfite, potassium sulfite, sodium hydrogensulfite, potassium hydrogensulfite, and a sulfurous acid adduct such as Rongalit (trade name, sodium formaldehyde sulfoxylate). A base and a radical initiator may be used in combination. The use amount of the radical initiator is appropriately selected in a range of 0 to 5.0 mols and is preferably 0 to 1.2 mols relative to 1 mol of the compound [II].

The temperature of the present reaction is selected freely, and ordinarily in a temperature range from −30° C. to the reflux temperature of the reaction system and is preferably 0° C. to 150° C.

The time of the present reaction differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water, extraction with organic solvent, concentration and the like, whereby a compound [I-1] can be isolated. The isolated compound [I-1] may be as necessary purified by column chromatography, recrystallization, etc.

[Production Method 2>

Of the present compounds, the compound represented by the general formula [I-1] can also be produced, for example, by the following method using a compound represented by the general formula [IV].

(In the above formula, L 2 is halogen atom or SO 2 M; and R 1 , R 2 , R 3 , R 4 and M each have the same meaning as given above.)

The compound represented by the general formula [I-1] can be produced by reacting a compound [IV] with a compound [V] in an appropriate solvent in the presence of an appropriate radical initiator.

The amount of the compound [V] used in the present reaction is selected appropriately in a range of 1.0 to 5.0 mols and is preferably 2.0 to 3.0 mols relative to 1 mol of the compound [IV].

As the solvent usable in the present reaction, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; a nitrite such as acetonitrile, propionitrile or the like; an ester such as ethyl acetate, ethyl propionate or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; a pyridine such as pyridine, picoline or the like; water; and a mixture thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.3 to 5 liters relative to 1 mol of the compound [IV].

As the radical initiator usable in the present reaction, there can be mentioned, for example, sulfurous acid, sodium sulfite, potassium sulfite, sodium hydrogensulfite, potassium hydrogensulfite, and a sulfurous acid adduct such as Rongalit (trade name, sodium formaldehyde sulfoxylate). The use amount of the radical initiator is appropriately selected in a range of 0.01 to 5.0 mols and is preferably 0.05 to 1.2 mols relative to 1 mol of the compound [IV].

The temperature of the present reaction is selected freely, and ordinarily in a temperature range from −30° C. to the reflux temperature of the reaction system and is preferably 0° C. to 150° C.

The time of the present reaction differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

[Production Method 3>

Of the present compounds, the compound represented by the general formula [I-1′] can also be produced, for example, by the following method using a compound represented by the general formula [VI].

(In the above formula, R 10 is electron withdrawing group such as trifluoromethyl group, nitro group, cyano group or the like; R 1 , R 3 and R 4 each have the same meaning as given above; L 3 is halogen atom, C 1 -C 6 alkylsulfonyloxy group, trifluoromethanesulfonyloxy group, nonafluorobutylsulfonyloxy group, phenylsulfonyloxy group, 4-toluenesulfonyloxy group, C 1 -C 6 alkylsulfonyl group or phenylsulfonyl group.)

The compound represented by the general formula [I-1′] can be produced by reacting a compound [VI] with a compound [VII] in an appropriate solvent in the presence of any of an appropriate base, copper and copper oxide (I), or in the presence of an appropriate base and copper, or in the presence of an appropriate base and copper oxide (I).

The amount of the compound [VII] used in the present reaction is selected appropriately in a range of 1.0 to 5.0 mols and is preferably 1.0 to 1.2 mols relative to 1 mol of the compound [VI].

As the solvent usable in the present reaction, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; an alcohol such as methanol, ethanol, 2-propanol, methyl cellosolve or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; a pyridine such as pyridine, picoline or the like; water; and a mixture thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.3 to 10 liters relative to 1 mol of the compound [VI].

›Advantages of the Invention · 9 of 25

The amounts of the base, copper and copper oxide (I) used in the present reaction are each selected appropriately in a range of 1.0 to 5.0 mols and are preferably 1.0 to 1.2 mols relative to 1 mol of the compound [VI].

The temperature of the present reaction is selected freely, and ordinarily in a temperature range from −70° C. to the reflux temperature of the reaction system and is preferably 0° C. to 150° C.

The time of the present reaction differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water, extraction with organic solvent, concentration and the like, whereby a compound [I-1] can be isolated. The isolated compound [I-1′] may be as necessary purified by column chromatography, recrystallization, etc.

[Production Method 4]

Of the present compounds, a compound represented by the general formula [I-1] can also be produced, for example, by a method represented by the following reaction formula using a compound represented by the general formula [VIII].

(In the above formula, R 1 , R 2 , R 3 , R 4 and M each have the same meaning as given above.)

The compound represented by the general formula [I-1] can be produced by converting a compound [VIII] to a diazonium salt in an appropriate solvent based on the method described in Organic Syntheses Coll., Vol. 3, p. 185 (1955) (for example, a method of using a mineral acid (e.g. hydrochloric acid or sulfuric acid) and a nitrous acid salt or an alkyl nitrite) and then reacting the diazonium salt with a mercaptan salt represented by a compound [IX] or a disulfide represented by a compound [X].

The amount of the compound [IX] or the compound [X] used in the present reaction is appropriately selected in a range of 0.3 to 5.0 mols and is preferably 0.5 to 2.0 mols relative to 1 mol of the compound [VIII].

The temperature of the present reaction is selected freely, and ordinarily in a temperature range from −30° C. to the reflux temperature of the reaction system and is preferably −10° C. to 100° C.

The time of the present reaction differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

(In the above formula, Y 1 is hydrogen atom or a halogen atom; and L 3 , R 1 , R 2 , R 3 and R 4 each have the same meaning as given above.)

The compound represented by the general formula [I-1] can be produced by reacting a compound [XI] with a metal or an organometallic compound in an appropriate solvent and then reacting the reaction product with a compound [XII] or a compound [X].

As the metal usable in the present reaction, there can be mentioned an alkali metal such as lithium, sodium, potassium or the like; an alkaline earth metal such as magnesium or the like; and so forth.

As the organometallic compound usable in the present reaction, there can be mentioned an alkyl lithium such as n-butyl lithium or the like; and so forth.

The amount of the metal or organometallic compound used in the present reaction is appropriately selected in a range of 1.0 to 3.0 mols and is preferably 1.0 to 1.1 mols relative to 1 mol of the compound [XI].

The amount of the compound [XII] or compound [X] used in the present reaction is appropriately selected in a range of 0.3 to 5.0 mols and is preferably 0.5 to 2.0 mols relative to 1 mol of the compound [XI].

›Advantages of the Invention · 10 of 25

The temperature of the present reaction is selected freely, and ordinarily in a temperature range from −100° C. to the reflux temperature of the reaction system and is preferably −78° C. to 100° C.

The time of the present reaction differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [I-1] can be isolated. The isolated compound [I-1] may be as necessary purified by column chromatography, recrystallization, etc.

A present compound represented by the general formula [I] can be produced by a method of the following reaction formula.

(In the above formula, L 1 , R 1 , R 2 , R 3 , R 4 and n each have the same meaning as given above.)

The present compound can be produced by reacting a compound [I′-1] with a compound [XIII] in an appropriate solvent in the presence of an appropriate base.

The amount of the compound [XIII] used in the present reaction is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.0 to 2.0 mols relative to 1 mol of the compound [I′-1].

As the solvent usable in the present reaction, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; a halogenated hydrocarbon such as dichloromethane, chloroform, 1,2-dichloroethane or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; an alcohol such as methanol, ethanol, 2-propanol or the like; a nitrile such as acetonitrile, propionitrile or the like; an ester such as ethyl acetate, ethyl propionate or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; a pyridine such as pyridine, picoline or the like; water; and a mixture thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.1 to 15 liters relative to 1 mol of the compound [I′-1].

As the base usable in the present reaction, there can be mentioned, for example, an inorganic base such as alkali metal hydroxide (e.g. sodium hydroxide or potassium hydroxide), alkaline earth metal hydroxide (e.g. calcium hydroxide or magnesium hydroxide), alkali metal carbonate (e.g. sodium carbonate or potassium carbonate), alkali metal bicarbonate (e.g. sodium hydrogencarbonate or potassium hydrogencarbonate) or the like; a metal hydride (e.g. sodium hydride or potassium hydride); a metal alcoholate (e.g. sodium methoxide, sodium ethoxide or potassium tert-butoxide); and an organic base (e.g. triethylamine, N,N-dimethylaniline, pyridine, 4-N,N-dimethylaminopyridine or 1,8-diazabicyclo[5.4.0]-7-undecene). Incidentally, the use amount of the base is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.0 to 1.5 mols relative to 1 mol of the compound [I′-1].

The temperature of the present reaction is selected freely, and ordinarily in a temperature range from −30° C. to the reflux temperature of the reaction system and is preferably 0° C. to 150° C.

The time of the present reaction differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [I] can be isolated. The isolated compound [I] may be as necessary purified by column chromatography, recrystallization, etc.

A present compound represented by the general formula [I] can also be produced by a method of the following reaction formula.

(In the above formula, R 1 , R 2 , R 3 , R 4 and n each have the same meaning as given above.)

The present compound can be produced by reacting a compound [I′-1] with a compound [XIV] in an appropriate solvent in the presence of a tri-substituted phosphine and an azodicarboxylic acid derivative or in the presence of phosphorane.

The amount of the compound [XIV] used in the present reaction is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.0 to 2.0 mols relative to 1 mol of the compound [I′-1].

As the solvent usable in the present reaction, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; an alcohol such as methanol, ethanol, 2-propanol or the like; a halogenated hydrocarbon such as dichloromethane, chloroform, 1,2-dichloroethane or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; a ketone such as acetone, methyl ethyl ketone, cyclohexanone or the like; acetic acid; water; and a mixed solvent thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.3 to 30 liters relative to 1 mol of the compound [I′-1].

As the tri-substituted phosphine usable in the present reaction, there can be mentioned, for example, triphenylphosphine, tributylphosphine, and trimethylphosphine. Incidentally, the use amount of the tri-substituted phosphine is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.0 to 3.0 mols relative to 1 mol of the compound [I′-1].

As the azodicarboxylic acid derivative usable in the present reaction, there can be mentioned, for example, diethyl azodicarboxylate, diisopropyl azodicarboxylate, dimethoxyethyl azodicarboxylate, and N,N,N′,N′-tetramethylazodicarboxylic acid amide. Incidentally, the use amount of the azodicarboxylic acid derivative is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.0 to 2.0 mols relative to 1 mol of the compound [I′-1].

›Advantages of the Invention · 11 of 25

As the phosphorane usable in the present reaction, there can be mentioned, for example, cyanomethylenetrimethylphosphorane and cyanomethylenetributylphosphorane. Incidentally, the use amount of the phosphorane is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.0 to 2.0 mols relative to 1 mol of the compound [I′-1].

The temperature of the present reaction is selected freely, and ordinarily in a temperature range from −30° C. to the reflux temperature of the reaction system and is preferably 0° C. to 150° C.

The time of the present reaction differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [I] can be isolated. The isolated compound [I] may be as necessary purified by column chromatography, recrystallization, etc.

Of the present compounds represented by the general formula [I], a compound represented by the general formula [I-2] can be produced, for example, by a method represented by the following reaction formula using a compound represented by the general formula [I-1].

(In the above formula, R 1 , R 2 , R 3 and R 4 each have the same meaning as given above; and m is an integer of 1 or 2.)

The compound represented by the general formula [I-2] can be produced by reacting a compound [I-1] with an oxidizing agent in an appropriate solvent in the presence or absence of an appropriate catalyst.

As the oxidizing agent usable in the present reaction, there can be mentioned, for example, hydrogen peroxide, m-chloroperbenzoic acid, sodium periodate, OXONE (trade name of E.I. DuPont, a substance containing potassium hydrogenperoxosulfate), N-chlorosuccinimide, N-bromosuccinimide, tert-butyl hypochlorite, and sodium hypochlorite. Incidentally, the use amount of the oxidizing agent depends upon the oxidation number m of the sulfur atom of the compound represented by the general formula [I-2], but is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 0.5 to 2.5 mols relative to 1 mol of the compound [I-1].

As the catalyst usable in the present reaction, there can be mentioned, for example, sodium tungstate. Incidentally, the use amount of the catalyst is appropriately selected in a range of 0 to 1.0 mol and is preferably 0 to 0.1 mol relative to 1 mol of the compound [I-1].

As the solvent usable in the present reaction, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; an alcohol such as methanol, ethanol, 2-propanol or the like; a halogenated hydrocarbon such as dichloromethane, chloroform, 1,2-dichloroethane or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; a ketone such as acetone, methyl ethyl ketone, cyclohexanone or the like; acetic acid; water; and a mixed solvent thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.3 to 45 liters relative to 1 mol of the compound [I-1].

The time of the present reaction differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [I-2] can be isolated. The isolated compound [I-2] may be as necessary purified by column chromatography, recrystallization, etc.

A present compound represented by the general formula [I′] can be produced, for example, by the method shown by the following reaction formula using a compound represented by the general formula [XV-2].

(In the above formula, R 1′ , R 2′ , R 3′ and n each have the same meaning as give above.)

The compound represented by the general formula [I′] can be produced by reacting the compound [XV-2] with an acid and a nitrous acid derivative in a solvent and then, as necessary, reacting the reaction product with a metal salt.

As the acid usable in the present reaction, there can be mentioned a mineral acid such as sulfuric acid, nitric acid or the like, or an organic acid such as trifluoroacetic acid, trifluoromethanesulfonic acid or the like. Incidentally, the use amount of the acid is appropriately selected in a range of 1 to 20 mols and is preferably 1.0 to 5.0 mols relative to 1 mol of the compound [XV-2].

As the nitrous acid derivative usable in the present reaction, there can be mentioned a nitrous acid salt such as sodium nitrite, potassium nitrite or the like, or an alkyl nitrite such as n-butyl nitrite, isopentyl nitrite, tert-butyl nitrite or the like. Incidentally, the use amount of the nitrous acid derivative is appropriately selected in a range of 1.0 to 3.0 mols and is preferably 1.0 to 1.5 mols relative to 1 mol of the compound [XV-2].

As the metal salt as necessary usable in the present reaction, there can be mentioned copper sulfate, copper nitrate, copper oxide, etc. Incidentally, the use amount of the metal salt is appropriately selected in a range of 0 to 2.0 mols and is preferably 0 to 1.1 mols relative to 1 mol of the compound [XV-2].

As the solvent usable in the present reaction, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; a halogenated hydrocarbon such as dichloromethane, chloroform, dichloroethane or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; an alcohol such as methanol, ethanol, 2-propanol or the like; a nitrile such as acetonitrile, propionitrile or the like; an ester such as ethyl acetate, ethyl propionate or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; a pyridine such as pyridine, picoline or the like; water; and a mixed solvent thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.3 to 10 liters relative to 1 mol of the compound [XV-2].

›Advantages of the Invention · 12 of 25

The temperature of the present reaction is selected freely in a temperature range from −30° C. to the reflux temperature of the reaction system and is preferably 0° C. to 150° C.

The time of the present reaction differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [I′] can be isolated. The isolated compound [I′] may be as necessary purified by column chromatography, recrystallization, etc.

The present compound represented by the general formula [I′] can also be produced by the method shown by the following reaction formula.

(In the above formula, R 11 is boronic acid (—B(OH) 2 group) or pinacolateboran-2-yl group; R 1′ , R 2′ , R 3′ and n each have the same meaning as given above.)

The compound represented by the general formula [I′] can be produced by reacting a compound [XVI-1] with an oxidizing agent in a solvent.

As the oxidizing agent usable in the present reaction, there can be mentioned, for example, hydrogen peroxide and 4-methylmorpholine-N-oxide. Incidentally, the use amount of the oxidizing agent is appropriately selected in a range of 1.0 to 6.0 mols and is preferably 1.0 to 1.4 mols relative to 1 mol of the compound [XVI-1].

As the solvent usable in the present reaction, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; an alcohol such as methanol, ethanol, 2-propanol or the like; a halogenated hydrocarbon such as dichloromethane, chloroform, 1,2-dichloroethane or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; a ketone such as acetone, methyl ethyl ketone, cyclohexanone or the like; acetic acid; water; and a mixed solvent thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.3 to 15 liters relative to 1 mol of the compound [XVI-1].

The temperature of the present reaction is selected freely in a temperature range from −30° C. to the reflux temperature of the reaction system and is preferably −10° C. to 150° C.

The time of the present reaction differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [I′] can be isolated. The isolated compound [I′] may be as necessary purified by column chromatography, recrystallization, etc.

Of the present compounds represented by the general formula [I], the compound represented by the general formula [I-4] can be produced, for example, by the method shown by the following reaction formula, using a compound represented by the general formula [I-3].

(In the above formula, L 4 is a halogen atom, methanesulfonyloxy group, trifluoromethanesulfonyloxy group, 1,1,2,2,3,3,4,4,4-nonafluorobutylsulfonyloxy group, 4-toluenesulfonyloxy group or benzenesulfonyloxy group; R 12 is hydrogen atom, cyano group, C 1 -C 6 alkyl group, C 1 -C 6 haloalkyl group, C 3 -C 8 cycloalkyl C 1 -C 6 alkyl group, C 3 -C 8 halocycloalkyl C 1 -C 6 alkyl group, C 3 -C 8 cycloalkyl group or C 3 -C 8 halocycloalkyl group; p is an integer of 1-12; R 1 , R 2 , R 3 and n each have the same meaning as given above.)

The compound represented by the general formula [I-4] can be produced by reacting a compound [I-3] and sulfide in an appropriate solvent in the presence or absence of base.

As the sulfide usable in the present reaction, there can be mentioned, for example, hydrosulfide of alkali metal such as sodium hydrosulfide or potassium hydrosulfide; thiocyanate of alkali metal such as sodium thiocyanate or potassium thiocyanate; alkylmercaptane such as methyl mercaptane, ethyl mercaptane or tert-butyl mercaptane; haloalkylmercaptane such as 2,2,2-trifluoroethyl mercaptane; and cycloalkylalkylmercaptane such as cyclopropylmethyl mercaptane. Incidentally, the use amount of the sulfide is appropriately selected in a range of 1.0 to 20 mols and is preferably 1.0 to 10 mols relative to 1 mol of the compound [I-3].

As the base usable in the present reaction, there can be mentioned, for example, an inorganic base such as alkali metal hydroxide (e.g. sodium hydroxide or potassium hydroxide), alkaline earth metal hydroxide (e.g. calcium hydroxide or magnesium hydroxide), alkali metal carbonate (e.g. sodium carbonate or potassium carbonate), alkali metal bicarbonate (e.g. sodium hydrogencarbonate or potassium hydrogencarbonate) or the like; a metal hydride (e.g. sodium hydride or potassium hydride); a metal alcoholate (e.g. sodium methoxide, sodium ethoxide or potassium tert-butoxide); and an organic base (e.g. triethylamine, N,N-dimethylaniline, pyridine, 4-N,N-dimethylaminopyridine or 1,8-diazabicyclo[5.4.0]-7-undecene). Incidentally, the use amount of the base is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.0 to 2.0 mols relative to 1 mol of the compound [I-3].

As the solvent usable in the present reaction, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; an alcohol such as methanol, ethanol, 2-propanol or the like; a nitrile such as acetonitrile, propionitrile or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; a pyridine such as pyridine, picoline or the like; and a mixture thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.3 to 10 liters relative to 1 mol of the compound [I-3].

›Advantages of the Invention · 13 of 25

The temperature of the present reaction is selected freely in a temperature range from 0° C. to the reflux temperature of the reaction system and is preferably room temperature to 150° C.

The time of the present reaction differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

In conducting the present reaction, potassium iodide may be added, and the use amount of potassium iodide is 0 to 5.0 mol, preferably 0 to 1.0 mol relative to 1 mol of the compound [I-3].

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [I-4] can be isolated. The isolated compound [I-4] may be as necessary purified by column chromatography, recrystallization, etc.

Of the present compounds represented by the general formula [I], the compound represented by the general formula [I-6] can be produced by, for example, the method shown by the following reaction formula, using a compound represented by the general formula [I-5].

(In the above formula, R 1 , R 2 , R 3 , n and p each have the same meaning as given above.)

The compound represented by the general formula [I-6] can be produced by reacting a compound [I-5] and trifluoromethylating agent in an appropriate solvent in the presence of an appropriate catalyst.

As the trifluoromethylating agent usable in the present reaction, there can be mentioned, for example, trifluoromethyltrimethylsilane or triethyltrifluoromethylsilane. Incidentally, the use amount of the trifluoromethylating agent is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.0 to 3.0 mols relative to 1 mol of the compound [I-5].

As the catalyst usable in the present reaction, there can be mentioned, for example, tetra-n-butylammoniumfluoride, cesium fluoride or potassium fluoride. Incidentally, the use amount of the catalyst is appropriately selected in a range of 0.01 to 10 mols and is preferably 0.1 to 6.0 mols relative to 1 mol of the compound [I-5].

As the solvent usable in the present reaction, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; a halogenated hydrocarbon such as dichloromethane, chloroform, 1,2-dichloroethane or the like; a nitrile such as acetonitrile, propionitrile or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; and a mixture thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.3 to 15 liters relative to 1 mol of the compound [I-5].

The temperature of the present reaction is selected freely in a temperature range from −30° C. to the reflux temperature of the reaction system and is preferably 0° C. to room temperature.

The time of the present reaction differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [I-6] can be isolated. The isolated compound [I-6] may be as necessary purified by column chromatography, recrystallization, etc.

From the compound represented by the general formula [I-7], having asymmetrical sulfur atom, of the present compounds represented by the general formula [I], respective optical isomer (enantiomer) can be separated by optical resolution.

(In the above formula, R 1 , R 2 , R 3 and R 4 each have the same meaning as given above.)

From the recemic mixture of compound represented by the general formula [I-7], respective (+)-enantiomer and (−)-enantiomer can be obtained by using a column for high performance liquid chromatography for optical isomer separation.

As the column for high performance liquid chromatography for optical isomer separation usable, there can be mentioned the column already marketed, for example, CHIRAL PAK AD (trade name) manufactured and sold by Daicel Corporation.

As the solvent usable in the optical resolution, there can be mentioned, for example, an aliphatic hydrocarbon such as hexane, heptane or the like; an alcohol such as methanol, ethanol, propanol, 2-propanol, butanol or the like; a halogenated hydrocarbon such as dichloromethane, chloroform, or the like; an ether such as diethyl ether, 1,2-dimethoxyethane, diisopropyl ether, tetrahydrofuran, 1,4-dioxane or the like; an ester such as ethyl acetate or the like; a nitrile such as acetonitrile or the like; an organic acid such as acetic acid, formic acid and the like; water; and a mixture thereof.

The temperature and time of the optical resolution may be changed freely in a wide range. Ordinally temperature is from −20° C. to 60° C., preferably 5° C. to 50° C., and time is 0.01 hour to 50 hours, preferably 0.1 hour to 2 hours.

A compound represented by the general formula [II] can be produced by each of the reaction formulas shown by the following step 1 to step 4. A compound represented by the general formula [IV] can be produced by the reaction formula shown by the following step 5. Incidentally, the compound [II] and the compound [IV] are interchangeable to each other by an oxidation reaction or a reduction reaction. Further, the compound [II] is also oxidized easily by the oxygen in the air, generating the compound [IV].

(In the above reaction formulas, Z 1 is a methyl group or a trifluoromethyl group; and R 2 , R 3 , R 4 and Y 1 each have the same meaning as given above.)

[Step 1]

A compound represented by the general formula [II] can be produced by oxidizing a compound [XVII] with an appropriate oxidizing agent to convert to a corresponding sulfoxide form, then reacting the sulfoxide form with acetic anhydride or trifluoroacetic anhydride to produce a compound [XVIII], thereafter hydrolyzing the compound [XVIII] based on the method described in Chem. Ber., Vol. 43, p. 1407 (1910). The compound [XVIII] may be used in the next reaction without being isolated and purified.

›Advantages of the Invention · 14 of 25

As the oxidizing agent usable in the present step, there can be mentioned, for example, hydrogen peroxide, m-chloroperbenzoic acid, sodium periodate, OXONE (trade name of E.I. DuPont, a substance containing potassium hydrogenperoxosulfate), N-chlorosuccinimide, N-bromosuccinimide, tert-butyl hypochlorite, and sodium hypochlorite. Incidentally, the use amount of the oxidizing agent is appropriately selected in a range of 1.0 to 3.0 mols and is preferably 1.0 to 1.2 mols relative to 1 mol of the compound [XVII].

The amount of the acetic anhydride or trifluoroacetic anhydride used in the present step is selected in a range from 1 mol to an amount sufficient to act as a solvent and is preferably 1.0 to 3.0 mols relative to 1 mol of the compound [XVII]

The reaction temperature of the present step is freely selected, in any reaction, in a range from −10° C. to the reflux temperature of the reaction system and is preferably 0° C. to 50° C.

The reaction time of the present step differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., in any reaction, but is ordinarily 5 minutes to 12 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [II] can be isolated. The isolated compound [II] may be as necessary purified by column chromatography, recrystallization, etc.

[Step 2]

The compound represented by the general formula [II] can also be produced by reacting a compound [XI] with a metal or an organometallic compound in a solvent and then reacting the reaction product with sulfur.

As the metal usable in the present step, there can be mentioned lithium, magnesium, etc. Incidentally, the use amount of the metal is appropriately selected in a range of 1.0 to 3.0 mols and is preferably 1.0 to 1.2 mols relative to 1 mol of the compound [XI].

As the organometallic compound usable in the present step, there can be mentioned an alkyllithium such as n-butyllithium or the like. Incidentally, the use amount of the organometallic compound is appropriately selected in a range of 1.0 to 3.0 mols and is preferably 1.0 to 1.2 mols relative to 1 mol of the compound [XI].

The amount of the sulfur used in the present step is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.0 to 2.0 mols relative to 1 mol of the compound [XI].

The reaction temperature of the present step is freely selected in a range from −60° C. to the reflux temperature of the reaction system and is preferably −60° C. to room temperature.

The reaction time of the present step differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 30 minutes to 12 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [II] can be isolated. The isolated compound [II] may be as necessary purified by column chromatography, recrystallization, etc.

[Step 3]

The compound represented by the general formula [II] can also be produced by converting a compound [VIII] to a diazonium salt in the same manner as in the above-mentioned Production method 4, then reacting the diazonium salt with a xanthogenic acid salt or a thiocyanic acid salt, thereafter hydrolyzing the reaction product.

As the xanthogenic acid salt usable in the present step, there can be mentioned, for example, sodium ethylxanthogenate, potassium ethylxanthogenate, potassium isopropylxanthogenate, and potassium butylxanthogenate. As the thiocyanic acid salt, there can be mentioned, for example, sodium thiocyanate, potassium thiocyanate, and ammonium thiocyanate. Incidentally, the use amount of the xanthogenic acid salt or thiocyanic acid salt is appropriately selected in a range of 1.0 to 3.0 mols and is preferably 1.0 to 1.5 mols relative to 1 mol of the compound [VIII].

As the solvent usable in the present step, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; a halogenated hydrocarbon such as dichloromethane, chloroform, 1,2-dichloroethane or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; an alcohol such as methanol, ethanol, 2-propanol or the like; a nitrile such as acetonitrile, propionitrile or the like; an ester such as ethyl acetate, ethyl propionate or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; a pyridine such as pyridine, picoline or the like; water; and a mixed solvent thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.3 to 10 liters relative to 1 mol of the compound [VIII].

The reaction temperature of the present step is freely selected in a range from −70° C. to the reflux temperature of the reaction system and is preferably −20° C. to 100° C.

The reaction time of the present step differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [II] can be isolated. The isolated compound [II] may be as necessary purified by column chromatography, recrystallization, etc.

›Advantages of the Invention · 15 of 25

[Step 4]

The compound represented by the general formula

[II] can also be produced by reacting a compound [XIX] with chlorosulfonic acid to obtain a compound [XX] and then reacting the compound [XX] with a reducing agent.

The amount of the chlorosulfonic acid used in the present step is appropriately selected in a range of 2.0 to 10 mols and is preferably 2.2 to 3.5 mols relative to 1 mol of the compound [XIX].

As the reducing agent usable in the present step, there can be mentioned lithium aluminum hydride, a combination of zinc and an acid, a combination of tin and an acid, and a combination of red phosphorus and iodine. Incidentally, the use amount of the reducing agent is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.5 to 2.0 mols relative to 1 mol of the compound [XIX].

As the acid usable as a component of the reducing agent in the present step, there can be mentioned a mineral acid such as hydrochloric acid, sulfuric acid or the like.

The reaction temperature of the present step is freely selected, in any reaction, in a range from 0° C. to the reflux temperature of the reaction system and is preferably 0° C. to 100° C.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [II] can be isolated. The isolated compound [II] may be as necessary purified by column chromatography, recrystallization, etc.

[Step 5]

The compound represented by the general formula [IV] can be produced by reacting a compound [XIX] with disulfur dichloride in a solvent in the presence or absence of a catalyst.

The amount of the disulfur dichloride used in the present step is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.0 to 1.5 mols relative to 1 mol of the compound [XIX].

As the catalyst usable in the present step, there can be mentioned, for example, a metal halide such as aluminum chloride, tin (II) chloride, tin (IV) chloride or the like. Incidentally, the use amount of the catalyst is appropriately selected in a range of 0 to 5.0 mols and is preferably 1.0 to 2.0 mols relative to 1 mol of the compound [XIX].

As the solvent usable in the present step, there can be mentioned, for example, a halogenated hydrocarbon such as dichloromethane, chloroform, 1,2-dichloroethane or the like; and an aromatic hydrocarbon such as chlorobenzene, dichlorobenzene or the like. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.3 to 10 liters relative to 1 mol of the compound [XIX].

The reaction temperature of the present step is freely selected in a range from −30° C. to the reflux temperature of the reaction system and is preferably −10° C. to 100° C.

The reaction time of the present step differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 1 to 24 hours.

Further, the compound [II] can be produced by reducing the compound [IV] based on the methods described in Organic Syntheses, Coll. Vol. 2, p. 580 (1943), J. Am. Chem. Soc., 60, 428 (1928), J. Am. Chem. Soc., 79, 2553 (1957), J. Org. Chem., 26, 3436 (1961), and J. Am. Chem. Soc., 96, 6081 (1974).

Of the compounds represented by the general formula [II], a compound represented by the general formula [II-1] can be produced by the method shown by the following reaction formula.

(In the above reaction formula, R 3 , R 4 , R 10 and L 3 each have the same meaning as given above.)

The compound represented by the general formula [II-1] can be produced by reacting a compound [VI] with sodium sulfide in a solvent in the presence of a base and then neutralizing the reaction product with a mineral acid or the like.

The amount of the sodium sulfide used in the present reaction is appropriately selected in a range of 1.0 to 3.0 mols and is preferably 1.0 to 1.5 mols relative to 1 mol of the compound [VI].

As the solvent usable in the present reaction, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; an alcohol such as methanol, ethanol, 2-propanol or the like; a halogenated hydrocarbon such as dichloromethane, chloroform, 1,2-dichloroethane or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; a ketone such as acetone, methyl ethyl ketone, cyclohexanone or the like; water; and a mixed solvent thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.3 to 10 liters relative to 1 mol of the compound [VI].

As the base usable in the present reaction, there can be mentioned, for example, an inorganic base such as alkali metal hydroxide (e.g. sodium hydroxide or potassium hydroxide), alkaline earth metal hydroxide (e.g. calcium hydroxide or magnesium hydroxide), alkali metal carbonate (e.g. sodium carbonate or potassium carbonate), alkali metal bicarbonate (e.g. sodium hydrogencarbonate or potassium hydrogencarbonate) or the like; a metal hydride (e.g. sodium hydride or potassium hydride); a metal alcoholate (e.g. sodium methoxide, sodium ethoxide or potassium tert-butoxide); and an organic base (e.g. triethylamine, N,N-dimethylaniline, pyridine, 4-N,N-dimethylaminopyridine or 1,8-diazabicyclo[5.4.0]-7-undecene). Incidentally, the use amount of the base is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.0 to 1.2 mols relative to 1 mol of the compound [VI].

As the mineral acid usable in the present reaction, there can be mentioned hydrochloric acid, sulfuric acid, etc. The use amount of the mineral acid is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.0 to 2.0 mols relative to 1 mol of the compound [VI].

›Advantages of the Invention · 16 of 25

The temperature of the present reaction is selected freely in a temperature range from −30° C. to the reflux temperature of the reaction system, and is preferably −20° C. to 100° C.

The time of the present reaction differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [II-1] can be isolated. The isolated compound [II-1] may be as necessary purified by column chromatography, recrystallization, etc.

A compound represented by the general formula [XV] can be produced by the method of the reaction formulas shown by the following [step 6] and [step 7].

(In the above reaction formulas, R 1 , R 2 , R 3 and n each have the same meaning as given above.)

[Step 6]

A compound represented by the general formula [XXII] can be produced by reacting a compound [XXI] with nitric acid in a solvent in the presence or absence of sulfuric acid.

As the solvent usable in the present step, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; an alcohol such as methanol, ethanol, 2-propanol or the like; a halogenated hydrocarbon such as dichloromethane, chloroform, 1,2-dichloroethane or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; a ketone such as acetone, methyl ethyl ketone, cyclohexanone or the like; water; and a mixed solvent thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.3 to 10 liters relative to 1 mol of the compound [XXI].

The amount of the nitric acid used in the present step is appropriately selected in a range of 1.0 to 40 mols and is preferably 1.0 to 10 mols relative to 1 mol of the compound [XXI]. The amount of sulfuric acid when used is appropriately selected in a range of 1 to 40 mols and is preferably 1.0 to 10 mols relative to 1.0 mol of the compound [XXI].

The reaction temperature of the present step is freely selected in a range from 0° C. to the reflux temperature of the reaction system and is preferably 0° C. to 150° C.

The reaction time of the present step differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [XXII] can be isolated. The isolated compound [XXII] may be as necessary purified by column chromatography, recrystallization, etc.

[Step 7]

The compound represented by the general formula [XV] can be produced by reacting the compound [XXII] with iron/acid, zinc/acid, tin/acid, tin dichloride/acid, nickel chloride/sodium tetrahydroborate, lithium aluminum hydride, palladium-activated carbon/hydrogen, or the like, for reduction.

As the acid usable in the present step, there can be mentioned a mineral acid such as hydrochloric acid, sulfuric acid or the like. The amount of the iron/acid, zinc/acid, tin/acid, tin dichloride/acid, nickel(II) chloride/sodium tetrahydroborate, lithium aluminum hydride, palladium-activated carbon/hydrogen, or the like, used in the present step is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.0 to 2.0 mols relative to 1 mol of the compound [XXII].

The reaction temperature of the present step is freely selected in a range from 0° C. to the reflux temperature of the reaction system and is preferably 0° C. to 100° C.

The reaction time of the present step differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [XV] can be isolated. The isolated compound [XV] may be as necessary purified by column chromatography, recrystallization, etc.

A compound represented by the general formula [XXV] can be produced by the method of the reaction formulas shown in the following [step 8] and [step 9].

(In the above reaction formulas, Z 2 is a same or different C 1 ˜C 6 alkyl group; and R 1 , R 2 , R 3 , Y 1 and n each have the same meaning as given above.)

[Step 8]

A compound represented by the general formula [XXIV] can be produced by reacting a compound [XXIII] with a metal or an organometallic compound in an appropriate solvent and then reacting the reaction product with a boric acid ester.

As the metal usable in the present step, there can be mentioned lithium, magnesium, etc. The use amount of the metal is appropriately selected in a range of 1.0 to 3.0 mols and is preferably 1.0 to 1.2 mols relative to 1 mol of the compound [XXIII].

As the organometallic compound usable in the present step, there can be mentioned an alkyllithium such as n-butyllithium or the like. The use amount of the organometallic compound is appropriately selected in a range of 1.0 to 3.0 mols and is preferably 1.0 to 1.2 mols relative to 1 mol of the compound [XXIII].

›Advantages of the Invention · 17 of 25

The reaction temperature of the present step is freely selected in a range from −100° C. to the reflux temperature of the reaction system, and is preferably −60° C. to room temperature.

The reaction time of the present step differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 5 minutes to 12 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [XXIV] can be isolated. The isolated compound [XXIV] may be as necessary purified by column chromatography, recrystallization, etc.

[Step 9]

The compound [XXV] can be produced by reacting the compound [XXIV] with an acid in an appropriate solvent.

As the solvent usable in the present step, there can be mentioned, for example, an ether such as diethyl ether, tetrahydrofuran, 1,4-dioxane or the like; an aromatic hydrocarbon such as benzene, toluene, xylene, chlorobenzene or the like; an aprotic polar solvent such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, dimethyl sulfoxide, sulfolane or the like; an alcohol such as methanol, ethanol, 2-propanol or the like; a halogenated hydrocarbon such as dichloromethane, chloroform, dichloroethane or the like; an aliphatic hydrocarbon such as pentane, hexane, cyclohexane, heptane or the like; a ketone such as acetone, methyl ethyl ketone, cyclohexanone or the like; water; and a mixed solvent thereof. Incidentally, the use amount of the solvent is 0.1 to 100 liters, preferably 0.1 to 5.0 liters relative to 1 mol of the compound [XXIV].

As the acid usable in the present step, there can be mentioned a mineral acid such as sulfuric acid, hydrochloric acid or the like. The use amount of the acid is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 0.5 to 2.0 mols relative to 1 mol of the compound [XXIV].

The reaction temperature of the present step is freely selected in a range from 0° C. to the reflux temperature of the reaction system and is preferably 0° C. to 100° C.

The reaction time of the present step differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [XXV] can be isolated. The isolated compound [XXV] may be as necessary purified by column chromatography, recrystallization, etc.

Of the compounds represented by the general formula [XV], a compound represented by [XV-1] can be produced by the method shown by the reaction formulas of the following [step 10] and [step 11].

(In the above reaction formulas, R 1 , R 2 , R 3 , Z 2 and L 1 each have the same meaning as given above.)

[Step 10]

A compound represented by the general formula [XXVII] can be produced by reacting a compound [XXVI] with chlorosulfonic acid, then reducing the reaction product with lithium aluminum hydride, zinc/acid, tin/acid, or red phosphorus/iodine, thereafter hydrolyzing the reaction product with a base.

As the acid usable in the present step, there can be mentioned a mineral acid such as hydrochloric acid, sulfuric acid or the like. The use amount of chlorosulfonic acid in the present step is appropriately selected in a range of 2.0 to 10 mols and is preferably 2.2 to 3.5 mols relative to 1 mol of the compound [XXVI].

The use amount of the lithium aluminum hydride, zinc/acid, tin/acid, or red phosphorus/iodine, in the present step is appropriately selected in a range of 1.0 to 5.0 mols and is preferably 1.5 to 2.0 mols relative to 1 mol of the compound [XXVI].

As the base usable in the present step, there can be mentioned sodium hydroxide, potassium hydroxide or the like. The use amount of the base is appropriately selected in a range of 1 to 5 mols and is preferably 1.0 to 3.0 mols relative to 1 mol of the compound [XXVI].

The reaction temperature of the present step is freely selected in a range from 0° C. to the reflux temperature of the reaction system and is preferably 0° C. to 100° C.

The reaction time of the present step differs depending upon the temperature of reaction, the substrate of reaction, the amount of reactant, etc., but is ordinarily 10 minutes to 24 hours.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [XXVII] can be isolated. The isolated compound [XXVII] may be as necessary purified by column chromatography, recrystallization, etc.

[Step 11]

The compound represented by the general formula [XV-1] can be produced by reacting the compound [XXVII] with a compound [III] in a solvent in the presence or absence of a base in the presence or absence of a radical initiator, in the same manner as in the Production method 1.

Each amount of the solvent and the base, usable in the present step is the same as in the Production method 1, and the reaction time and the reaction temperature in the present step are each the same as in the Production method 1.

After the completion of the reaction, the reaction mixture is subjected to operations such as pouring into water or the like, extraction with organic solvent, concentration and the like, whereby a compound [XV-1] can be isolated. The isolated compound [XV-1] may be as necessary purified by column chromatography, recrystallization, etc.

The pest control agent of the present invention is characterized by containing, as an active ingredient, an alkyl phenyl sulfide derivative represented by the general formulas [I] or [I′], or an agriculturally acceptable salt thereof. The present pest control agent is representatively an insecticide and miticide.

›Advantages of the Invention · 18 of 25

The present pest control agent may as necessary contain an additive component (carrier) ordinarily used in agricultural chemical formulations.

As the additive component, there can be mentioned a carrier (e.g. solid carrier or liquid carrier), a surfactant, a binder or a tackifier, a thickening agent, a coloring agent, a spreader, a sticker, an anti-freeze, a solidification inhibitor, a disintegrator, a decomposition inhibitor, etc. As necessary, there may be used other additive components such as antiseptic, vegetable chip and the like. These additive components may be used in one kind or in combination of two or more kinds.

The above additive components are explained.

As the solid carrier, there can be mentioned, for example, mineral carriers such as pyrophyllite clay, kaolin clay, silicastone clay, talc, diatomaceous earth, zeolite, bentonite, acid clay, active clay, Attapulgus clay, vermiculite, perlite, pumice, white carbon (e.g. synthetic silicic acid or synthetic silicate), titanium dioxide and the like; vegetable carriers such as wood flour, corn culm, walnut shell, fruit stone, rice hull, sawdust, wheat bran, soybean flour, powder cellulose, starch, dextrin, saccharide and the like; inorganic salt carriers such as calcium carbonate, ammonium sulfate, sodium sulfate, potassium chloride and the like; and polymer carriers such as polyethylene, polypropylene, polyvinyl chloride, polyvinyl acetate, ethylene-vinyl acetate copolymer, urea-aldehyde resin and the like.

As the liquid carrier, there can be mentioned, for example, monohydric alcohols such as methanol, ethanol, propanol, isopropanol, butanol, cyclohexanol and the like; polyhydric alcohols such as ethylene glycol, diethylene glycol, propylene glycol, hexylene glycol, polyethylene glycol, polypropylene glycol, glycerine and the like; polyhydric alcohol derivatives such as propylene type glycol ether and the like; ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, diisobutyl ketone, cyclohexanone, isophorone and the like; ethers such as diethyl ether, 1,4-dioxane, cellosolve, dipropyl ether, tetrahydrofuran and the like; aliphatic hydrocarbons such as normal paraffin, naphthene, isoparaffin, kerosene, mineral oil and the like; aromatic hydrocarbons such as toluene, C 9 ˜C 10 alkylbenzene, xylene, solvent naphtha, alkylnaphthalene, high-boiling aromatic hydrocarbon and the like; halogenated hydrocarbons such as 1,2-dichloroethane, chloroform, carbon tetrachloride and the like; esters such as ethyl acetate, diisopropyl phthalate, dibutyl phthalate, dioctyl phthalate, dimethyl adipate and the like; lactones such as γ-butyrolactone and the like; amides such as dimethylformamide, diethylformamide, dimethylacetamide, N-alkylpyrrolidinone and the like; nitriles such as acetonitrile and the like; sulfur compounds such as dimethyl sulfoxide and the like; vegetable oils such as soybean oil, rapeseed oil, cottonseed oil, coconut oil, castor oil and the like; and water.

As to the surfactant, there is no particular restriction. However, the surfactant preferably gels or swells in water. There can be mentioned, for example, non-ionic surfactants such as sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, polyoxyethylene fatty acid ester, polyoxyethylene resin acid ester, polyoxyethylene fatty acid diester, polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, polyoxyethylene dialkylphenyl ether, polyoxyethylene alkylphenyl etherformalin condensate, polyoxyethylene polyoxypropylene block polymer, alkyl polyoxyethylene polypropylene block polymer ether, polyoxyethylene alkyl amine, polyoxyethylene fatty acid amide, polyoxyethylene fatty acid bisphenyl ether, polyalkylene benzyl phenyl ether, polyoxyalkylene styryl phenyl ether, acetylene diol, polyoxyalkylene-added acetylene diol, polyoxyethylene ether type silicone, ester type silicone, fluorine-containing surfactant, polyoxyethylene castor oil, polyoxyethylene hardened castor oil and the like; anionic surfactants such as alkyl sulfate, polyoxyethylene alkyl ether sulfate, polyoxyethylene alkyl phenyl ether sulfate, polyoxyethylene styryl phenyl ether sulfate, alkylbenzenesulfonic acid salt, ligninsulfonic acid salt, alkylsulfosuccinic acid salt, naphthalenesulfonic acid salt, alkylnaphthalenesulfonic acid salt, naphthalenesulfonic acid-formalin condensate salt, alkylnaphthalenesulfonic acid-formalin condensate salt, fatty acid salt, polycarboxylic acid salt, N-methyl-fatty acid sarcosinate, resin acid salt, polyoxyethylene alkyl ether phosphate, polyoxyethylene alkylphenyl ether phosphate and the like; cationic surfactants including alkyl amine salts such as laurylamine hydrochloride, stearylamine hydrochloride, oleylamine hydrochloride, stearylamine acetate, stearylaminopropylamine acetate, alkyl trimethyl ammonium chloride, alkyl dimethyl benzalkonium chloride and the like; and ampholytic surfactants such as betaine type (e.g. dialkyldiaminoethylbetaine or alkyldimethylbenzylbetaine), amino acid type (e.g. dialkylaminoethylglycine or alkyldimethylbenzylglycine) and the like.

As the binder and tackifier, there can be mentioned, for example, carboxymethyl cellulose or a salt thereof, dextrin, water-soluble starch, xanthane gum, guar gum, sucrose, polyvinylpyrrolidone, gum arabi, polyvinyl alcohol, polyvinyl acetate, sodium polyacrylate, polyethylene glycol having an average molecular weight of 6,000 to 20,000, polyethylene oxide having an average molecular weight of 100,000 to 5,000,000, and natural phospholipid (e.g. cephalinic acid or lecithin).

As the thickening agent, there can be mentioned, for example, water-soluble polymers such as xanthan gum, guar gum, carboxymethyl cellulose, polyvinylpyrrolidone, carboxyvinyl polymer, acrylic polymer, starch derivative, polysaccharide and the like; and inorganic fine powders such as high-purity bentonite, white carbon and the like.

As the coloring agent, there can be mentioned, for example, inorganic pigments such as iron oxide, titanium oxide, Prussian Blue and the like; and organic dyes such as Alizarine dye, azo dye, metal phthalocyanine dye and the like.

›Advantages of the Invention · 19 of 25

As the spreader, there can be mentioned, for example, silicone-based surfactant, cellulose powder, dextrin, processed starch, polyaminocarboxylic acid chelate compound, crosslinked polyvinylpyrrolidone, maleic acid and styrene, methacrylic acid copolymer, half ester between polyhydric alcohol polymer and dicarboxylic acid anhydride, and water-soluble salt of polystyrenesulfonic acid.

As the sticker, there can be mentioned, for example, surfactant (e.g. sodium dialkylsulfosuccinate, polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, or polyoxyethylene fatty acid ester), paraffin, terpene, polyamide resin, polyacrylic acid salt, polyoxyethylene, wax, polyvinyl alkyl ether, alkylphenol-formalin condensate, and synthetic resin emulsion.

As the anti-freeze, there can be mentioned, for example, polyhydric alcohol (e.g. ethylene glycol, diethylene glycol, propylene glycol, or glycerine).

As the solidification inhibitor, there can be mentioned, for example, polysaccharide (e.g. starch, alginic acid, mannonse or galactose), polyvinylpyrrolidone, white carbon, ester gum and petroleum resin.

As the disintegrator, there can be mentioned, for example, sodium tripolyphosphate, sodium hexametaphosphate, stearic acid metal salt, cellulose powder, dextrin, methacrylic acid ester copolymer, polyvinylpyrrolidone, polyaminocarboxylic acid chelate compound, sulfonated styrene-isobutylene-maleic anhydride copolymer, and starch-polyacrylonitrile graft copolymer.

As the decomposition inhibitor, there can be mentioned, for example, desiccants such as zeolite, quick lime, magnesium oxide and the like; antioxidants such as phenol type, amine type, sulfur type, phosphoric acid type and the like; and ultraviolet absorbents such as salicylic acid type, benzophenone type and the like.

When the present pest control agent contains the above-mentioned additive components, their contents based on mass are selected in a range of ordinarily 5 to 95%, preferably 20 to 90% in the case of carrier (e.g. solid carrier or liquid carrier), ordinarily 0.1 to 30%, preferably 0.5 to 10% in the case of surfactant, and ordinarily 0.1 to 30%, preferably 0.5 to 10% in the case of other additives.

The present pest control agent is used in any formulation selected from dust formulation, dust-granule mixture, granule, wettable powder, water-soluble concentrate, water-dispersible granule, tablet, Jumbo, emulsifiable concentrate, oil formulation, solution, flowable concentrate, emulsion, microemulsion, suspoemulsion, ultra-low volume formulation, microcapsule, smoking agent, aerosol, baiting agent, paste, etc.

In actual use of the formulation, the formulation can be used per se or after dilution with a diluent (e.g. water) in a given concentration. The application of the formulation containing the present compound or of its dilution product can be conducted by a method ordinarily used, such as dispersion (e.g. spraying, misting, atomizing, powder dispersion, granule dispersion, on-water-surface dispersion, or inbox dispersion), in-soil application (e.g. mixing or drenching), on-surface application (e.g. coating, dust coating or covering), immersion, poison bait, smoking and the like. It is also possible to mix the above-mentioned active ingredient with a livestock feed in order to prevent the infestation and growth of injurious pest, particularly injurious insect in the excreta of livestock.

The proportion (mass %) of the active ingredient in the present pest control agent is appropriately selected so as to meet the necessity. The active ingredient is appropriately selected, for example, in the following range.

In dust formulation, dust-granule mixture, etc.

0.01 to 20%, preferably 0.05 to 10%

In granule, etc.

0.1 to 30%, preferably 0.5 to 20%

In wettable powder, water-dispersible granule, etc.

1 to 70%, preferably 5 to 50%

In water-soluble concentrate, solution, etc

1-95%, preferably 10 to 80%

In emulsifiable concentrate, etc.

5 to 90%, preferably 10 to 80%

In oil formulation, etc.

1 to 50%, preferably 5 to 30%

In flowable concentrate, etc.

5 to 60%, preferably 10 to 50%

In emulsion, microemulsion, suspoemulsion, etc.

5 to 70%, preferably 10 to 60%

In tablet, bait, paste, etc.

1 to 80%, preferably 5 to 50%

In smoking agent, etc.

0.1 to 50%, preferably 1 to 30%

In aerosol, etc.

0.05 to 20%, preferably 0.1 to 10%

The formulation is sprayed after dilution in an appropriate concentration, or applied directly.

When the present pest control agent is used after dilution with a diluent, the concentration of active ingredient is generally 0.1 to 5,000 ppm. When the formulation is used per se, the application amount thereof per unit area is 0.1 to 5,000 g per 1 ha in terms of active ingredient compound; however, the application amount is not restricted thereto.

Incidentally, the present pest control agent is sufficiently effective when using the present compound alone as an active ingredient. However, in the present pest control agent, there may be mixed or used in combination, as necessary, fertilizers and agricultural chemicals such as insecticide, miticide, nematicide, synergist, fungicide, antiviral agent, attractant, herbicide, plant growth-controlling agent and the like. In this case, a higher effect is exhibited.

Below are shown examples of the known insecticides, miticides, nematicides and synergist compounds, which may be mixed or used in combination.

1. Acetylcholinesterase Inhibitors

(1A) carbamates: alanycarb, aldicarb, aldoxycarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC, xylylcarb;

(1B) Organophosphates: acephate, azamethiphos, azinphosethyl, azinphos-methyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demoton-S-methyl, diamidafos, diazinon, dichlorvos, dicrotophos, dimethoate, dimethylvinphos, dioxabenzofos, disulfoton, DSP, EPN, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fenthion, fonofos, fosthiazate, fosthietan, heptenophos, isamidofos, isazophos, isofenphos-methyl, isopropyl O-(methoxyaminothiophosphoryl)salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, oxydeprofos, parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenofos, propaphos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, thionazin, triazophos, trichlorfon, vamidothion, dichlofenthion, imicyafos, isocarbophos, mesulfenfos, flupyrazofos

›Advantages of the Invention · 20 of 25

2. GABA-Gated Chloride Channel Antagonists

(2A) Cyclodiene organochlorines: chlordane, endosulfan, gamma-BCH;

(2B) Phenylpyrazoles: acetoprol, ethiprole, fipronil, pyrafluprole, pyriprole, RZI-02-003 (code number)

3. Sodium Channel Modulators

(3A) Pyrethroids/Pyrethrins: acrinathrin, allethrin (includes d-cis-trans and d-trans), bifenthrin, bioallethrin, bioallethrin S-cyclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin (includes beta-), cyhalothrin (includes gamma- and lambda-), cypermethrin (includes alpha-, beta-, theta- and zeta-), cyphenothrin [includes (IR)-trans-isomers], deltamethrin, empenthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, halfenprox, imiprothrin, metofluthrin, permethrin, phenothrin [includes (IR)trans-isomer], prallethrin, profluthrin, pyrethrine, resmethrin, RU15525 (code number), silafluofen, tefluthrin, tetramethrin, tralomethrin, transfluthrin, ZX18901 (code number), fluvalinate (includes tau-), tetramethylfluthrin, meperfluthrin;

(3B) DDT/Methoxychlor: DDT, methoxychlor

4. Nicotinic Acetylcholine Receptor Agonist/Antagonist

(4A) Neonicotinoids: acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam;

(4B) Nicotine: nicotine-sulfate

5. Nicotinic Acetylcholine Receptor Allosteric Activators

Spinosines: spinetoram, spinosad

6. Chloride Channel Activators

Abamectins, Milbemycins: abamectin, emamectin benzoate, lepimectin, milbemectin, ivermectin, polynactins

7. Juvenile Hormone Mimics

diofenolan, hydroprene, kinoprene, methothrin, fenoxycarb, pyriproxyfen

8. Miscellaneous Non-Specific (Multi-Site) Inhibitors

1,3-dichloropropene, DCIP, ethylene dibromide, methyl bromide, chloropicrin, sulfuryl fluoride

9. Antifeedant

pymetrozine, flonicamid, pyrifluquinazon

10. Mite Growth Inhibitor

clofentezine, diflovidazin, hexythiazox, etoxazole

11. Microbial Disruptors of Insect Midgut Membranes

BT agent: Bacillus sphaericus, Bacillus thuringiensis subsp. aizawai, Bacillus thuringiensis subsp. israelensis, Bacillus thuringiensis subsp. kurstaki, Bacillus thuringiensis subsp. tenebrionis , Bt crop proteins (Cry1Ab, Cry1Ac, Cry1Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34/35Ab1), Bacillus popilliae, Bacillus subtillis

12. Inhibitors of Mitochondrial ATP Synthase Diafenthiuron;

Organotin miticides: azocyclotin, cyhexatin, fenbutatin oxide;

propargite, tetradifon

13. Uncouplers of Oxidative Phosphorylation Via Disruption of the Proton Gradient

chlorfenapyr, DNOC

14. Nicotinic Acetylcholine Receptor Channel Blockers

Nereistoxin analogues: bensultap, cartap, thiocyclam, thiosultap

15. Inhibitors of Chitin Biosynthesis, Type O

Benzoylureas: bistrifluron, chlorfluazoron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, triflumuron, fluazuron

16. Inhibitors of Chitin Biosynthesis, Type 1

buprofezin

17. Molting Disruptor, Dipteran

cyromazine

18. Ecdysone Receptor Agonist (Ecdysis Acceleration)

Diacylhydrazines: chromafenozide, halofenozide, methoxyfenozide, tebufenozide

19. Octopamine Receptor Agonist

amitraz

20. Mitochondrial Complex III Electron Transport Inhibitors

hydramethylnon, acequinocyl, fluacrypyrim, cyenopyrafen

21. Mitochondrial Complex II Electron Transport Inhibitors

cyflumetofen, cyenopyrafen, NNI-0711 (code number)

22. Mitochondrial Complex I Electron Transport Inhibitors

METI miticides and insecticides: fenazaquin, fenpyroximate, pyridaben, pyrimidifen, tebufenpyrad, tolfenpyrad

Other: rotenone

23. Sodium Channel Blockers

indoxacarb, metaflumizon

24. Inhibitors of Lipid Synthesis

Tetronic and Tetramic acid derivatives: spirodiclofen, spiromesifen, spirotetramat

25. Mitochondrial Complex IV Electron Transport Inhibitors

aluminum phosphide, phosphine, zinc phosphide, calcium cyanide

26. Neuronal Inhibitors (Unknown Mode of Action)

bifenazate

27. Aconitase Inhibitors

sodium fluoroacetate

28. Synergists

piperonyl butoxide, DEF

29. Ryanodine Receptor Modulators

chlorantraniliprole, flubendiamide, cyantraniliprole

30. Compounds with Unknown Mode of Action

azadirachtin, amidoflumet, benclothiaz, benzoximate, bromopropylate, chinomethionat, CL900167 (code number), cryolite, dicofol, dicyclanil, dienochlor, dinobuton, fenbutatin oxide, fenothiocarb, fluensulfone, flufenerim, flsulfamide, karanjin, metham, methoprene, methoxyfenozide, methyl isothiocyanate, pyridalyl, pyrifluquinazon, sulcofuron-sodium, sulfluramid, sulfoxaflor, flupyradifurone, flometoquin, IKI-3106 (code number)

31. Entomopathogenic Fungi, Nematode-Pathogenic Microorganisms

Beauveria bassiana, Beauveria tenella, Verticillium lecanii, Pacilimyces tenuipes, Paecilomyces fumosoroceus, Beauveria brongniartii, Monacrosporium phymatophagum, Pasteuriapenetrans

32. Sex Pheromone

(Z)-11-hexadecenal, (Z)-11-hexadecenyl acetate, litlure-A, litlure-B, Z-13-eicosene-10-one, (Z,E)-9,12-tetradecadienyl acetate, (Z)-9-tetradecen-1-ol, (Z)-11-tetradecenyl acetate, (Z)-9,12-tetradecadienyl acetate, (Z,E)-9,11-detradecadienyl acetate

Next, there are shown examples of the known fungicide or disease damage control agent compounds which may be mixed or used in combination.

1. Nucleic Acid Biosynthesis Inhibitor

Acylalanines: benalaxyl, benalaxyl-M, furalaxyl, metalaxyl, metalaxyl-M;

Oxazolidinones: oxadixyl;

Butyrolactones: clozylacon, ofurace;

Hydroxy-(2-amino)pyrimidines: bupirimate, dimethirimol, ethirimol;

Isoxazole: hymexazol;

Isothiazolones: octhilinone;

Carboxylic acids: oxolinic acid

2. Mitosis and Cell Division Inhibitors

Benzoimidazoles: benomyl, carbendazim, fuberidazole, thiabendazole;

Thiophanates: thiophanate, thiophanate-methyl;

N-phenylcarbamates: diethofencarb;

Toluamides: zoxamide;

Phenylureas: pencycuron;

Pyridinylmethylbenzamides: fluopicolide

3. Respiratory Inhibitors

Pyrimidineamines: diflumetorim;

Carboxamides: benodanil, flutolanil, mepronil, fluopyram, fenfuram, carboxin, oxycarboxin, thifluzamide, bixafen, furametpyr, isopyrazam, penflufen, penthiopyrad, sedaxane, boscalid, fluxapyroxad, isofetamid, benzovindiflupyr;

Methoxy-acrylates: azoxystrobin, enestroburin, picoxystrobin, pyraoxystrobin, coumoxystrobin, enoxastrobin, flufenoxystrobin;

›Advantages of the Invention · 21 of 25

Methoxy-carbamates: pyraclostrobin, pyrametostrobin, triclopyricarb;

Oxyimino acetates: kresoxim-methyl, trifloxystrobin;

Oxyimino-acetamides: dimoxystrobin, metominostrobin, orysastrobin, fenaminstrobin;

Oxazolidine-diones: famoxadone;

Dihydro-dioxazines: fluoxastrobin;

Imidazolinones: fenamidone;

Benzyl-carbamates: pyribencarb;

Cyano-imidazoles: cyazofamid;

Sulfamoyl-triazoles: amisulbrom;

Dinitrophenyl crotonates: binapacryl, methyldinocap, dinocap;

2,6-Dinitro-anilines: fluazinam;

Pyrimidinone hydrazones: ferimzone;

Triphenyl tin: TPTA, TPTC, TPTH;

Thiophene-carboxamides: silthiofam

Triazolo-pyrimidylamines: ametoctradin

4. Amino Acid and Protein Synthesis Inhibitors

Anilino-pyrimidines: cyprodinil, mepanipyrim, pyrimethanil;

Enopyranuronic acid: blasticidin-S, mildiomycin;

Hexopyranosyl antibiotic: kasugamycin;

Glucopyranosyl antibiotic: streptomycin;

Tetracycline antibiotic: oxytetracycline

5. Signal Transduction Inhibitors

Quinoline: quinoxyfen;

Quinazolines: proquinazid;

Phenylpyrroles: fenpiclonil, fludioxonil;

Dicarboxyimides: chlozolinate, iprodione, procymidone, vinclozolin

6. Lipid Synthesis and Membrane Integrity Inhibitors

Phosphoro-thiolates: edifenphos, iprobenfos, pyrazophos;

Dithiolanes: isoprothiolane;

Aromatic hydrocarbons: biphenyl, chloroneb, dicloran, quintozene, tecnazene, tolclofos-methyl;

1,2,4-Thiadiazoles: etridiazole;

Carbamates: iodocarb, propamocarb-hydrochloride, prothiocarb;

Cinnamic acid amides: dimethomorph, flumorph;

Valineamide carbamates: benthiavalicarb-isopropyl, iprovalicarb, valifenalate;

Mandelic acid amides: mandipropamid;

Bacillus subtilis and the fungicidal lipopeptides produced: Bacillus subtilis (strain: QST 713)

7. Inhibitors of Sterol Biosynthesis in Membranes

Piperazines: triforine;

Pyridines: pyrifenox;

Pyrimidines: fenarimol, nuarimol;

Imidazoles: imazalil, oxpoconazole-fumarate, pefurazoate, prochloraz, triflumizole;

Triazoles: azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, furconazole, furconazole-cis, quinconazole;

Morpholines: aldimorph, dodemorph, fenpropimorph, tridemorph;

Piperidines: fenpropidin, piperalin;

Spiroketal amines: spiroxamine;

Hydroxyanilides: fenhexamid;

Thiocarbamates: pyributicarb;

Allylamines: naftifine, terbinafine

8. Glucan Synthesis Inhibitors

Glucopyranosyl type antibiotic: validamycin;

Peptidylpyridine nucleotide compound: polyoxin

9. Melanine Synthesis Inhibitors

Isobenzo-furanones: phthalide;

Pyrrolo-quinolines: pyroquilon;

Triazolobenzo-thiazoles: tricyclazole;

Carboxamides: carpropamid, diclocymet;

Propionamides: fenoxanil

10. Host Plant Defense Inducers

Benzothiadiazoles: acibenzolar-S-methyl;

Benzoisothiazoles: probenazole;

Thiadiazole-carboxamides: tiadinil, isotianil

Natural product: laminarin

11. Compounds with Unknown Mode of Action

Copper compound: copper hydroxide, copper dioctanoate, copper oxychloride, copper sulfate, cuprous oxide, oxinecopper, Bordeaux mixture, copper nonyl phenol sulphonate;

Sulfur compound: sulfur;

Dithiocarbamates: ferbam, mancozeb, maneb, metiram, propineb, thiram, zineb, ziram, cufraneb;

Phthalimides: captan, folpet, captafol;

Chloronitriles: chlorothalonil;

Sulfamides: dichlofluanid, tolylfluanid;

Guanidines: guazatine, iminoctadine-albesilate, iminoctadine-triacetate, dodine;

Other compound: anilazine, dithianon, cymoxanil, fosetyl (alminium, calcium, sodium), phosphorus acid and salts, tecloftalam, triazoxide, flusulfamide, diclomezine, methasulfocarb, ethaboxam, cyflufenamid, metrafenone, potassium bicarbonate, sodium bicarbonate, BAF-045 (code number), BAG-010 (code number), benthiazole, bronopol, carvone, chinomethionat, dazomet, DBEDC, debacarb, dichlorophen, difenzoquat-methyl sulfate, dimethyl disulfide, diphenylamine, ethoxyquin, flumetover, fluoroimide, flutianil, furancarboxylic acid, metam, nabam, natamycin, nitrapyrin, nitrothal-isopropyl, ophenylphenol, oxazinylazole, oxyquinoline sulfate, phenazine oxide, polycarbamate, pyriofenone, fenpyrazamine, silver, pyrisoxazole, tebufloquin, tolnifanide, trichlamide, mineral oils, organic oils, tolprocarb, oxathiapiprolin

Below are shown examples of the known herbicidal compounds and plant growth regulators which may be mixed or used in combination.

A1. Acetyl CoA Carboxylase (ACCase) Inhibitors

(A1-1) Aryloxyphenoxy propionates: clodinafop-propargyl, cyhalofop-butyl, diclofop-methyl, diclofop-P-methyl, fenoxaprop-P-ethyl, fluazifop-butyl, fluazifop-P-butyl, haloxyfop, haloxyfop-etotyl, haloxyfop-P, metamifop, propaquizafop, quizalofop-ethyl, quizalofop-P-ethyl, quizalofop-P-tefuryl, fenthiaprop-ethyl;

(A1-2) Cyclohexandiones: alloxydim, butroxydim, clethodim, cycloxydim, profoxydim, sethoxydim, tepraloxydim, tralkoxydim;

(A1-3) Phenylpyrazolines: aminopyralid, pinoxaden;

B. Acetolactate Synthase (ALS) Inhibitors

(B-1) Imidazolinones: imazamethabenz-methyl, imazamox, imazapic (includes salts with amine, etc.), imazapyr (includes salts with isopropylamine, etc.), imazaquin, imazathapyr;

(B-2) Pyrimidinyloxy benzoate: bispyribac-sodium, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrithiobac-sodium, pyrimisulfan, triafamone;

(B-3) Sulfonylaminocarbonyl-triazolinones: flucarbazonesodium, thiencarbazone (includes sodium salt, methyl ester, etc.), propoxycarbazone-sodium, procarbazone-sodium, iofensulfuron-sodium;

(B-4) Sulfonylureas: amidosulfuron, azimsulfuron, bensulfuron-methyl, chlorimuron-ethyl, chlorsulfuron, cinosulfuron, cyclosulfamuron, ethametsulfuron-methyl, ethoxysulfuron, flazasulfuron, flupyrsulfuron-methyl-sodium, foramsulfuron, halosulfuron-methyl, imazosulfuron, iodosulfulon-methyl-sodium, mesosulfuron-methyl, thifensulfuron-methyl, triasulfuron, tribenuron-methyl, trifloxysulfuron-sodium, triflusulfuron-methyl, tritosulfuron, orthosulfamuron, propgirisulfuron, metazosulfuron, flucetosulfuron;

›Advantages of the Invention · 22 of 25

(B-5) Triazolopyrimidines: cloransulam-methyl, diclosulam, florasulam, flumetsulam, metosulam, penoxsulam, pyroxsulam;

C1. Photosynthesis at Photosystem II Inhibitors (1)

(C1-1) Phenylcarbamates: desmedipham, phenmedipham;

(C1-2) Pyridazinones: chloridazon, brompyrazon;

(C1-3) Triazines: ametryn, atrazine, cyanazine, desmetryne, dimethametryn, eglinazine-ethyl, prometon, prometryn, propazine, simazine, simetryn, terbumeton, terbuthylazine, terbutryn, trietazine;

(C1-4) Triazinones: metamitron, metribuzin;

(C1-5) Triazolinones: amicarbazone;

(C1-6) Uracils: bromacil, lenacil, terbacil;

C2. Photosynthesis at Photosystem II Inhibitors (2)

(C2-1) Amides: pentanochlor, propanil;

(C2-2) Ureas: chlorbromuron, chlorotoluron, chloroxuron, dimefuron, diuron, ethidimuron, fenuron, fluometuron, isoproturon, isouron, linuron, methabenzthiazuron, metobromuron, metoxuron, monolinuron, neburon, siduron, tebuthiuron, metobenzuron;

C3. Photosynthesis at Photosystem II Inhibitors (3)

(C3-1) Benzothiadiazones: bentazone;

(C3-2) Nitriles: bromofenoxim, bromoxynil (includes esters of butyric acid, octanoic acid, heptanoic acid, etc.), ioxynil;

(C3-3) Phenylpyrazines: pyridafol, pyridate;

D. Photosystem-I-Electron Acceptors

(D-1) Bipyridyliums: diquat, paraquat dichloride;

E. Protoporphyrinogen Oxydaze (PPO) Inhibitors

(E-1) Diphenylethers: acifluorfen-sodium, bifenox, chlomethoxyfen, ethoxyfen-ethyl, fluoroglycofen-ethyl, fomesafen, lactofen, oxyfluorfen;

(E-2) N-phenylphthalimides: cinidon-ethyl, flumiclorac-pentyl, flumioxazin, chlorphthalim;

(E-3) Oxydiazoles: oxadiargyl, oxadiazon;

(E-4) Oxazolidinediones: pentoxazone;

(E-5) Phenylpyrazoles: fluazolate, pyraflufen-ethyl;

(E-6) Pyrimidinediones: benzfendizone, butafenacil, saflufenacil, tiafenacil;

(E-7) Thiadiazoles: fluthiacet-methyl, thidiazimin;

(E-8) Triazolinones: azafenidin, carfentrazone-ethyl, sulfentrazone, bencarbazone;

(E-9) Other compound: flufenpyr-ethyl, profluazol, pyraclonil, SYP-298 (code number), SYP-300 (code number);

F1. Inhibitors of Carotenoid Biosynthesis at the Phytoene Desaturase Step (PDS)

(F1-1) Pyridazinones: norflurazon;

(F1-2) Pyrimidinecarboxamides: diflufenican, picolinafen;

(F1-3) Other compound: beflubutamid, fluridone, flurochloridone, flurtamone;

F2. 4-Hydroxyphenyl-Pyruvate-Dioxygenase (HPPD) Inhibitors

(F2-1) Callistemones: mesotrione;

(F2-2) Isoxazoles: pyrasulfotole, isoxaflutole, isoxachlortole;

(F2-3) Pyrazoles: benzofenap, pyrazolynate, pyrazoxyfen, topramezone;

(F2-4) Triketones: sulcotrione, tefuryltrione, tembotrione, pyrasulfotole, topramezone, bicyclopyrone;

F3. Carotinoid Biosynthesis Inhibitors (Unknown Target)

(F3-1) Diphenyl ethers: aclonifen;

(F3-2) Isoxazolidinones: clomazone;

(F3-3) Triazoles: amitrole;

G. EPSP Synthase Inhibitors (Aromatic Amino Acid Biosynthesis Inhibitors)

(G-1) Glycines: glyphosate (includes salts of sodium, amine, propylamine, isopropylamine, dimethylamine, trimesium, etc.);

H. Glutamine Synthetase Inhibitors

(H-1) Phosphinic acids: bilanafos, glufosinate (includes salts of amine, sodium, etc.);

I. Dihydropteroate (DHP) Synthetase Inhibitors

(I-1) Carbamates: asulam;

K1. Microtubule Assembly Inhibitors

(K1-1) Benzamides: propyzamide, tebutam;

(K1-2) Benzoic acids: chlorthal-dimethyl;

(K1-3) Dinitroanilines: benfluralin, butralin, dinitramine, ethalfluralin, fluchloralin, oryzalin, pendimethalin, prodiamine, trifluralin;

(K1-4) Phosphoroamidates: amiprofos-methyl, butamifos;

(K1-5) Pyridines: dithiopyr, thiazopyr;

K2. Inhibitors of Mitosis/Microtubule Organization

(K2-1) Carbamates: carbetamide, chlorpropham, propham, swep, karbutilate;

K3. Very-Long-Chain Fatty Acids (VLCFAs) Inhibitors (Cell Division Inhibitors)

(K3-1) Acetamides: diphenamid, napropamide, naproanilide;

(K3-2) Chloroacetamides: acetochlor, alachlor, butachlor, butenachlor, diethatyl-ethyl, dimethachlor, dimethenamid, dimethenamid-P, metazachlor, metolachlor, pethoxamid, pretilachlor, propachlor, propisochlor, S-metolachlor, thenylchlor;

(K3-3) Oxyacetamides: flufenacet, mefenacet;

(K3-4) Tetrazolinones: fentrazamide;

(K3-5) Other compound: anilofos, bromobutide, cafenstrole, indanofan, piperophos, fenoxasulfone, pyroxasulfone, ipfencarbazone;

L. Cellulose Synthesis Inhibitors

(L-1) Benzamides: isoxaben;

(L-2) Nitriles: dichlobenil, chlorthiamid;

(L-3) Triazolocarboxamides: flupoxame;

M. Uncouplers (Membrane Disruptors)

(M-1) Dinitrophenols: dinoterb, DNOC (includes salts of amine, sodium, etc.);

N. Lipid Biosynthesis Inhibitors (Excluding ACCase Inhibitors)

(N-1) Benzofurans: benfuresate, ethofumesate;

(N-2) Halogenated carboxylic acids: dalapon, flupropanate, TCA (includes salts of sodium, calcium, ammonia, etc.);

(N-3) Phosphorodithioates: bensulide;

(N-4) Thiocarbamates: butylate, cycloate, dimepiperate, EPIC, esprocarb, molinate, orbencarb, pebulate, prosulfocarb, thiobencarb, tiocarbazil, tri-allate, vernolate;

O. Synthetic Auxins

(O-1) Benzoic acids: chloramben, 2,3,6-TBA, dicamba (includes salts of amine, diethylamine, isopropylamine, diglycolamine, sodium, lithium, etc.);

(O-2) Phenoxycarboxylic acids: 2,4,5-T, 2,4-D (includes salts of amine, diethylamine, triethanolamine, isopropylamine, sodium, lithium, etc.), 2,4-DB, clomeprop, dichlorprop, dichlorprop-P, MCPA, MCPA-thioethyl, MCPB (includes sodium salt, ethylester, etc.), mecoprop (includes salts of sodium, potassium, isopropylamine, triethanolamine, dimethylamine, etc.), mecoprop-P;

(O-3) Pyridine carboxylic acids: clopyralid, fluroxypyr, picloram, triclopyr, triclopyr-butotyl, halauxifen-methyl;

(O-4) Quinoline carboxylic acids: quinclorac, quinmerac;

(O-5) Other compound: benazolin;

P. Auxin Transport Inhibitors

(P-1) Phthalamates: naptalam (includes salts with sodium, etc.);

(P-2) Semicarbazones: diflufenzopyr;

Z. Compounds with Unknown Mode of Action

flamprop-M (includes methyl, ethyl and isopropyl esters), flamprop (includes methyl, ethyl and isopropyl esters), chlorflurenol-methyl, cinmethylin, cumyluron, daimuron, methyldymuron, difenzoquat, etobenzanid, fosamine, pyributicarb, oxaziclomefone, acrolein, AE-F-150954 (code number), aminocyclopyrachlor, cyanamide, heptamaloxyloglucan, indaziflam, triaziflam, quinoclamine, endothal-disodium, phenisopham, SL573 (code number), cyclopyrimonate

›Advantages of the Invention · 23 of 25

Plant growth-controlling agent: 1-methylcyclopropene, 1-naphthylacetamide, 2,6-diisopropylnaphthalene, 4-CPA, benzylaminopurine, ancymidol, aviglycine, carvone, chlormequat, cloprop, cloxyfonac, cloxyfonac-potassium, cyclanilide, cytokinins, daminozide, dikegulac, dimethipin, ethephon, ethychlozate, flumetralin, flurenol, flurprimidol, forchlorfenuron, gibberellin acid, inabenfide, indole acetic acid, indole butyric acid, maleic hydrazide, mefluidide, mepiquat chloride, n-decanol, paclobutrazol, prohexadionecalcium, prohydrojasmon, sintofen, thidiazuron, triacontanol, trinexapac-ethyl, uniconazole, uniconazole-P, 4-oxo-4-(2-phenylethyl)aminobutyric acid (chemical name, CAS registration No.: 1083-55-2)

Next, there are shown examples of the known safners which may be mixed or used in combination.

benoxacor, furilazole, dichlormid, dicyclonone, DKA-24 (N1,N2-diallyl-N2-dichloroacetylglycineamide), AD-67 (4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane), PPG-1292 (2,2-dichloro-N-(1,3-dioxolan-2-ylmethyl)-N-(2-propenyl)acetamide), R-29148 (3-dichloroacetyl-2,2,5-trimethyl-1,3-oxazolidine), cloquintcet-methyl, 1,8-Naphthalic Anhydride, mefenpyrdiethyl, mefenpyr, mefenpyr-ethyl, fenchlorazole O ethyl, fenclorim, MG-191 (2-dichloromethyl-2-methyl-1,3-dioxane), cyometrinil, flurazole, fluxofenim, isoxadifen, isoxadifenethyl, mecoprop, MCPA, daimuron, 2,4-D, MON 4660 (code number), oxabetrinil, cyprosulfamide, lower alkyl-substituted benzoic acid, TI-35 (code number) and N-(2-methoxybenzoyl)-4-[(methylaminocarbonyl)amino]benzenesulfonamide (chemical name, CAS registration No.: 129531-12-0)

The pest control agent of the present invention constituted as above exhibits an excellent control effect to pest of Orthoptera, Thysanoptera, Hemiptera, Coleoptera, Diptera, Lepidoptera, Hymenoptera, Collembola, Thysanura, Blattodea, Isoptera, Psocoptera, Mallophaga, Anoplura, plant-feeding mites, plant parasitic nematodes, plant parasitic mollusk pests, other crop pests, nuisance pests, sanitary insects, parasites, etc. As examples of such pests, the following organism species can be mentioned.

As the Orthopteran pest, there can be mentioned, for example,

Tettigoniidae: Ruspolia lineosa , etc.,

Gryllidae: Teleogryllus emma , etc.,

Gryllotalpidae: Gryllotalpa orientalis,

Acrididae: Oxya hyla intricate, Locusta migratoria, Melanoplus sanguinipes , etc.,

Pyrgomorphidae: Atractomorpha lata,

Eneopteridae: Euscrytus japonicus,

Tridactylidae: Xya japonica , etc.

As the Thysanopteran pests, there can be mentioned, for example,

Thripidae: Frankliniella intonsa, Frankliniella occidentalis, Scirtothrips dorsalis, Thrips palmi, Thrips tabaci , etc.,

Phlaeothripidaes: Ponticulothrips diospyrosi, Haplothrips aculeatus , etc.

As the Hemipteran pests, there can be mentioned, for example,

Cicadidae: Mogannia minuta , etc.,

Aphrophoridae: Aphorphora intermedia , etc.,

Membracidae: Machaerotypus sibiricus , etc.,

Cicadellidae: Arboridia apicalis, Empoasca onukii, Nephotettix cincticeps, Recilia dorsalis , etc.,

Cixiidae: Pentastiridius apicalis , etc.,

Delphacidae: Laodelphax striatella, Nilaparvata lugens, Sogatella furcifera , etc.,

Meenoplidae: Nisia nervosa , etc.,

Derbidae: Kamendaka saccharivora , etc.,

Cixidia okunii: Achilus flammeus , etc.,

Ricaniidae: Orosanga japonicus , etc.,

Flatidae: Mimophantia maritima , etc.,

Psyllidae: Cacopsylla pyrisuga , etc.,

Calophyidae: Calophya mangiferae , etc.,

Phylloxeridae: Daktulosphaira vitifoliae , etc.,

Adelgidae: Adelges laricis, Adelges tsugae , etc.,

Aphydidae: Acyrthosiphon pisum, Aphis gossypii, Aphis spiraecola, Lipaphis erysimi, Myzus persicae, Schizaphis graminum, Rhopalosiphum padi , etc.,

Aleyrodidae: Aleurocanthus spiniferus, Bemisia tabaci, Bemisia argentifolii, Trialeurodes vaporariorum , etc.,

Margarodidae: Drosicha corpulenta, Icerya purchasi , etc.,

Pseudococcidae: Dysmicoccus brevipes, Planococcus citri, Pseudococcus comstocki , etc.,

Coccidae: Ceroplastes ceriferus , etc.,

Aclerdidae: Aclerda takahasii , etc.,

Diaspididae: Aonidella aurantii, Diaspidiotus perniciosus, Unaspis yanonensis , etc.,

Miridae: Lygus hesperus, Trigonotylus caelestialium , etc.,

Tingidae: Stephanitis pyrioides, Stephanitis nashi , etc.,

Pentatomidae: Eysarcoris aeneus, Lagynotomus elongatus, Nezara viridula, Plautia crossota , etc.,

Plataspidae: Megacopta cribaria , etc.,

Lygaeidae: Cavelerius saccharivorus , etc.,

Malcidae: Malcus japonicus , etc.,

Pyrrhocoridae: Dysdercus cingulatus , etc.,

Alydidae: Leptocorisa acuta, Leptocorisa chinensis , etc.,

Coreidae: Anacanthocoris striicornis , etc.,

Rhopalidae: Rhopalus maculatus , etc.,

Cimicidae: Cimex lectularius , etc.

As the Coleoptera pests, there can be mentioned, for example,

Scarabaeidae: Anomala cuprea, Anomala rufocuprea, Popillia japonica, Oryctes rhinoceros , etc.,

Elateridae: Agriotes ogurae fuscicollis, Melanotus okinawensis, Melanotos fortnumi fortnumi , etc.,

Dermestidae: Anthrenus verbasci , etc.,

Bostrychidae: Heterobostrychus hamatipennis , etc.,

Anobiidae: Stegobium paniceum , etc.,

Ptinidae: Pitinus clavipes , etc.,

Trogossitidae: Tenebroides mauritanicus , etc.,

Cleridae: Necrobia rufipes,

Nitidulidae: Carpophilus hemipterus , etc.,

Silvanidae: Ahasverus advena , etc.,

Laemophloeidae: Cryptolestes ferrugineus , etc.,

Coccinellidae: Epilachna varivestis, Henosepilachna vigintioctopunctata , etc.,

Tenebrionidae: Tenebrio molitor, Tribolium castaneum , etc.,

Meloidae: Epicauta gorhami , etc.,

Cerambycidae: Anoplophora glabripennis, Xylotrechus pyrrhoderus, Monochamus alternatus endai , etc.,

Bruchidae: Callosobruchus chinensis , etc.,

Chrysomelidae: Leptinotarsa decemlineata, Diabrotica virgifera, Phaedon brassicae, Phyllotreta striolata , etc.,

Brentidae: Cylas formicarius , etc.,

Curculionidae: Hypera postica, Listroderes costirostris, Euscepes postfasciatus , etc.,

Erirhinidae: Echinocnemus bipunctatus, Lissorhoptrus oryzophilus , etc.,

Dryophthoridae: Sitophilus zeamais, Sphenophrus vestitus , etc.,

Scolytidae: Tomicus piniperda , etc.,

Platypodidae: Crossotarsus niponicus , etc.,

Lyctidae: Lyctus brunneus , etc.

›Advantages of the Invention · 24 of 25

As the Diptera pests, there can be mentioned, for example,

Tipulidae: Tipila aino , etc.,

Bibionidae: Plecia nearctica , etc.,

Mycetophidae: Exechia shiitakevora , etc.,

Sciaridae: Pnyxia scabiei , etc.,

Cecidomyiidae: Asphondylia yushimai, Mayetiola destructor , etc.,

Culicidae: Aedes aegypti, Culex pipiens pallens , etc.,

Simuliidae: Simulim takahasii , etc.,

Chironomidae: Chironomus oryzae , etc.,

Tabanidae: Chrysops suavis, Tabanus trigonus , etc.,

Syrphidae: Eumerus strigatus , etc.,

Tephritidae: Bactrocera dorsalis, Euphranta japonia, Ceratitis capitata , etc.,

Agromyzidae: Liriomyza trifolii, Chromatomyia horticola , etc.,

Chloropidae: Meromyza nigriventris , etc.,

Drosophilidae: Drosophila suzukii, Drosophila melanogaster , etc.,

Ephydridae: Hydrellia griseola , etc.,

Hippoboscidae: Hippobosca equina , etc.,

Scatophagidae: Parallelpmma sasakawae , etc.,

Anthomyiidae: Delia antiqua, Delia platura , etc.,

Fanniidae: Fannia canicularis , etc.,

Muscidae: Musca domestica, Stomoxys calcitrans , etc.,

Sarcophagidae: Sarcophaga peregrina , etc.,

Gasterophilidae: Gasterophilus intestinalis , etc.,

Hypodermatidae: Hypoderma lineatum , etc.,

Oestridae: Oestrus ovis , etc.

As the Lepidoptera pests, there can be mentioned, for example,

Hepialidae: Endoclita excrescens , etc.,

Heliozelidae: Antispila ampelopsia , etc.,

Cossidae: Zeuzera multistrigata leuconota , etc.,

Tortricidae: Archips fuscocupreanus, Adoxophyes orana fasciata, Grapholita molesta, Homona magnanima, Leguminivora glycinivorella, Cydia pomonella , etc.,

Cochylidae: Eupoecilia ambiguella , etc.,

Psychidae: Bambalina sp., Eumeta minuscula , etc.,

Tineidae: Nemapogon granella, Tinea translucens , etc.,

Bucculatricidae: Bucculatrix pyrivorella , etc.,

Lyonetiidae: Lyonetia clerkella , etc.,

Gracilariidae: Caloptilia theivora, Phyllonorycter ringoniella , etc.,

Phyllocnistidae: Phyllocnistis citrella , etc.,

Acrolepiidae: Acrolepiopsis sapporensis , etc.,

Yponomeutidae: Plutella xylostella, Yponomeuta orientalis , etc.,

Argyresthidae: Argyresthia conjugella , etc.,

Sesidae: Nokona regalis , etc.,

Gelechiidae: Phthorimaea operculella, Sitotroga cerealella, Pectinophora gossypiella , etc.,

Carposinidae: Carposina sasakii , etc.,

Zygaenidae: Illiberis pruni , etc.,

Limacodidae: Monema flavescens , etc.,

Crambidae: Ancylolomia japonica, Chilo suppressalis, Cnaphalocrosis medinalis, Ostrinia furnacalis, Ostrinia nubilalis , etc.,

Pyralidae: Cadra cautella, Galleria mellonella , etc.,

Pterophoridae: Nippoptilia vitis , etc.,

Papilionidae: Papilio xuthus , etc.,

Pieridae: Pieris rapae crucivora , etc.,

Hesperiidae: Parnara guttata guttata , etc.,

Geometridae: Ascotis selenaria , etc.,

Lasiocampidae: Dendrolimus spectabilis, Malacosomaneustrium testaceum , etc.,

Sphingidae: Agrius convolvuli , etc.,

Lymantriidae: Arna pseudoconspersa, Lymantria dispar , etc.,

Arctiidae: Hyphantria cunea , etc.,

Noctuidae: Agrotis ipsilon, Autographa nigrisigna, Helicoverpa armigera, Helicoverpa zea, Heliothis virescens, Spodoptera exigua, Spodoptera litura , etc.

As the Hymenoptera pests, there can be mentioned, for example,

Argidae: Arge pagana , etc.,

Tenthredinidae: Apethymus kuri, Athalia rosae ruficornis , etc.,

Cynipidae: Dryocosmus kuriphilus , etc.,

Vespidae: Vespa simillima xanthoptera , etc.,

Formicidae: Solenopsis invicta , etc.,

Megachilidae: Megachile nipponica , etc.

As the Oder Collembola pests, there can be mentioned, for example,

Sminthuridae: Bourletiella hortensis , etc.

As the order Thysanura pests, there can be mentioned, for example,

Lepismatidae: Lepisma saccharina, Ctenolepisma villosa , etc.

As the Blattodea pests, there can be mentioned, for example,

Blattidae: Periplaneta americana,

Blattellidae: Blattella germanica , etc.

As the Order Isoptera pests, there can be mentioned, for example,

Kalotermitidae: Incisitermes minor , etc.,

Rhinotermitidae: Coptotermes formosanus , etc.,

Termitidae: Odontotermes formosanus , etc.

As the order Psocoptera pests, there can be mentioned, for example,

Trogiidae: Trogium pulsatorium , etc.,

Liposcelididae: Liposcelis corrodens , etc.

As the order Mallohaga pests, there can be mentioned, for example,

Menoponidae: Lipeurus caponis , etc.,

Trichodectidae: Damalinia bovis , etc.

As the order Anoplura pests, there can be mentioned, for example,

Haematopinidae: Haematopinus suis , etc.,

Pediculine: Pediculus humanus , etc.,

Linognathidae: Linognathus setosus , etc.,

Pthiridae: Phthrius pubis , etc.

As the plant-feeding mites, there can be mentioned, for example,

Eupodidae: Penthaleus major , etc.,

Tarsonemidae: Phytonemus pallidus, Polyphagotarsonemus latus , etc.,

Pyemotidae: Siteroptes sp., etc.,

Tenuipalpidae: Brevipalpus lewisi , etc.,

Tuckerellidae: Tuckerella pavoniformis , etc.,

Tetranychidae: Eotetranychus boreus, Panonychus citri, Panonychus ulmi, Tetranychus urticae, Tetranychus kanzawai , etc.,

Nalepellidae: Trisetacus pini , etc.,

Eriophyidae: Aculops pelekassi, Epitrimerus pyri, Phyllocoptruta oleivola , etc.,

Diptilomiopidae: Diptacus crenatae , etc.,

Acaridae: Aleuroglyphus ovatus, Tyrophagus putrescentiae, Rhizoglyphus robini , etc.

As the plant-parasitic nematodes, there can be mentioned, for example,

Longidoridae: Xiphinema index , etc.,

Trichodoridae: Paratrichodorus minor , etc.,

Rhabditidae: Rhabditella sp., etc.,

Tylenchidae: Aglenchus sp., etc.,

Tylodoridae: Cephalenchus sp., etc.,

Anguinidae: Nothotylenchus acris, Ditylenchus destructor , etc.,

Hoplolaimidae: Rotylenchulus reniformis, Helicotylenchus dihystera , etc.,

Paratylenchidae: Paratylenchus curvitatus , etc.,

Meloidogynidae: Meloidogyne incognita, Meloidogyne hapla , etc.,

Heteroderidae: Globodera rostochiensis, Heterodera glycines , etc.,

Telotylenchidae: Tylenchorhynchus claytoni etc.,

Psilenchidae: Psilenchus sp., etc.,

Criconematidae: Criconemoides sp., etc.,

Tylenchulidae: Tylenchulus semipenetrans , etc.,

Spaeronematidae: Sphaeronema camelliae , etc.,

Pratylenchidae: Radopholus citrophilus, Radopholus similis, Nacobbus aberrans, Pratylenchus penetrans, Pratylenchus coffeae , etc.,

Iotonchiidae: Iotonchium ungulatum , etc.,

Aphelenchidae: Aphelenchus avenae , etc.,

›Advantages of the Invention · 25 of 25

Aphelenchoididae: Aphelenchoides besseyi, Aphelenchoides fragariae , etc.,

Palasitaphelenchidae: Bursaphelenchus xylophilus , etc.

As the plant-parasitic mollusk pests, there can be mentioned, for example,

Pilidae: Pomacea canaliculata , etc.,

Veronicellidae: Leavicaulis alte , etc.,

Achatinidae: Achatina fulica , etc.,

Philomycidae: Meghimatium bilineatum , etc.,

Succineidae: Succinea lauta , etc.,

Didcidae: Discus pauper , etc.,

Zonitidae: Zonitoides yessoensis , etc.,

Limacidae: Limacus flavus, Deroceras reticulatum , etc.,

Helicarionidae: Parakaliella harimensis , etc.,

Bradybaenidae: Acusta despecta sieboldiana, Bradybaena similaris , etc.

As other pests such as injurious animals, uncomfortable animals, sanitary insects, livestock insects, parasites and the like, there can be mentioned, for example,

Acari Macronysshidae: Ornithonyssus sylvialum , etc.,

Varroidae: Varroa jacobsoni , etc.,

Dermanyssidae: Dermanyssus gallinae , etc.,

Macronyssidae: Ornithonyssus sylvialum , etc.,

Ixodidae: Boophilus microplus, Rhipicephalus sanguineus, Haemaphysalis longicornis , etc.,

Sacroptidae: Sarcoptes scabiei , etc.,

Isopoda Armadillididae: Armadillidium vulgare , etc.,

Decapoda Astacidae: Procambarus clarkii , etc.,

Porcellionidae: Armadillidium vulgare , etc.,

Chilopoda pests: Scutigeromorpha Sutigeridae, Thereuonema tuberculata, Scolopendromorpha Scolopendra subpinipes , etc.

Diplopoda pests: Polydesmida Paradoxosomatidae Oxidus gracillis , etc.

Araneae Latrodectus hasseltii: Theridiiadae hasseltii , etc.,

Clubionidae: Chiracanthium japonicum , etc.,

Order Scorpionida: Androctonus crassicauda , etc.,

Parasitic roundworm: Ascaris lumbricoides, Syphacia sp., Wucherebia bancrofti , etc.,

Parasitic flatworm: Distomum sp., Paragonimus westermanii, Metagonimus yokokawai, Schistosoma japonicum, Taenia solium, Taeniarhynchus saginatus, Echinococcus sp., Diphyllobothrium latum , etc.

The present pest control agent exhibits control effect also to the above-mentioned pests, etc., which already have resistances to existing pest control agents. Furthermore, the present control agent can be applied to plants which already have resistances to insects, diseases, herbicides, etc., owing to genetic modification, artificial mating, etc.

Next, there are described the production methods, formulation methods and applications of the present compound, in detail by way of Examples. However, the present invention is in no way restricted by these Examples.

There are also described the production methods of the intermediates for production of the present compound.

EXAMPLES

›Examples30

›Example 1

Production of 2-fluoro-4-methyl-5-(2,2,2-trifluoroethylthio)phenol (Present Compound No. C-0001)

To 300 ml of toluene were added 32.0 g (119 mmol) of 2-fluoro-4-methyl-5-(2,2,2-trifluoroethylthio)phenyl boronic acid produced by the method described in PCT International Publication No. WO 2007/034755 and 15.4 g (131 mmol) of N-methylmorpholine-N-oxide, followed by refluxing for 1 hour under heating. The reaction mixture was allowed to cool to room temperature. The solvent was distilled off under reduced pressure. The residue was subjected to extraction with ethyl acetate. The organic phase obtained was washed with water and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=4:1), to obtain 25.5 g (yield: 89%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

2.38 (3H, s), 3.32 (2H, q), 5.28 (1H, brs),

6.95 (1H, d), 7.22 (1H, d)

›Example 2

Production of 4-methyl-3-(2,2,2-trifluoroethylthio)phenol (Present Compound No. C-0005)

49.7 g (225 mmol) of 4-methyl-3-(2,2,2-trifluoroethylthio)aniline was suspended in 500 ml of a 15% aqueous sulfuric acid solution. Thereinto was dropwise added an aqueous solution obtained by dissolving 18.6 g (270 mmol) of sodium nitrite in 100 ml of water, at 0 to 5° C. with ice-cooling. After the completion of the dropwise addition, the mixture was stirred for 1 hour with the temperature being kept. The reaction mixture was gradually dropped at 120° C. into a solution obtained by dissolving 71.8 g (450 mmol) of anhydrous copper sulfate in 400 ml of 60% sulfuric acid. The mixture was allowed to cool to room temperature and subjected to extraction with ethyl acetate. The organic phase obtained was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The crude product obtained was purified by column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=10:1), to obtain 19 g (yield: 38%) of an intended product.

1 H-NMR (400 MHz, CDCl 3 /TMS δ (ppm))

2.36 (3H, s), 3.38 (2H, q), 5.61 (1H, brs),

6.69 (1H, dd), 6.93 (1H, s), 7.03 (1H, d)

›Example 3

Production of 5,5-dimethylhexyl-[2-fluoro-4-methyl-5-(2,2,2-trifluoroethylthio)phenyl] ether (Present Compound No. A-0085)

To 70 ml of tetrahydrofuran were added 1.6 g (6.7 mmol) of 2-fluoro-4-methyl-3-(2,2,2-trifluoroethylthio)phenol, 1.7 g (13 mmol) of 5,5-dimethylhexanol, 2.0 g (9.9 mmol) of diisopropyl azodicarboxylate and 2.6 g (9.9 mmol) of triphenylphosphine. A reaction was carried out at room temperature for 16 hours. After confirmation of the completion of the reaction, the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=4:1), to obtain 2.3 g (yield: 97%) of an intended product.

Incidentally, the production method of 5,5-dimethylhexanol is described in, for example, J. Am. Chem. Soc., 119 (29), 6909 (1997).

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

0.88 (9H, s), 1.19-1.27 (2H, m), 1.36-1.48 (2H, m),

1.77 (2H, quint), 2.41 (3H, s), 3.29 (2H, q),

4.01 (2H, t), 6.95 (1H, d), 7.15 (1H, d)

›Example 4

Production of 5,5-dimethylhexyl-[2-fluoro-4-methyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl] ether (Present Compound No. A-0086)

In 70 ml of chloroform was dissolved 2.3 g (6.5 mmol) of 5,5-dimethylhexyl-{2-fluoro-4-methyl-5-(2,2,2-trifluoroethylthio)phenyl ether. Thereto was added, in portions in about 10 minutes, 1.5 g (6.5 mmol) of 3-chloroperbenzoic acid (purity: about 75%) at room temperature. A reaction was carried out for 1 hour. After confirmation of the completion of the reaction, the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate:triethylamine=5:1:0.01), to obtain 2.2 g (yield: 92%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

0.89 (9H, s), 1.19-1.27 (2H, m), 1.37-1.49 (2H, m),

1.81 (2H, quint), 2.31 (3H, s), 3.30-3.48 (2H, m),

4.10 (2H, t), 6.98 (1H, d), 7.55 (1H, d)

›Example 5

Production of 5-trifluoromethylthiopentyl-[4-methyl-3-(2,2,2-trifluoroethylthio)phenyl] ether (Present Compound No. A-0438)

To 100 ml of tetrahydrofuran were added 1.5 g (4.3 mmol) of 5-thiocyanatopentyl-{4-methyl-3-(2,2,2-trifluroethylthio)phenyl} ether and 1.8 g (13 mmol) of trifluoromethyltrimetylsilane. Thereto was added, at 0° C., 5 ml (5.0 mmol) of a tetra-n-butylammonium fluoridetetrahydrofuran (1 mol/liter) solution. A reaction was carried out for 1 hour. After confirmation of the completion of the reaction, the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=10:1), to obtain 1.3 g (yield: 77%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

1.56-1.64 (2H, m), 1.73-1.85 (4H, m), 2.38 (3H, s),

2.91 (2H, t), 3.40 (2H, q), 3.94 (2H, t), 6.75 (1H, dd), 7.00 (1H, d), 7.11 (1H, d)

›Example 6

Production of 5-chloropentyl-[4-methyl-3-(2,2,2-trifluoroethylthio)phenyl] ether (Present Compound No. A-0279)

To 100 ml of acetonitrile were added 2.5 g (11 mmol) of 4-methyl-3-(2,2,2-trifluoroethylthio)phenol, 2.5 g (13 mmol) of 1-bromo-5-chloropentane, 1.9 g (14 mmol) of potassium carbonate and 0.35 g (1.1 mmol) of tetra-n-butylammonium bromide. The mixture was refluxed for 5 hours under heating and then allowed to cool to room temperature. The solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=10:1), to obtain 2.9 g (yield: 79%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

1.56-1.66 (2H, m), 1.74-1.93 (4H, m), 2.38 (3H, s),

3.36 (2H, q), 3.56 (2H, t), 3.94 (2H, t), 6.74 (1H, d), 7.00 (1H, s), 7.09 (1H, d)

›Example 7

Production of 5-thiocyanatopentyl-[4-methyl-3-(2,2,2-trifluoroethylthio)phenyl] ether (Present Compound No. A-0672)

To 100 ml of ethanol were added 2.0 g (6.1 mmol) of 5-chloropentyl-{4-methyl-3-(2,2,2-trifluoroethylthio)phenyl} ether, 4.0 g (41 mmol) of potassium thiocyanate and 0.10 g (0.61 mmol) of potassium iodide. The mixture was refluxed for 10 hours under heating and then allowed to cool to room temperature. The solvent was distilled off under reduced pressure. To the residue was added ethyl acetate to conduct extraction. The organic phase obtained was washed with water and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=10:1), to obtain 1.8 g (yield: 84%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

1.53-1.68 (2H, m), 1.76-1.87 (4H, m), 2.38 (3H, s),

3.00 (2H, t), 3.39 (2H, q), 3.97 (2H, t), 6.74 (1H, d), 7.00 (1H, s), 7.13 (1H, d)

›Example 8

Production of 5-trifluoromethylthiopentyl-[4-methyl-3-(2,2,2-trifluoroethylsulfinyl)phenyl] ether (Present Compound No. A-0439)

In 100 ml of chloroform was dissolved 0.98 g (2.5 mmol) of 5-trifluoromethylthiopentyl-{4-methyl-5-(2,2,2-trifluoroethylthio)phenyl} ether. Thereto was added, in portions in about 10 minutes, 0.58 g (2.5 mmol) of 3-chloroperbenzoic acid (purity: about 75%) at room temperature. A reaction was carried out for 1 hour. After confirmation of the completion of the reaction, the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate:triethylamine=5:1:0.01), to obtain 0.78 g (yield: 77%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

1.57-1.64 (2H, m), 1.73-1.88 (4H, m), 2.31 (3H, s),

2.92 (2H, t), 2.32-3.45 (2H, m), 4.05 (2H, t),

6.97 (1H, dd), 7.15 (1H, d), 7.48 (1H, d)

›Example 9

Production of 4-chloro-2-fluoro-5-(2,2,2-trifluoroethylthio)phenol (Present Compound No. C-0003)

To 200 ml of toluene were added 33 g (114 mmol) of 4-chloro-2-fluoro-5-(2,2,2-trifluoroethylthio)phenyl boronic acid and 16 g (137 mmol) of N-methylmorpholine-N-oxide. The mixture was refluxed for 1 hour under heating. After confirmation of the completion of the reaction, the mixture was allowed to cool to room temperature. Then the solvent was distilled off under reduced pressure, and the residue was subjected to extraction with ethyl acetate. The organic phase obtained was washed with water and dried over anhydrous magnesium sulfate and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography to obtain 24.5 g (yield: 82%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

3.43 (2H, q), 5.31 (1H, d), 7.16 (1H, d), 7.31 (1H, d)

›Example 10

Production of 5-bromopentyl-[4-chloro-2-fluoro-5-(2,2,2-trifluoroethylthio)phenyl] ether (Present Compound No. A-0273)

To 60 ml of acetonitrile were added 3.0 g (11.5 mmol) of 4-chloro-2-fluoro-5-(2,2,2-trifluoroethylthio)phenol, 13.2 g (57.4 mmol) of 1,5-dibromopentane, 2.1 g (15.0 mmol) of potassium carbonate and 0.37 g (1.15 mmol) of tetra-n-butylammonium bromide. The mixture was refluxed for 1.5 hour under heating. The mixture was allowed to cool to room temperature, and insoluble matters were removed by filtration. Then the filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=20:1), to obtain 4.2 g (yield: 89%) of an intended product.

1 H-NMR (400 MHz, CDCl 3 /TMS δ (ppm))

1.59-1.69 (2H, m), 1.82-1.99 (4H, m), 3.36-3.47 (4H, m), 4.03 (2H, t), 7.20 (1H, d), 7.23 (1H, d)

›Example 11

Production of 5-thiocyanatopentyl-[4-chloro-2-fluoro-5-(2,2,2-trifluoroethylthio)phenyl] ether (Present Compound No. A-0670)

To 60 ml of ethanol were added 4.2 g (10.3 mmol) of 5-bromopentyl-[4-chloro-2-fluoro-5-(2,2,2-trifluoroethylthio)phenyl] ether and 5.0 g (51.5 mmol) of potassium thiocyanate. The mixture was refluxed for 4 hours under heating. The mixture was allowed to cool to room temperature, and the solvent was distilled off under reduced pressure. Then extraction was conducted by adding water and ethyl acetate. The organic phase obtained was dried over anhydrous magnesium sulfate and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=10:1), to obtain 3.9 g (yield: 98%) of an intended product.

1 H-NMR (400 MHz, CDCl 3 /TMS δ (ppm))

1.59-1.69 (2H, m), 1.82-1.99 (4H, m), 2.99 (2H, t)

3.42 (2H, q), 4.04 (2H, t), 7.20 (1H, d), 7.23 (1H, d)

›Example 12

Production of 5-trifluoromethylthiopentyl-[4-chloro-2-fluoro-5-(2,2,2-trifluoroethylthio)phenyl] ether (Present Compound No. A-0433)

To 60 ml of tetrahydrofuran were added 3.9 g (10.1 mmol) of 5-thiocyanatopentyl-[4-chloro-2-fluoro-5-(2,2,2-trifluoroethylthio)phenyl] ether and 4.5 g (31.6 mmol) of trifluoromethyltrimethylsilane. Thereto was added 1.0 ml (1.04 mmol) of tetrahydrofuran solution (1 mol/liter) of tetra-n-butylammonium fluoride at 0° C., and reaction was carried out. The mixture was stirred overnight at room temperature. Then, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=20:1), to obtain 2.60 g (yield: 60%) of an intended product.

1 H-NMR (400 MHz, CDCl 3 /TMS δ (ppm))

1.58-1.66 (2H, m), 1.73-1.89 (4H, m), 2.92 (2H, t),

3.41 (2H, q), 4.03 (2H, t), 7.21 (1H, d), 7.23 (1H, d)

›Example 13

Production of 5-trifluoromethylthiopentyl-[4-chloro-2-fluoro-5-(2,2,2-trifluoroethylsulfinyl)phenyl] ether (Present Compound No. A-0434)

In 50 ml of chloroform was dissolved 2.60 g (6.03 mmol) of 5-trifluoromethylthiopentyl-[4-chloro-2-fluoro-5-(2,2,2-trifluoroethylthio)phenyl] ether. Thereto was added 1.39 g (6.04 mmol) of 3-chloroperbenzoic acid (purity: about 75%) at 0° C., and the mixture was stirred overnight at room temperature. Then, the solvent was distilled off under reduced pressure, 1 ml of triethylamine was added to the residue, and the residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=5:1), to obtain 2.06 g (yield: 76%) of an intended product.

1 H-NMR (400 MHz, CDCl 3 /TMS δ (ppm))

1.57-1.66 (2H, m), 1.74-1.93 (4H, m), 2.92 (2H, t),

3.30-3.43 (1H, m), 3.66-3.78 (1H, m), 4.13 (2H, t),

7.21 (1H, d), 7.54 (1H, d)

›Example 14

Production of 2,4-dichloro-5-(2,2,2-trifluoroethylthio)phenol (Present Compound No. C-0014)

To 150 ml of toluene was added 29.0 g (50% aqueous solution, 124 mmol) of N-methylmorpholine-N-oxide, and dehydration was conducted by heating under reflux for 1 hour. To the reaction mixture was dropwise added 31.5 g (103 mmol) of 2,4-dichloro-5-(2,2,2-trifluoroethylthio)phenylboronic acid dissolved in ethyl acetate, and the mixture was refluxed for 3 hours under heating. Then, the mixture was allowed to cool to room temperature, and 10% aqueous hydrochloric acid was added, followed by extraction with ethyl acetate. The organic phase obtained was washed with saturated sodium chloride solution, dried over anhydrous magnesium sulfate and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=10:1), to obtain 27.2 g (yield: 95%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

3.48 (2H, q), 5.70 (1H, s), 7.20 (1H, s), 7.41 (1H, s)

›Example 15

Production of 6-bromohexyl-[2,4-dichloro-5-(2,2,2-trifluoroethylthio)phenyl] ether (Present Compound No. A-0283)

To 30 ml of acetonitrile were added 1.0 g (3.61 mmol) of 2,4-dichloro-5-(2,2,2-trifluoroethylthio)phenol, 3.5 g (14.4 mmol) of 1,6-dibromohexane, 0.65 g (15.0 mmol) of potassium carbonate and 0.12 g (0.37 mmol) of tetra-n-butylammonium bromide. The mixture was refluxed for 3 hours under heating. The mixture was allowed to stand at room temperature, and insoluble matters were removed by filtration. Then the filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=20:1), to obtain 1.51 g (yield: 95%) of an intended product.

1 H-NMR (400 MHz, CDCl 3 /TMS δ (ppm))

1.50-1.60 (4H, m), 1.81-1.93 (4H, m),

3.39-3.49 (4H, m), 4.02 (2H, t), 7.13 (1H, s),

7.45 (1H, s)

›Example 16

Production of 6-thiocyanatohexyl-[2,4-dichloro-5-(2,2,2-trifluoroethylthio)phenyl] ether (Present Compound No. A-0678)

In 30 ml of ethanol were added 1.51 g (3.43 mmol) of 6-bromohexyl-[2,4-dichloro-5-(2,2,2-trifluoroethylthio)phenyl] ether and 1.67 g (17.2 mmol) of potassium thiocyanate. The mixture was refluxed for 3 hours under heating. The mixture was allowed to cool to room temperature, and the solvent was distilled off under reduced pressure. Then extraction was conducted by adding ethyl acetate and water. The organic phase obtained was dried over anhydrous magnesium sulfate and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=10:1), to obtain 1.04 g (yield: 73%) of an intended product.

1 H-NMR (400 MHz, CDCl 3 /TMS δ (ppm))

1.50-1.62 (4H, m), 1.83-1.92 (4H, m), 2.96 (2H, t),

3.45 (2H, q), 4.03 (2H, t), 7.13 (1H, s), 7.46 (1H, s)

›Example 17

Production of 6-trifluoromethylthiohexyl-[2,4-dichloro-5-(2,2,2-trifluoroethylthio)phenyl] ether (Present Compound No. A-0478)

To 30 ml of tetrahydrofuran were added 1.04 g (2.49 mmol) of 6-thiocyanatohexyl-[2,4-dichloro-5-(2,2,2-trifluoroethylthio)phenyl] ether and 1.06 g (7.45 mmol) of trifluoromethyltrimethylsilane. Thereto was added 0.25 ml (concentration: 1 mol/liter, 0.25 mmol) of tetrahydrofuran solution of tetra-n-butylammonium fluoride at 0° C., and reaction mixture was stirred for 2 hours at room temperature. Then, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=20:1), to obtain 0.73 g (yield: 64%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

1.44-1.62 (4H, m), 1.67-1.90 (4H, m), 2.90 (2H, t),

3.44 (2H, q), 4.02 (2H, t), 7.13 (1H, s), 7.46 (1H, s)

›Example 18

Production of 6-trifluoromethylthiohexyl-[2,4-dichloro-5-(2,2,2-trifluoroethylsulfinyl)phenyl] ether (Present Compound No. A-0479)

In 30 ml of chloroform was dissolved 0.53 g (1.15 mmol) of 6-trifluoromethylthiohexyl-[2,4-dichloro-5-(2,2,2-trifluoroethylthio)phenyl] ether. Thereto was added 0.26 g (1.13 mmol) of 3-chloroperbenzoic acid (purity: about 75%) at 0° C., and the mixture was stirred for 3 hours at room temperature. Then, the solvent was distilled off under reduced pressure, 0.5 ml of triethylamine was added to the residue, and the residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=5:1), to obtain 0.41 g (yield: 75%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

1.48-1.64 (4H, m), 1.63-1.94 (4H, m), 2.90 (2H, t),

3.28-3.44 (1H, m), 3.68-3.81 (1H, m), 4.13 (2H, t)

7.47 (1H, s), 7.48 (1H, s)

›Example 19

Production of 2,4-dichloro-5-(2,2,2-trifluoroethylsulfinyl)phenol (Present Compound No. C-0015)

In 80 ml of chloroform was dissolved 10.0 g (36.08 mmol) of 2,4-dichloro-5-(2,2,2-trifluoroethylthio)phenol. Thereto was added 9.80 g (39.75 mmol) of 3-chloroperbenzoic acid (purity: about 70%) under ice cooling, and the mixture was stirred for 30 minutes at room temperature. Then, saturated aqueous solution of sodium thiosulfate was added to the reaction mixture to decompose excess peroxide. Thereafter, the solvent was distilled off under reduced pressure, and extraction was conducted by adding ethyl acetate and water. The organic phase obtained was washed by aqueous potassium carbonate solution and saturated aqueous sodium chloride solution in this order, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, to obtain 9.30 g (yield: 88%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

3.30-3.44 (1H, m), 3.66-3.80 (1H, m), 7.40 (1H, s),

7.61 (1H, s)

›Example 20

Production of 2-(4-trifluoromethylphenyl)ethyl-[2,4-dichloro-5-(2,2,2-trifluoroethylsulfinyl)phenyl] ether (Present Compound No. A-0767)

In 30 ml of tetrahydrofuran were dissolved 0.5 g (1.71 mmol) of 2,4-dichloro-5-(2,2,2-trifluoroethylsulfinyl)phenol, 0.33 g (1.74 mmol) of 2-(4-trifluoromethylphenyl)ethanol and 0.49 g (1.87 mmol) of triphenylphosphine. Thereto was added 0.38 g (1.87 mmol) of diisopropyl azodicarboxylate at room temperature, and the reaction mixture was stirred for 16 hours. Then, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=5:1), to obtain 0.41 g (yield: 52%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

3.21-3.40 (3H, m), 3.64-3.79 (1H, m), 4.31-4.36 (2H, m), 7.44-7.46 (4H, m), 7.58 (2H, d)

›Example 21

Production of 2,4-dimethyl-5-(2,2,2-trifluoroethylthio)phenol (Present Compound No. C-0017)

To 200 ml of toluene were added 20.24 g (58.5 mmol) of [2,4-dimethyl-5-(2,2,2-trifluoroethylthio)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (a compound described in PCT International Publication No. WO 2012/176856 as Compound No. 55-47) and 8.22 g (70.16 mmol) of N-methylmorpholine-N-oxide. The mixture was refluxed for 2 hours under heating. The reaction mixture was allowed to cool to room temperature, washed and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and the residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=20:1), to obtain 10.54 g (yield: 76%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

2.20 (3H, s), 2.36 (3H, s), 3.32 (2H, q), 4.78 (1H, s), 6.93 (1H, s), 6.98 (1H, s)

›Example 22

Production of 2,4-dimethyl-5-(2,2,2-trifluoroethylsulfinyl)phenol (Present Compound No. C-0018)

In 30 ml of chloroform was dissolved 2.60 g (11.0 mmol) of 2,4-dimethyl-5-(2,2,2-trifluoroethylthio)phenol. Thereto was added 3.25 g (13.18 mmol) of 3-chloroperbenzoic acid (purity: about 70%) under ice cooling, and the mixture was stirred for 30 minutes at room temperature. Then, saturated aqueous solution of sodium thiosulfate was added to the reaction mixture to decompose excess peroxide. Thereafter, the solvent was distilled off under reduced pressure, and phase separation was conducted by adding ethyl acetate and water. The organic phase obtained was washed by aqueous potassium carbonate solution and saturated aqueous sodium chloride solution, and dried over magnesium sulfate. The solvent was distilled off under reduced pressure, to obtain 2.13 g (yield: 77%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

2.25 (6H, s), 3.35-3.53 (2H, m), 6.98 (1H, s),

7.63 (1H, s), 7.69 (1H, s)

›Example 23

Production of 2-(4′-trifluoromethoxyphenyl)ethyl-[2,4-dimethyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl] ether (Present Compound No. A-0783)

In 30 ml of tetrahydrofuran were dissolved 0.3 g (1.19 mmol) of 2,4-dimethyl-5-(2,2,2-trifluoroethylsulfinyl)phenol, 0.29 g (1.41 mmol) of 2-(4′-trifluoromethoxyphenyl)ethanol and 0.41 g (1.56 mmol) of triphenylphosphine. Thereto was added 0.31 g (1.53 mmol) of diisopropyl azodicarboxylate at room temperature, and stirred for 16 hours. The solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=5:1), and the residue was washed with n-hexane, to obtain 0.21 g (yield: 40%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

2.18 (3H, s), 2.26 (3H, s), 3.13 (2H, t),

3.32-3.41 (2H, m), 4.24-4.25 (2H, m),

6.70 (1H, s), 7.16 (2H, d), 7.30-7.36 (3H, m)

›Example 24

Production of 6-bromohexyl-[2,4-dimethyl-5-(2,2,2-trifluoroethylthio)phenyl] ether (Present Compound No. A-0284)

To 60 ml of acetonitrile were added 1.14 g (4.83 mmol) of 2,4-dimethyl-5-(2,2,2-trifluoroethylthio)phenol, 4.71 g (19.31 mmol) of 1,6-dibromohexane, 0.73 g (5.28 mmol) of potassium carbonate and catalytic amount of tetra-n-butylammonium bromide. The mixture was refluxed for 3 hours under heating. The mixture was allowed to cool to room temperature, and insoluble matters were removed by filtration. Then the solvent of filtrate was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=40:1-20:1), to obtain 1.87 g (yield: 97%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

1.53 (4H, m), 1.70-2.03 (4H, m), 2.17 (3H, s),

2.38 (3H, s), 3.26-3.43 (4H, m), 3.94 (2H, t),

6.96 (1H, s), 6.99 (1H, s)

›Example 25

Production of 6-thiocyanatohexyl-[2,4-dimethyl-5-(2,2,2-trifluoroethylthio)phenyl] ether (Present Compound No. A-0679)

To 60 ml of ethanol were added 1.87 g (4.68 mmol) of 6-bromohexyl-[2,4-dimethyl-5-(2,2,2-trifluoroethylthio)phenyl] ether and 2.28 g (23.46 mmol) of potassium thiocyanate. The mixture was refluxed for 8 hours under heating. The mixture was allowed to cool to room temperature, and the solvent was distilled off under reduced pressure. Then extraction was conducted by adding ethyl acetate and water. The organic phase obtained was washed with water, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=20:1), to obtain 1.37 g (yield: 77%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

1.53-1.54 (4H, m), 1.82-1.87 (4H, m), 2.17 (3H, s)

2.38 (3H, s), 2.96 (2H, t), 3.31 (2H, q), 3.94 (2H, t)

6.96 (1H, s), 6.70 (1H, s)

›Example 26

Production of 6-trifluoromethylthiohexyl-[2,4-dimethyl-5-(2,2,2-trifluoroethylthio)phenyl] ether (Present Compound No. A-0480)

To 100 ml of tetrahydrofuran were added 1.37 g (3.63 mmol) of 6-thiocyanatohexyl-[2,4-dimethyl-5-(2,2,2-trifluoroethylthio)phenyl] ether and 1.29 g (9.07 mmol) of trifluoromethyltrimethylsilane. Thereto was added 0.4 ml (0.4 mmol) of tetrahydrofuran solution of tetra-n-butylammonium fluoride (1 mol/liter) at 0° C., and the mixture was stirred for 4 hours at 0° C. Then, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=20:1), to obtain 1.36 g (yield: 89%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

1.49-1.53 (4H, m), 1.71-1.82 (4H, m), 2.17 (3H, s)

2.38 (3H, s), 2.90 (2H, t), 3.30 (2H, q), 3.94 (2H, t)

6.96 (1H, s), 6.70 (1H, s)

›Example 27

Production of 6-trifluoromethylthiohexyl-[2,4-dimethyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl]ether (Present Compound No. A-0481)

In 40 ml of chloroform was dissolved 1.36 g (3.23 mmol) of 6-trifluoromethylthiohexyl-[2,4-dimethyl-5-(2,2,2-trifluoroethylthio)phenyl]ether. Thereto was added 0.67 g (2.72 mmol) of 3-chloroperbenzoic acid (purity: about 70%) under ice cooling, and the mixture was stirred for 30 minutes at room temperature. Then, saturated aqueous solution of sodium thiosulfate was added to the reaction mixture to decompose excess peroxide. Thereafter, the solvent was distilled off under reduced pressure, and extraction was conducted by adding ethyl acetate and water. The organic phase obtained was washed by aqueous potassium carbonate solution and saturated aqueous sodium chloride solution in this order, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=5:1), to obtain 0.87 g (yield: 62%) of an intended product.

1 H-NMR (400 MHz, CDCl 3 /TMS δ (ppm))

1.50-1.52 (4H, m), 1.72-1.85 (4H, m), 2.23 (3H, s),

2.28 (3H, s), 2.90 (2H, t), 3.28-3.47 (2H, m),

4.04 (2H, t), 7.01 (1H, s), 7.36 (1H, s)

›Example 28 · 1 of 3

Production of 5-trifluoromethylthiopentyl-[4-chloro-2-fluoro-5-(2,2,2-trifluoroethylsulfinyl)phenyl]ether optical isomer

An optical active column (internal diameter: 20 mm, length: 250 mm), CHIRAL PAK AD (trade name) manufactured by Daicel Corporation, was equipped with high performance liquid chromatography equipment, and a mixed solvent (hexane:2-propanol=97:3) was perfused as mobile phase. Then, 150 mg of 5-trifluoromethylthiopentyl-[4-chloro-2-fluoro-5-(2,2,2-trifluoroethylsulfinyl)phenyl]ether (racemic mixture) dissolved in 2-propanol was injected, and analysis was conducted in a following conditions.

flow speed: 8.0 ml/minute

temperature: room temperature

detector: ultraviolet absorption detector (254 nm)

As a result, there observed peak 1 (retention time: 17.8 minutes) and peak 2 (retention time: 30.2 minutes), and 70 mg of a compound of respective peaks (both optical purity was 100% e.e.) were isolated. Measurement of respective Reflective Index revealed that Specific Rotation of the component of peak 1 was [α] D 25 =−120.28° (C=0.50/methanol) and Specific Rotation of the component of peak 2 was [α] D 25 =+119.32° (C=0.50/methanol).

Accordingly, the component of the peak 1 is (−)-5-trifluoromethylthiopentyl-[4-chloro-2-fluoro-5-(2,2,2-trifluoroethylsulfinyl)phenyl]ether [(−)-enantiomer of the present compound No. A-0434], and the component of the peak 2 is (+)-5-trifluoromethylthiopentyl-[4-chloro-2-fluoro-5-(2,2,2-trifluoroethylsulfinyl)phenyl]ether [(+)-enantiomer of the present compound No. A-0434].

Reference Example 1

Production of p-acetotoluidine

100 g (933.3 mmol) of p-toluidine and 154.8 g (1,120 mmol) of potassium carbonate were dissolved in a mixed solvent of 1,000 ml of ethyl acetate and 500 ml of water. Thereinto was dropped 87.9 g (1,120 mmol) of acetyl chloride with ice-cooling, followed by stirring for 2 hours. Extraction with ethyl acetate was carried out. The organic phase obtained was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure. The crude crystal obtained was washed with hexane to obtain 130 g (yield: 93%) of p-acetotoluidine.

1 H-NMR (400 MHz, CDCl 3 /TMS δ (ppm))

2.16 (3H, s), 2.31 (3H, s), 7.11-7.16 (3H, m),

7.37 (2H, d)

Reference Example 2

Production of 3-chlorosulfonyl-4-methylacetoanilide

130 g (871 mmol) of p-acetotoluidine was gradually added to 405 g (3,477 mmol) of chlorosulfonic acid at room temperature, followed by stirring at 60° C. for 1 hour. The reaction mixture was allowed to stand at room temperature and then poured into ice water. Extraction with ethyl acetate was conducted. The organic phase obtained was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 162 g (yield: 75%) of 3-chlorosulfonyl-4-methylacetoanilide.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

2.22 (3H, s), 2.73 (3H, s), 7.37 (2H, d),

7.50 (1H, brs), 8.00 (1H, s), 8.02 (1H, d)

Reference Example 3

Production of 3-acetylthio-4-methylacetoanilide

162 g (654 mmol) of 3-chlorosulfonyl-4-methylacetoanilide was dissolved in 700 ml of acetic acid. Thereto were added 30 g (983 mmol) of red phosphorus and 1.7 g (6.6 mmol) of iodine, followed by stirring for 5 hours under heating and refluxing. The reaction mixture was allowed to cool to room temperature and then filtered through Celite. The filtrate was concentrated under reduced pressure. The residue was dissolved in ethyl acetate. The solution was washed with an aqueous sodium thiosulfate solution and water. The organic phase obtained was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 77.5 g (yield: 53%) of 3-acetylthio-4-methylacetoanilide.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

2.12 (3H, s), 2.30 (3H, s), 2.43 (3H, s),

7.21-7.28 (2H, m), 7.46 (1H, d), 7.54 (1H, s)

Reference Example 4

Production of 4-methyl-3-mercaptoaniline

77.5 g (347 mmol) of 3-acetylthio-4-methylacetoanilide was suspended in 700 ml of water. Thereto was added 111 g (2,777 mmol) of sodium hydroxide with stirring. The mixture was stirred for 2 hours under heating and refluxing, and then was allowed to cool to room temperature. The mixture was adjusted to pH 5 using an aqueous hydrochloric acid solution (36%) with stirring under ice-cooling. Extraction with ethyl acetate was conducted. The organic phase obtained was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 47.6 g (yield: 99%) of 4-methyl-3-mercaptoaniline.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

2.21 (3H, s), 3.21 (1H, s), 3.64 (2H, brs),

6.43 (1H, dd), 6.64 (1H, d), 6.92 (1H, d)

Reference Example 5

Production of 4-methyl-3-(2,2,2-trifluoroethylthio)aniline

47.6 g (342 mmol) of 4-methyl-3-mercaptoaniline was dissolved in 500 ml of N,N-dimethylformamide. Thereto was added 71 g (513 mmol) of potassium carbonate, followed by stirring for 1 hour. To the reaction mixture were added 4.8 g (31.1 mmol) of Rongalit and 122 g (582 mmol) of 2,2,2-trifluoroidoethane in this order, followed by stirring overnight at room temperature. Water was added and extraction with ethyl acetate was conducted. The organic phase obtained was washed with a saturated aqueous sodium chloride solution and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure. The crude product obtained was purified by silica gel column chromatography (developing solvent: a mixed solvent of n-hexane:ethyl acetate=10:1), to obtain 63.8 g (yield: 84%) of 4-methyl-3-(2,2,2-trifluoroethylthio)aniline.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

2.34 (3H, s), 3.37 (2H, q), 3.59 (2H, brs),

6.56 (1H, dd), 6.82 (1H, d), 6.99 (1H, d)

Reference Example 6

Production of 4-chloro-2-fluoro-5-(2,2,2-trifluoroethylthio)phenyl boronic acid

To 180 ml of diethyl ether was dissolved 15.9 g (49.1 mmol) of (5-bromo-4-chloro-2-fluorophenyl)-2,2,2-trifluoroethylsulfide which was produced by a method described in PCT International Publication No. WO 2012/176856, and the mixture was cooled to −70° C. under nitrogen atmosphere. Thereto was dropwise added 30 ml of n-butyllithium (n-hexane solution, 1.64 mol/liter) for 10 minutes. After 5 minutes, a mixed solution obtained by dissolving 5.1 g (49.1 mmol) of trimethyl borate in 10 ml of diethylether was dropwise added in 10 minutes. Then, the temperature of the reaction mixture was raised to −20° C., 48 g of 20% sulfuric acid was dropwise added, and reaction was conducted in a room temperature for 1.5 hour. To the reaction mixture, ethyl acetate was added, the organic phase obtained was washed with water and aqueous sodium chloride solution, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and the residue was washed with n-hexane, to obtain 9.64 g (yield: 68%) of an intended product.

›Example 28 · 2 of 3

1 H-NMR (400 MHz, CDCl 3 /TMS δ (ppm))

3.49 (2H, q), 7.30 (1H, d), 8.29 (1H, d)

Reference Example 7

Production of 2,4-dichloro-5-(2,2,2-trifluoroethylthio)phenyl boronic acid

To 700 ml of diethyl ether was dissolved 46.4 g (136 mmol) of (5-bromo-2,4-dichlorophenyl)-2,2,2-trifluoroethylsulfide which was produced by a method described in PCT International Publication No. WO 2012/176856, and the mixture was cooled to −70° C. under nitrogen atmosphere. Thereto was dropwise added 82.7 ml of n-butyllithium (n-hexane solution, 1.64 mol/liter) for 10 minutes. After 5 minutes, a mixed solution obtained by dissolving 14.1 g (136 mmol) of trimethyl borate in 100 ml of diethylether was dropwise added in 10 minutes. Then, the temperature of the reaction mixture was raised to −20° C., 230 ml of 12% (approximately) sulfuric acid was dropwise added, and reaction was conducted in a room temperature for 1.5 hour. The solvent was distilled of under reduced pressure, and to the residue, ethyl acetate was added. The organic phase obtained was washed with water and aqueous sodium chloride solution, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and the residue was washed with n-hexane, to obtain 32.58 g (yield: 79%) of an intended product.

1 H-NMR (300 MHz, CDCl 3 /TMS δ (ppm))

3.49 (2H, q), 5.34 (2H, s), 7.47 (1H, s), 8.11 (1H, s)

The physical properties (melting point, refractive index, 1 H-NMR spectrum data and specific rotation of optical isomer) of the present compounds [I] and [I′] synthesized based on the Examples (including the physical properties shown in the Examples) are shown in Table 43 to Table 71. Incidentally, the compound Nos. and symbols in Tables have the same meanings as given above.

Next, there are specifically explained examples of formulating the present pest control agent by using the present alkyl phenyl sulfide derivative produced as above or the agriculturally acceptable salt thereof. The kinds and proportions of compounds and additives used in each formulation are not restricted to those shown in the following Formulation Examples and may be varied in a wide range. In the following explanation, “parts (part)” refer (refers) to mass parts (mass part).

[Formulation Example 1] Emulsifiable Concentrate

The above materials were dissolved homogeneously to obtain an emulsifiable concentrate.

[Formulation Example 2] Wettable Powder

The above materials were mixed and ground to obtain a wettable powder.

[Formulation Example 3] Dust Formulation

The above materials were mixed and ground to obtain a dust formulation.

[Formulation Example 4] Granule

The above materials were mixed homogeneously and ground. Thereto was added 20 parts of water, followed by kneading. The kneaded material was passed through an extrusion-granulator to obtain granules of 14 to 32 meshes. The granules were dried to obtain a granule.

[Formulation Example 5] Flowable Concentrate

The above materials were mixed for 30 minutes using a high-speed stirrer and then ground using a wet grinder to obtain a flowable concentrate.

The next, the effect of the present pest control agent is shown by Test Examples.

[Test Example 1] Control Effect Test for Tetranychus urticae Koch (Two Spotted Spider Mite)

A wettable powder prepared based on Formulation Example 2 was diluted with water into an active ingredient concentration of 4 ppm. In the solution were immersed soybean seedlings which had been inoculated with 35 female adults of two spotted spider mite. The soybean seedlings were dried in the air and placed in a thermostat of 25° C. After 13 days, the number of living female adults was examined and the control value of the active ingredient was determined using the calculation formula of the following Mathematical Expression 1. This test was conducted with no replication.

Control value=100−[(number of living female adults after 13 days, in treated seedlings)/(number of living female adults after 13 days, in non-treated seedlings)]×100 [Mathematical Expression 1]

Tests similar to the above were conducted using, as comparative compounds, compound Nos. 22 and 23 described in JP-A-1975-29744, compound Nos. 3, 4, 5, 6 described in JP-A-1976-19121 and compound Nos. 18, 19 and 36 described in JP-A-1988-41451. The structures of these comparative compounds are as follows.

Compound Nos. of the compounds which gave, in the above test, a control value of 90 or above, are shown below. A-0013, A-0017, A-0018, A-0024, A-0047, A-0052, A-0055, A-0056, A-0075, A-0077, A-0078, A-0079, A-0085, A-0086, A-0088, A-0089, A-0090, A-0092, A-0094, A-0108, A-0113, A-0115, A-0116, A-0117, A-0120, A-0123, A-0125, A-0126, A-0130, A-0133, A-0141, A-0144, A-0145, A-0147, A-0157, A-0160, A-0164, A-0168, A-0170, A-0175, A-0181, A-0185, A-0204, A-0212, A-0216, A-0220, A-0222, A-0223, A-0224, A-0244, A-0257, A-0262, A-0271, A-0277, A-0316, A-0318, A-0319, A-0320, A-0321, A-0322, A-0324, A-0325, A-0326, A-0327, A-0328, A-0329, A-0330, A-0331, A-0338, A-0339, A-0340, A-0341, A-0343, A-0346, A-0347, A-0352, A-0353, A-0356, A-0359, A-0360, A-0363, A-0365, A-0368, A-0369, A-0379, A-0387, A-0388, A-0391, A-0392, A-0393, A-0394, A-0396, A-0406, A-0416, A-0418, A-0432, A-0434, A-0438, A-0439, A-0440, A-0441, A-0443, A-0444, A-0445, A-0446, A-0447, A-0448, A-0449, A-0471, A-0472, A-0473, A-0474, A-0475, A-0476, A-0477, A-0478, A-0479, A-0481, A-0482, A-0483, A-0484, A-0485, A-0487, A-0489, A-0495, A-0502, A-0503, A-0504, A-0505, A-0507, A-0508, A-0510, A-0524, A-0525, A-0526, A-0533, A-0536, A-0539, A-0543, A-0544, A-0553, A-0554, A-0555, A-0556, A-0557, A-0558, A-0559, A-0560, A-0561, A-0562, A-0563, A-0570, A-0571, A-0573, A-0574, A-0575, A-0576, A-0577, A-0578, A-0587, A-0588, A-0589, A-0590, A-0591, A-0592, A-0594, A-0599, A-0605, A-0606, A-0610, A-0611, A-0616, A-0617, A-0618, A-0622, A-0623, A-0625, A-0626, A-0631, A-0632, A-0638, A-0640, A-0642, A-0644, A-0665, A-0674, A-0683, A-0684, A-0686, A-0690, A-0692, A-0693, A-0694, A-0695, A-0697, A-0698, A-0703, A-0709, A-0710, A-0711, A-0712, A-0713, A-0716, A-0717, A-0724, A-0728, A-0734, A-0735, A-0736, A-0741, A-0743, A-0744, A-0745, A-0746, A-0748, A-0751, A-0752, A-0753, A-0754, A-0755, A-0757, A-0758, A-0761, A-0762, A-0763, A-0764, A-0765, A-0766, A-0767, A-0768, A-0769, A-0772, A-0773, A-0774, A-0775, A-0776, A-0778, A-0779, A-0780, A-0781, A-0782, A-0783, A-0784, A-0786, A-0787, A-0788, A-0789, A-0790, A-0791, A-0792, A-0793, A-0797, A-0798, A-0799, A-0800, A-0802, A-0805, A-0806, A-0807, A-0808, A-0809, A-0810, A-0813, A-0814, A-0816, A-0817, A-0818, A-0819, A-0820, A-0821, A-0822, A-0823, A-0824, A-0825, A-0826, A-0827, A-0838, A-0839, A-0844, A-0845, A-0853, A-0855, A-0856, A-0857, A-0860, A-0869, A-0870, A-0878, A-0880, A-0881, A-0885, A-0902, A-0913, A-0914, A-0915, A-0916, A-0917, A-0918, A-0921, A-0923, A-0924, A-0936, A-0940, A-0941, A-0942, A-0948, A-0956, A-0957, A-0969, A-0971, A-0973, A-0978, A-0979, A-0980, A-0982, A-0983, A-0984, A-0985, A-0988, A-0989, A-0990, A-0991, A-0992, A-1011, A-1032, A-1033, A-1052, A-1081, A-1087, A-1088, A-1107, A-1108, A-1112, A-1113, A-1119, A-1125, A-1126, A-1127, A-1128, A-1132, A-1136, A-1138, A-1140, A-1142, A-1149, A-1150, A-1151, A-1152, A-1154, A-1155, A-1156, A-1157, A-1158, A-1159, A-1164, A-1165, A-1166, A-1167, A-1175, A-1177, A-1178, A-1180, A-1181, A-1183, A-1185, A-1188, A-1190, A-1192, A-1195, A-1196, A-1200, A-1201, A-1207, A-1210, A-1211, B-0005, B-0006, B-0007, B-0008, B-0009, B-0010, B-0011, B-0017, B-0018, B-0019, B-0022, B-0023, B-0029, B-0055, B-0060, B-0063, B-0068, B-0070, B-0072, B-0073, B-0074, B-0075, B-0076, B-0078, B-0079, B-0080, B-0082, B-0084, B-0086, B-0088, B-0090, B-0092, B-0094, B-0096, B-0099, B-0102, B-0104, B-0106, B-0108

›Example 28 · 3 of 3

Any of comparative compounds 22 and 23 (described in JP-A-1975-29744), 3, 4, 5 and 6 (described in JP-A-1976-19121) and 18, 19 and 36 (described in JP-A-1988-41451) showed no activity at a concentration of 4 ppm.

[Test Example 2] Insecticidal Activity Test for Nilaparvata lugens Stál (Brown Rice Planthopper)

A wettable powder prepared based on Formulation Example 2 was diluted with water into an active ingredient concentration of 100 ppm. In the solution was immersed sprouting unhulled rice. They were placed in a 60-ml plastic cup. Thereinto were released 10 3-instar larvae of brown rice planthopper. The cup was covered with a lid and placed in a thermostat of 25° C. After 6 days, the number of living insects was counted and the mortality of insect was determined from the calculation formula of the following Mathematical Expression 2. This test was conducted with no replication.

Mortality (%)=100−[(number of living insects after 6 days)/(number of tested insects)]×100 [Mathematical Expression 2]

As in the case of Test Example 1, tests similar to the above were conducted using, as comparative compounds, compound Nos. 22 and 23 described in JP-A-1975-29744, compound Nos. 4, 5, 6 described in JP-A-1976-19121 and compound Nos. 18, 19 and 36 described in JP-A-1988-41451.

Compound Nos. of the compounds which gave, in the above test, a mortality of 90% or above, are shown below. A-0001, A-0004, A-0005, A-0006, A-0007, A-0015, A-0018, A-0022, A-0023, A-0025, A-0032, A-0035, A-0037, A-0038, A-0039, A-0043, A-0044, A-0046, A-0047, A-0051, A-0052, A-0056, A-0070, A-0074, A-0075, A-0077, A-0078, A-0085, A-0086, A-0087, A-0088, A-0089, A-0090, A-0091, A-0092, A-0108, A-0122, A-0123, A-0125, A-0130, A-0133, A-0141, A-0144, A-0145, A-0147, A-0157, A-0159, A-0160, A-0163, A-0164, A-0167, A-0168, A-0169, A-0170, A-0172, A-0173, A-0175, A-0180, A-0181, A-0185, A-0186, A-0187, A-0188, A-0199, A-0200, A-0203, A-0205, A-0206, A-0208, A-0211, A-0212, A-0213, A-0214, A-0215, A-0216, A-0217, A-0218, A-0219, A-0220, A-0221, A-0222, A-0223, A-0224, A-0228, A-0229, A-0230, A-0243, A-0244, A-0253, A-0254, A-0256, A-0257, A-0259, A-0260, A-0262, A-0263, A-0266, A-0271, A-0277, A-0285, A-0307, A-0308, A-0311, A-0314, A-0317, A-0319, A-0324, A-0325, A-0328, A-0329, A-0338, A-0340, A-0341, A-0346, A-0360, A-0369, A-0379, A-0405, A-0406, A-0415, A-0416, A-0417, A-0418, A-0431, A-0432, A-0433, A-0434, A-0436, A-0437, A-0438, A-0439, A-0440, A-0446, A-0447, A-0448, A-0472, A-0473, A-0474, A-0475, A-0503, A-0504, A-0505, A-0535, A-0539, A-0543, A-0544, A-0553, A-0554, A-0556, A-0557, A-0570, A-0572, A-0574, A-0587, A-0610, A-0617, A-0625, A-0626, A-0631, A-0644, A-0683, A-0684, A-0703, A-0732, A-0734, A-0741, A-0743, A-0744, A-0745, A-0747, A-0751, A-0753, A-0755, A-0761, A-0763, A-0764, A-0765, A-0766, A-0772, A-0777, A-0778, A-0779, A-0780, A-0781, A-0786, A-0787, A-0788, A-0789, A-0797, A-0798, A-0809, A-0811, A-0813, A-0815, A-0821, A-0822, A-0823, A-0824, A-0825, A-0834, A-0838, A-0839, A-0844, A-0846, A-0847, A-0853, A-0855, A-0857, A-0877, A-0968, A-0969, A-0970, A-0971, A-0972, A-0973, A-0975, A-0976, A-0977, A-0978, A-0979, A-0981, A-0982, A-0983, A-0984, A-0985, A-0988, A-0991, A-0992, A-0998, A-1003, A-1004, A-1005, A-1006, A-1008, A-1009, A-1032, A-1033, A-1037, A-1044, A-1051, A-1087, A-1093, A-1094, A-1107, A-1125, A-1136, A-1140, A-1142, A-1158, A-1159, A-1177, A-1180, A-1185, A-1187, A-1188, A-1195, A-1210, A-1211, A-1212, A-1213, B-0003, B-0004, B-0005, B-0007, B-0012, B-0013, B-0022, B-0028, B-0029, B-0032, B-0033, B-0035, B-0051, B-0053, B-0055, B-0058, B-0059, B-0060, B-0063, B-0066, B-0086, B-0088, B-0093, B-0101, C-0001

Any of comparative compounds 22 and 23 (described in JP-A-1975-29744), 4, 5 and 6 (described in JP-A-1976-19121) and 18, 19 and 36 (described in JP-A-1988-41451) each showed no activity even at a concentration of 100 ppm.

›Tables in the description — 75

TABLE 1 — [I]

Compound No.	R 1	R 2	R 3	n	R 4
A-0001	CH 2 CF 3	Me	F	0	Me
A-0002	CH 2 CF 3	Me	F	1	nPropyl
A-0003	CH 2 CF 3	Cl	F	1	nPropyl
A-0004	CH 2 CF 3	CN	F	0	isopropyl
A-0005	CH 2 CF 3	CN	F	1	isopropyl
A-0006	CH 2 CF 3	Me	F	0	isopropyl
A-0007	CH 2 CF 3	Me	F	1	isopropyl
A-0008	CH 2 CF 3	Me	F	1	nButyl
A-0009	CH 2 CF 3	Cl	F	1	nButyl
A-0010	CH 2 CF 3	CN	F	0	nButyl
A-0011	CH 2 CF 3	CN	F	1	nButyl
A-0012	CH 2 CF 3	CN	F	0	nPentyl
A-0013	CH 2 CF 3	CN	F	1	nPentyl
A-0014	CH 2 CF 3	Me	F	0	nHexyl
A-0015	CH 2 CF 3	Me	F	1	nHexyl
A-0016	CH 2 CF 3	Cl	F	1	nHexyl
A-0017	CH 2 CF 3	CN	F	0	nHexyl
A-0018	CH 2 CF 3	CN	F	1	nHexyl
A-0019	CH 2 CF 3	Me	H	1	nHexyl
A-0020	CH 2 CF 3	Me	Cl	1	nHexyl
A-0021	CH 2 CF 3	Cl	Cl	1	nHexyl
A-0022	CH 2 CF 3	Me	F	0	nHeptyl
A-0023	CH 2 CF 3	Me	F	1	nHeptyl
A-0024	CH 2 CF 3	CN	F	0	nHeptyl
A-0025	CH 2 CF 3	CN	F	1	nHeptyl
A-0026	CH 2 CF 3	Me	F	1	nOctyl
A-0027	CH 2 CF 3	CN	F	0	nOctyl
A-0028	CH 2 CF 3	CN	F	1	nOctyl
A-0029	CH 2 CF 3	Me	F	1	nNonyl
A-0030	CH 2 CF 3	Me	F	0	nDecyl

TABLE 2

Compound No.	R 1	R 2	R 3	n	R 4
A-0031	CH 2 CF 3	Me	F	1	nDecyl
A-0032	CH 2 CF 3	Me	F	0	CH 2 CH(Me)CH 3
A-0033	CH 2 CF 3	Me	F	1	CH 2 CH(Me)CH 3
A-0034	CH 2 CF 3	Cl	F	1	CH 2 CH(Me)CH 3
A-0035	CH 2 CF 3	CN	F	0	CH 2 CH(Me)CH 3
A-0036	CH 2 CF 3	CN	F	1	CH 2 CH(Me)CH 3
A-0037	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH(Me)CH 3
A-0038	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(Me)CH 3
A-0039	CH 2 CF 3	CN	F	0	CH 2 CH 2 CH(Me)CH 3
A-0040	CH 2 CF 3	CN	F	1	CH 2 CH 2 CH(Me)CH 3
A-0041	CH 2 CF 3	Me	F	1	CH 2 CH(Me)CH 2 CH 3
A-0042	CH 2 CF 3	Me	F	1	CH(Me)CH 2 CH 2 CH 3
A-0043	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH(Me)CH 3
A-0044	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(Me)CH 3
A-0045	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH(Me)CH 3
A-0046	CH 2 CF 3	CN	F	0	CH 2 CH 2 CH 2 CH(Me)CH 3
A-0047	CH 2 CF 3	CN	F	1	CH 2 CH 2 CH 2 CH(Me)CH 3
A-0048	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(Me)CH 2 CH 3
A-0049	CH 2 CF 3	Me	F	1	CH 2 CH(Me)CH 2 CH 2 CH 3
A-0050	CH 2 CF 3	Me	F	1	CH(Me)CH 2 CH 2 CH 2 CH 3
A-0051	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH(Me)CH 3
A-0052	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH(Me)CH 3
A-0053	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH(Me)CH 3
A-0054	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH(Me)CH 3
A-0055	CH 2 CF 3	CN	F	0	CH 2 CH 2 CH 2 CH 2 CH(Me)CH 3
A-0056	CH 2 CF 3	CN	F	1	CH 2 CH 2 CH 2 CH 2 CH(Me)CH 3
A-0057	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(Me)CH 2 CH 3
A-0058	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(Me)CH 2 CH 2 CH 3
A-0059	CH 2 CF 3	Me	F	1	CH 2 CH(Me)CH 2 CH 2 CH 2 CH 3
A-0060	CH 2 CF 3	Me	F	1	CH(Me)CH 2 CH 2 CH 2 CH 2 CH 3
A-0061	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH(Me)CH 3
A-0062	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH(Me)CH 3
A-0063	CH 2 CF 3	Me	F	1	CH 2 tBu
A-0064	CH 2 CF 3	CN	F	0	CH 2 tBu
A-0065	CH 2 CF 3	CN	F	1	CH 2 tBu
A-0066	CH 2 CF 3	Me	F	1	CH 2 tBu
A-0067	CH 2 CF 3	Me	F	1	CH 2 CH 2 tBu
A-0068	CH 2 CF 3	CN	F	0	CH 2 CH 2 tBu
A-0069	CH 2 CF 3	CN	F	1	CH 2 CH 2 tBu
A-0070	CH 2 CF 3	Me	F	0	CH 2 CH 2 tBu

TABLE 3 — Compound

No.	R 1	R 2	R 3	n	R 4
A-0071	CH 2 CF 3	Me	F	1	CH 2 CH 2 tBu
A-0072	CH 2 CF 3	Me	F	1	CH 2 CH(Me)tBu
A-0073	CH 2 CF 3	Me	F	1	CH(Me)CH 2 tBu
A-0074	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 tBu
A-0075	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 tBu
A-0076	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 tBu
A-0077	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 tBu
A-0078	CH 2 CF 3	CN	F	0	CH 2 CH 2 CH 2 tBu
A-0079	CH 2 CF 3	CN	F	1	CH 2 CH 2 CH 2 tBu
A-0080	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 tBu
A-0081	CH 2 CF 3	Me	F	2	CH 2 CH 2 CH 2 tBu
A-0082	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(Me)tBu
A-0083	CH 2 CF 3	Me	F	1	CH 2 CH(Me)CH 2 tBu
A-0084	CH 2 CF 3	Me	F	1	CH(Me)CH 2 CH 2 tBu
A-0085	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 tBu
A-0086	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0087	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 tBu
A-0088	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0089	CH 2 CF 3	CN	F	0	CH 2 CH 2 CH 2 CH 2 tBu
A-0090	CH 2 CF 3	CN	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0091	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 CH 2 tBu
A-0092	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0093	CH 2 CF 3	Me	Cl	0	CH 2 CH 2 CH 2 CH 2 tBu
A-0094	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0095	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0096	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0097	CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0098	CHF 2	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0099	tBu	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0100	CH 2 tBu	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0101	CH 2 CH(Me) 2	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0102	CH 2 CH═CCl 2	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0103	CH 2 CH≡CH	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0104	CH 2 CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0105	CH 2 cPr	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0106	CF 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0107	CH 2 CHF 2	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0108	CH 2 CF 3	Cl	H	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0109	CH 2 COOMe	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0110	CH 2 CF 3	Me	F	2	CH 2 CH 2 CH 2 CH 2 tBu

TABLE 4 — Compound

No.	R 1	R 2	R 3	n	R 4
A-0111	CH 2 COOH	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0112	CH 2 tBu	Me	F	0	CH 2 CH 2 CH 2 CH 2 tBu
A-0113	CH 2 CHF 2	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0114	CH 2 tBu	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0115	CH 2 cPr	Me	F	0	CH 2 CH 2 CH 2 CH 2 tBu
A-0116	CH 2 CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0117	CH 2 cPr	Me	F	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0118	CH 2 CF 3	Me	Me	0	CH 2 CH 2 CH 2 CH 2 tBu
A-0119	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 tBu
A-0120	CH 2 CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 tBu
A-0121	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(Me)tBu
A-0122	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH(Me)CH 2 tBu
A-0123	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(Me)CH 2 tBu
A-0124	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH(Me)CH 2 tBu
A-0125	CH 2 CF 3	CN	F	0	CH 2 CH 2 CH(Me)CH 2 tBu
A-0126	CH 2 CF 3	CN	F	1	CH 2 CH 2 CH(Me)CH 2 tBu
A-0127	CH 2 CF 3	Me	F	1	CH 2 CH(Me)CH 2 CH 2 tBu
A-0128	CH 2 CF 3	Me	F	1	CH(Me)CH 2 CH 2 CH 2 tBu
A-0129	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0130	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0131	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0132	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0133	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0134	CH 2 CF 3	Cl	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0135	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH(Me)tBu
A-0136	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(Me)CH 2 tBu
A-0137	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(Me)CH 2 CH 2 tBu
A-0138	CH 2 CF 3	Me	F	1	CH 2 CH(Me)CH 2 CH 2 CH 2 tBu
A-0139	CH 2 CF 3	Me	F	1	CH(Me)CH 2 CH 2 CH 2 CH 2 tBu
A-0140	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0141	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0142	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0143	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0144	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0145	CH 2 CF 3	CN	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0146	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0147	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0148	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0149	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH(Me)tBu
A-0150	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH(Me)CH 2 tBu

TABLE 5 — Compound

No.	R 1	R 2	R 3	n	R 4
A-0151	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(Me)CH 2 CH 2 tBu
A-0152	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(Me)CH 2 CH 2 CH 2 tBu
A-0153	CH 2 CF 3	Me	F	1	CH 2 CH(Me)CH 2 CH 2 CH 2 CH 2 tBu
A-0154	CH 2 CF 3	Me	F	1	CH(Me)CH 2 CH 2 CH 2 CH 2 CH 2 tBu
A-0155	CH 2 CF 3	Me	F	1	CH 2 CF 3
A-0156	CH 2 CF 3	Me	F	1	CH(Me)CF 3
A-0157	CH 2 CF 3	Me	F	1	CH 2 CH 2 CF 3
A-0158	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CF 3
A-0159	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CF 3
A-0160	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CF 3
A-0161	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CF 3
A-0162	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CF 3
A-0163	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CF 3
A-0164	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CF 3
A-0165	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CF 3
A-0166	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CF 3
A-0167	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CF 3
A-0168	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CF 3
A-0169	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CF 3
A-0170	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CF 3
A-0171	CH 2 CF 3	Me	F	1	CH(CF 3 )CF 3
A-0172	CH 2 CF 3	Me	F	0	CH 2 CF 2 CF 3
A-0173	CH 2 CF 3	Me	F	1	CH 2 CF 2 CF 3
A-0174	CH 2 CF 3	Cl	F	0	CH 2 CF 2 CF 3
A-0175	CH 2 CF 3	Cl	F	1	CH 2 CF 2 CF 3
A-0176	CH 2 CF 3	Me	F	1	CH 2 CF 2 CF 3
A-0177	CH 2 CF 3	Me	F	1	CH 2 CF(CF 3 )CF 3
A-0178	CH 2 CF 3	Me	F	1	CH 2 CF 2 CF 2 CF 3
A-0179	CH 2 CF 3	Cl	F	1	CH 2 CF 2 CF 2 CF 3
A-0180	CH 2 CF 3	CN	F	0	CH 2 CF 2 CF 2 CF 3
A-0181	CH 2 CF 3	CN	F	1	CH 2 CF 2 CF 2 CF 3
A-0182	CH 2 CF 3	Me	F	1	CH 2 CF 2 CF(CF 3 )CF 3
A-0183	CH 2 CF 3	Me	F	1	CH 2 CF(CF 3 )CF 2 CF 3
A-0184	CH 2 CF 3	Me	F	0	CH 2 CF 2 CF 2 CF 2 CF 3
A-0185	CH 2 CF 3	Me	F	1	CH 2 CF 2 CF 2 CF 2 CF 3
A-0186	CH 2 CF 3	Cl	F	0	CH 2 CF 2 CF 2 CF 2 CF 3
A-0187	CH 2 CF 3	Cl	F	1	CH 2 CF 2 CF 2 CF 2 CF 3
A-0188	CH 2 CF 3	CN	F	0	CH 2 CF 2 CF 2 CF 2 CF 3
A-0189	CH 2 CF 3	CN	F	1	CH 2 CF 2 CF 2 CF 2 CF 3
A-0190	CH 2 CF 3	Me	H	1	CH 2 CF 2 CF 2 CF 2 CF 3

TABLE 6 — Com- pound

No.	R 1	R 2	R 3	n	R 4
A-0191	CH 2 CF 3	Me	Cl	1	CH 2 CF 2 CF 2 CF 2 CF 3
A-0192	CH 2 CF 3	Me	F	1	CH 2 CF 2 CF 2 CF(CF 3 )CF 3
A-0193	CH 2 CF 3	Me	F	1	CH 2 CF 2 CF(CF 3 )CF 2 CF 3
A-0194	CH 2 CF 3	Me	F	1	CH 2 CF(CF 3 )CF 2 CF 2 CF 3
A-0195	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 OCHF 2
A-0196	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 OCHF 2
A-0197	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 OCHF 2
A-0198	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 OCHF 2
A-0199	CH 2 CF 3	Me	F	0	CH 2 CH 2 OCH 2 CF 3
A-0200	CH 2 CF 3	Me	F	1	CH 2 CH 2 OCH 2 CF 3
A-0201	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 OCH 2 CF 3
A-0202	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 OCH 2 CF 3
A-0203	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 OCH 2 CF 3
A-0204	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 OCH 2 CF 3
A-0205	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 OCH 2 CF 3
A-0206	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 OCH 2 CF 3
A-0207	CH 2 CF 3	CN	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 OCH 2 CF 3
A-0208	CH 2 CF 3	CN	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 OCH 2 CF 3
A-0209	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 OCH 2 CF 3
A-0210	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 OCH 2 CF 3
A-0211	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0212	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0213	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0214	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0215	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0216	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0217	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0218	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0219	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0220	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0221	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0222	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0223	CH 2 CF 3	OMe	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0224	CH 2 CF 3	OMe	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 OC(CF 3 ) 3
A-0225	CH 2 CF 3	Cl	F	0	CF 2 CHFOCF 2 CF 2 CF 3
A-0226	CH 2 CF 3	Cl	F	1	CF 2 CHFOCF 2 CF 2 CF 3
A-0227	CH 2 CF 3	Me	F	0	CH 2 CF 2 OCF 2 CF 2 OCF 3
A-0228	CH 2 CF 3	Me	F	1	CH 2 CF 2 OCF 2 CF 2 OCF 3
A-0229	CH 2 CF 3	Cl	F	0	CH 2 CF 2 OCF 2 CF 2 OCF 3
A-0230	CH 2 CF 3	Cl	F	1	CH 2 CF 2 OCF 2 CF 2 OCF 3

TABLE 7 — Com- pound

No.	R 1	R 2	R 3	n	R 4
A-0231	CH 2 CF 3	Me	F	0	CF 2 CHFOCF 2 CF(CF 3 )OCF 2 CF 2 CF 3
A-0232	CH 2 CF 3	Me	F	1	CF 2 CHFOCF 2 CF(CF 3 )OCF 2 CF 2 CF 3
A-0233	CH 2 CF 3	Cl	F	0	CF 2 CHFOCF 2 CF(CF 3 )OCF 2 CF 2 CF 3
A-0234	CH 2 CF 3	Cl	F	1	CF 2 CHFOCF 2 CF(CF 3 )OCF 2 CF 2 CF 3
A-0235	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 OcPr
A-0236	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 OcPr
A-0237	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 OcPen
A-0238	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 OcPen
A-0239	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH═CH 2
A-0240	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH≡CH
A-0241	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH═C(Me)Me
A-0242	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH═CH 2
A-0243	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH≡CH
A-0244	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH≡CH
A-0245	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH═C(Me)Me
A-0246	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH═CH 2
A-0247	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH≡CH
A-0248	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH═C(Me)Me
A-0249	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH(Me)CH 2 CH 2 CH═C(Me) 2
A-0250	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(Me)CH 2 CH 2 CH═C(Me) 2
A-0251	CH 2 CF 3	Me	F	0	CH 2 CH 2 CF═CF 2
A-0252	CH 2 CF 3	Me	F	1	CH 2 CH 2 CF═CF 2
A-0253	CH 2 CF 3	Me	F	0	CH 2 CH═C(Cl)CF 3
A-0254	CH 2 CF 3	Me	F	1	CH 2 CH═C(Cl)CF 3
A-0255	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CF═CF 2
A-0256	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CF═CF 2
A-0257	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CF═CF 2
A-0258	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CF═CF 2
A-0259	CH 2 CF 3	Me	F	1	CH 2 CH═C═CF 2
A-0260	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 Cl
A-0261	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 Br
A-0262	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 Br
A-0263	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 Br
A-0264	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 Br
A-0265	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 Br
A-0266	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 Br
A-0267	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 CH 2 CH 2 Br
A-0268	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 Br
A-0269	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 Br
A-0270	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 Br

TABLE 8 — Com- pound

No.	R 1	R 2	R 3	n	R 4
A-0271	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 Cl
A-0272	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 Cl
A-0273	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 Br
A-0274	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 Br
A-0275	CH 2 CF 3	OMe	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 Br
A-0276	CH 2 CF 3	OMe	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 Br
A-0277	CH 2 CF 3	CN	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 Cl
A-0278	CH 2 CF 3	CN	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 Cl
A-0279	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 CH 2 CH 2 Cl
A-0280	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 Cl
A-0281	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 Br
A-0282	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 Br
A-0283	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 Br
A-0284	CH 2 CF 3	Me	Me	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 Br
A-0285	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 Cl
A-0286	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 Cl
A-0287	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 Br
A-0288	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 Br
A-0289	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 Cl
A-0290	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 Cl
A-0291	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH(CH 3 )CH 2 CH 2 Br
A-0292	CH 2 CF 3	Me	F	0	CH 2 CH 2 OH
A-0293	CH 2 CF 3	Me	F	1	CH 2 CH 2 OH
A-0294	CH 2 CF 3	Me	H	0	CH 2 CH 2 OH
A-0295	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 OH
A-0296	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 OH
A-0297	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 OH
A-0298	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 OH
A-0299	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 OH
A-0300	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 OH
A-0301	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 OH
A-0302	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 OH
A-0303	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 OH
A-0304	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 OH
A-0305	CH 2 CF 3	Me	F	0	CH 2 CH 2 cPr
A-0306	CH 2 CF 3	Me	F	1	CH 2 CH 2 cPr
A-0307	CH 2 CF 3	Me	F	0	CH 2 CH 2 cPr(2,2-F 2 )
A-0308	CH 2 CF 3	Me	F	1	CH 2 CH 2 cPr(2,2-F 2 )
A-0309	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 cPr
A-0310	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 cPr

TABLE 9 — Compound

No.	R 1	R 2	R 3	n	R 4
A-0311	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 cPr(2,2-F 2 )
A-0312	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 cPr(2,2-F 2 )
A-0313	CH 2 CF 3	Me	F	1	CH 2 cPr(1-Ph)
A-0314	CH 2 CF 3	Cl	F	1	CH 2 cPr(1-Ph)
A-0315	CH 2 CF 3	Me	F	0	CH 2 cHex(4-tBu)
A-0316	CH 2 CF 3	Me	F	1	CH 2 cHex(4-tBu)
A-0317	CH 2 CF 3	Me	F	0	CH 2 cHex(4-CF 3 )
A-0318	CH 2 CF 3	Me	F	1	CH 2 cHex(4-CF 3 )
A-0319	CH 2 CF 3	Me	F	0	CH 2 cHex(4,4-F 2 )
A-0320	CH 2 CF 3	Me	F	1	CH 2 cHex(4,4-F 2 )
A-0321	CH 2 CF 3	Cl	F	0	CH 2 cHex(4,4-F 2 )
A-0322	CH 2 CF 3	Cl	F	1	CH 2 cHex(4,4-F 2 )
A-0323	CH 2 CF 3	Me	F	1	CH 2 CH 2 cHex
A-0324	CH 2 CF 3	Me	F	0	CH 2 CH 2 cHex(4-CF 3 )
A-0325	CH 2 CF 3	Cl	F	0	CH 2 CH 2 cHex(4-CF 3 )
A-0326	CH 2 CF 3	Me	F	1	CH 2 CH 2 cHex(4-CF 3 )
A-0327	CH 2 CF 3	Cl	F	1	CH 2 CH 2 cHex(4-CF 3 )
A-0328	CH 2 CF 3	Me	F	0	CH 2 CH 2 cHex(4,4-F 2 )
A-0329	CH 2 CF 3	Cl	F	0	CH 2 CH 2 cHex(4,4-F 2 )
A-0330	CH 2 CF 3	Me	F	1	CH 2 CH 2 cHex(4,4-F 2 )
A-0331	CH 2 CF 3	Cl	F	1	CH 2 CH 2 cHex(4,4-F 2 )
A-0332	CH 2 CF 3	Me	F	1	CH 2 CH 2 cHex(4-SCF 3 )
A-0333	CH 2 CF 3	Cl	F	1	CH 2 CH 2 cHex(4-SCF 3 )
A-0334	CH 2 CF 3	Me	F	1	CH 2 CH 2 cHex(4-SCHF 2 )
A-0335	CH 2 CF 3	Me	F	1	CH 2 CH 2 cHex(4-OCHF 2 )
A-0336	CH 2 CF 3	Me	F	1	CH 2 CH 2 cHex(4-OCF 3 )
A-0337	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 cHex
A-0338	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 cHex(4-CF 3 )
A-0339	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 cHex(4-CF 3 )
A-0340	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 cHex(4-CF 3 )
A-0341	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 cHex(4-CF 3 )
A-0342	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 cHex(4-tBu)
A-0343	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 cHex(4-tBu)
A-0344	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 cHex(4-SCF 3 )
A-0345	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 cHex
A-0346	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 cHex
A-0347	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 cHex
A-0348	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 cHex(4-CF 3 )
A-0349	CH 2 CF 3	Me	F	0	CH 2 CH 2 (adamant-1-yl)
A-0350	CH 2 CF 3	Me	F	1	CH 2 CH 2 (adamant-1-yl)

TABLE 10

Compound No.	R 1	R 2	R 3	n	R 4
A-0351	CH 2 CF 3	Me	F	1	CH 2 CH 2 StBu
A-0352	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 StBu
A-0353	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SCH 2 tBu
A-0354	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 SCH 2 tBu
A-0355	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )StBu
A-0356	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 StBu
A-0357	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )StBu
A-0358	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 StBu
A-0359	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCH 3
A-0360	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCH 3
A-0361	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCH(CH 3 ) 2
A-0362	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCH(CH 3 ) 2
A-0363	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 StBu
A-0364	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 StBu
A-0365	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 StBu
A-0366	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 StBu
A-0367	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 StBu
A-0368	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCH 3
A-0369	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCH 3
A-0370	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCH(CH 3 ) 2
A-0371	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(CH 3 )StBu
A-0372	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )CH 2 StBu
A-0373	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 CH 2 StBu
A-0374	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 StBu
A-0375	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 StBu
A-0376	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 StBu
A-0377	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 ScPen
A-0378	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 ScHex
A-0379	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 ScPr
A-0380	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 ScPr
A-0381	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O)Me
A-0382	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 S(═O)tBu
A-0383	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)Me
A-0384	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)tBu
A-0385	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 S(═O)cPen
A-0386	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 S(═O)cHex
A-0387	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)cPr
A-0388	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)cPr
A-0389	CH 2 CF 3	Me	F	1	CH 2 CH 2 S(═O) 2 Me
A-0390	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O) 2 Me

TABLE 11

Compound No.	R 1	R 2	R 3	n	R 4
A-0391	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 S(═O) 2 Me
A-0392	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 S(═O) 2 Me
A-0393	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 Me
A-0394	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 Me
A-0395	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 tBu
A-0396	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 tBu
A-0397	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 Me
A-0398	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 Me
A-0399	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 cPr
A-0400	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 cPr
A-0401	CH 2 CF 3	Me	F	0	CH 2 SCF 3
A-0402	CH 2 CF 3	Me	F	1	CH 2 SCF 3
A-0403	CH 2 CF 3	Me	F	1	CH 2 CH 2 SCF 3
A-0404	CH 2 CF 3	Me	H	1	CH 2 CH 2 SCF 3
A-0405	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SCF 3
A-0406	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SCF 3
A-0407	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 SCF 3
A-0408	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 SCF 3
A-0409	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 SCF 3
A-0410	CH 2 CF 3	Me	Me	0	CH 2 CH 2 CH 2 SCF 3
A-0411	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 SCF 3
A-0412	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 CH 2 SCF 3
A-0413	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 SCF 3
A-0414	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )SCF 3
A-0415	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SCF 3
A-0416	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 SCF 3
A-0417	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 SCF 3
A-0418	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 SCF 3
A-0419	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 SCF 3
A-0420	CH 2 CF 3	Me	Cl	0	CH 2 CH 2 CH 2 CH 2 SCF 3
A-0421	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 SCF 3
A-0422	CH 2 CF 3	Me	Me	0	CH 2 CH 2 CH 2 CH 2 SCF 3
A-0423	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 SCF 3
A-0424	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 CH 2 CH 2 SCF 3
A-0425	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 SCF 3
A-0426	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )SCF 3
A-0427	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 SCF 3
A-0428	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 SCF 2 CF 3
A-0429	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SCF(CF 3 ) 2
A-0430	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 SCF(CF 3 ) 2

TABLE 12

Compound No.	R 1	R 2	R 3	n	R 4
A-0431	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0432	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0433	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0434	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0435	CH 2 CF 3	Cl	F	2	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0436	CH 2 CF 3	CN	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0437	CH 2 CF 3	CN	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0438	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0439	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0440	CH 2 CF 3	Me	Cl	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0441	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0442	CH 2 CF 3	Me	Me	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0443	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0444	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0445	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0446	CH 2 CF 3	Cl	H	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0447	CH 2 CF 3	Cl	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0448	CH 2 CF 3	OMe	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0449	CH 2 CF 3	OMe	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0450	CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0451	CHF 2	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0452	tBu	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0453	CH 2 tBu	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0454	CH 2 CH(Me) 2	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0455	CH 2 CH═CCl 2	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0456	CH 2 CH═CH	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0457	CH 2 CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0458	CH 2 cPr	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0459	CF 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0460	CH 2 CHF 2	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0461	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 2 CF 3
A-0462	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCF(CF 3 ) 2
A-0463	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF(CF 3 ) 2
A-0464	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(CH 3 ) SCF 3
A-0465	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )CH 2 SCF 3
A-0466	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 CH 2 SCF 3
A-0467	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCF 2 CF 3
A-0468	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(SCF 3 )CH 2 CH 2
A-0469	CH 2 CF 3	Me	F	1	CH 2 CH(SCF 3 )CH 2 CH 2 CH 2
A-0470	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3

TABLE 13

Compound No.	R 1	R 2	R 3	n	R 4
A-0471	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0472	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0473	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0474	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0475	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0476	CH 2 CF 3	Me	Cl	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0477	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0478	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0479	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0480	CH 2 CF 3	Me	Me	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0481	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0482	CH 2 CHF 2	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0483	CH 2 CHF 2	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0484	CH 2 CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0485	CH 2 CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0486	CH 2 cPr	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0487	CH 2 cPr	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0488	CH 2 tBu	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0489	CH 2 tBu	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0490	CH 2 C≡CH	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0491	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF(CF 3 ) 2
A-0492	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF(CF 3 ) 2
A-0493	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH(CH 3 )SCF 3
A-0494	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(CH 3 )CH 2 SCF 3
A-0495	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH(CH 3 )CH 2 CH 2 SCF 3
A-0496	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )CH 2 CH 2 SCF 3
A-0497	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 CH 2 CH 2 SCF 3
A-0498	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 2 CF 3
A-0499	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(SCF 3 )CH 2 CH 3
A-0500	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(SCF 3 )CH 2 CH 2 CH 2
A-0501	CH 2 CF 3	Me	F	1	CH 2 CH(SCF 3 )CH 2 CH 2 CH 2 CH 2
A-0502	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0503	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0504	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0505	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0506	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0507	CH 2 CF 3	Me	Cl	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0508	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0509	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0510	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
Compound No.	R 1	R 2	R 3	n	R 4
A-0511	CH 2 CF 3	Me	Me	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0512	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 3
A-0513	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH(CH 3 )SCF 3
A-0514	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH(CH 3 )CH 2 SCF 3
A-0515	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(CH 3 )CH 2 CH 2 SCF 3
A-0516	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )CH 2 CH 2 CH 2 SCF 3
A-0517	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 CH 2 CH 2 CH 2 SCF 3
A-0518	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF 2 CF 3
A-0519	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCF(CF 3 ) 2
A-0520	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O)CF 3
A-0521	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 S(═O)CF 3
A-0522	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CF 3
A-0523	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CF 3
A-0524	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CF 3
A-0525	CH 2 CF 3	Cl	F	2	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CF 3
A-0526	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CF 3
A-0527	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CF 3
A-0528	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CF 3
A-0529	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O) 2 CF 3
A-0530	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 S(═O) 2 CF 3
A-0531	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CF 3
A-0532	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CF 3
A-0533	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CF 3
A-0534	CH 2 CF 3	Cl	F	2	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CF 3
A-0535	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CF 3
A-0536	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CF 3
A-0537	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CF 3
A-0538	CH 2 CF 3	Me	F	1	CH 2 CH 2 SCHF 2
A-0539	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SCHF 2
A-0540	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 SCHF 2
A-0541	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 SCHF 2
A-0542	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )SCHF 2
A-0543	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0544	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0545	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0546	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0547	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0548	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0549	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0550	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )SCHF 2

TABLE 15

Compound No.	R 1	R 2	R 3	n	R 4
A-0551	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 SCHF 2
A-0552	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 SCH 2 CHF 2
A-0553	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0554	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0555	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0556	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0557	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0558	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0559	CH 2 CF 3	Cl	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0560	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0561	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0562	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0563	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0564	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(CH 3 )SCHF 2
A-0565	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )CH 2 SCHF 2
A-0566	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 CH 2 SCHF 2
A-0567	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CHF 2
A-0568	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(SCHF 2 )CH 2 CH 2
A-0569	CH 2 CF 3	Me	F	1	CH 2 CH(SCHF 2 )CH 2 CH 2 CH 2
A-0570	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0571	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0572	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0573	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0574	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0575	CH 2 CF 3	Cl	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0576	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0577	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0578	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0579	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH(CH 3 )SCHF 2
A-0580	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(CH 3 )CH 2 SCHF 2
A-0581	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )CH 2 CH 2 SCHF 2
A-0582	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 CH 2 CH 2 SCHF 2
A-0583	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(SCHF 2 )CH 2 CH 2
A-0584	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(SCHF 2 )CH 2 CH 2 CH 2
A-0585	CH 2 CF 3	Me	F	1	CH 2 CH(SCHF 2 )CH 2 CH 2 CH 2 CH 2
A-0586	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CHF 2
A-0587	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0588	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0589	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0590	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2

TABLE 16

Compound No.	R 1	R 2	R 3	n	R 4
A-0591	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0592	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0593	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCHF 2
A-0594	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O)CHF 2
A-0595	CH 2 CF 3	Me	F	1	CH(CH 3 )CH 2 S(═O)CHF 2
A-0596	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 S(═O)CHF 2
A-0597	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )S(═O)CHF 2
A-0598	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 S(═O)CHF 2
A-0599	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CHF 2
A-0600	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CHF 2
A-0601	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(CH 3 )S(═O)CHF 2
A-0602	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )CH 2 S(═O)CHF 2
A-0603	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 CH 2 S(═O)CHF 2
A-0604	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CHF 2
A-0605	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CHF 2
A-0606	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CHF 2
A-0607	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CHF 2
A-0608	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O) 2 CHF 2
A-0609	CH 2 CF 3	Me	F	1	CH(CH 3 )CH 2 S(═O) 2 CHF 2
A-0610	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 S(═O) 2 CHF 2
A-0611	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 S(═O) 2 CHF 2
A-0612	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 S(═O) 2 CHF 2
A-0613	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )S(═O )2 CHF 2
A-0614	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 S(═O) 2 CHF 2
A-0615	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CHF 2
A-0616	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CHF 2
A-0617	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CHF 2
A-0618	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CHF 2
A-0619	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(CH 3 )S(═O) 2 CHF 2
A-0620	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )CH 2 S(═O) 2 CHF 2
A-0621	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 CH 2 S(═O) 2 CHF 2
A-0622	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CHF 2
A-0623	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CHF 2
A-0624	CH 2 CF 3	Me	F	1	CH 2 CH 2 SCH 2 CF 3
A-0625	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SCH 2 CF 3
A-0626	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 SCH 2 CF 3
A-0627	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )SCH 2 CF 3
A-0628	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0629	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0630	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3

TABLE 17

Compound No.	R 1	R 2	R 3	n	R 4
A-0631	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0632	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0633	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0634	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0635	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0636	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )SCH 2 CF 3
A-0637	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 SCH 2 CF 3
A-0638	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0639	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0640	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0641	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0642	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0643	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0644	CH 2 CF 3	Cl	H	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0645	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(CH 3 )SCH 2 CF 3
A-0646	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )CH 2 SCH 2 CF 3
A-0647	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 CH 2 SCH 2 CF 3
A-0648	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0649	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0650	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0651	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0652	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0653	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH(CH 3 )SCH 2 CF 3
A-0654	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(CH 3 )CH 2 SCH 2 CF 3
A-0655	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 CH 2 CH 2 SCH 2 CF 3
A-0656	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 CF 3
A-0657	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SCH(CF 3 ) 2
A-0658	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 SCH(CF 3 ) 2
A-0659	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCH(CF 3 ) 2
A-0660	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCH(CF 3 ) 2
A-0661	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCCl 3
A-0662	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCCl 3
A-0663	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SCN
A-0664	CH 2 CF 3	Me	Me	0	CH 2 CH 2 CH 2 SCN
A-0665	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 SCN
A-0666	CH 2 CF 3	Me	Me	0	CH 2 CH 2 CH 2 CH 2 SCN
A-0667	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 CH 2 CH 2 SCN
A-0668	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCN
A-0669	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCN
A-0670	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCN

TABLE 18

Compound No.	R 1	R 2	R 3	n	R 4
A-0671	CH 2 CF 3	CN	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCN
A-0672	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCN
A-0673	CH 2 CF 3	OMe	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCN
A-0674	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH(Me)CH 2 CH 2 SCN
A-0675	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCN
A-0676	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCN
A-0677	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCN
A-0678	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCN
A-0679	CH 2 CF 3	Me	Me	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCN
A-0680	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCN
A-0681	CH 2 CF 3	Me	Me	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 SCN
A-0682	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 SiMe 3
A-0683	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SCF═CFCF 3
A-0684	CH 2 CF 3	Me	F	0	CH 2 Ph
A-0685	CH 2 CF 3	Me	F	0	CH(Me)Ph
A-0686	CH 2 CF 3	Me	F	1	CH 2 Ph
A-0687	CH 2 CF 3	Me	F	0	CH 2 Ph(2-CF 3 )
A-0688	CH 2 CF 3	Me	F	1	CH 2 Ph(2-CF 3 )
A-0689	CH 2 CF 3	Me	F	0	CH 2 Ph(3-CF 3 )
A-0690	CH 2 CF 3	Me	F	0	CH 2 Ph(4-CF 3 )
A-0691	CH 2 CF 3	Me	F	0	CH(Me)Ph(4-CF 3 )
A-0692	CH 2 CF 3	Me	F	1	CH 2 Ph(4-CF 3 )
A-0693	CH 2 CF 3	Cl	F	0	CH 2 Ph(4-CF 3 )
A-0694	CH 2 CF 3	Cl	F	1	CH 2 Ph(4-CF 3 )
A-0695	CH 2 CF 3	Me	Cl	0	CH 2 Ph(4-CF 3 )
A-0696	CH 2 CF 3	Me	Cl	1	CH 2 Ph(4-CF 3 )
A-0697	CH 2 CF 3	CN	H	0	CH 2 Ph(4-CF 3 )
A-0698	CH 2 CF 3	CN	H	1	CH 2 Ph(4-CF 3 )
A-0699	CH 2 CF 3	Me	F	0	CH 2 Ph(2,5-(CF 3 ) 2 )
A-0700	CH 2 CF 3	Me	F	1	CH 2 Ph(2,5-(CF 3 ) 2 )
A-0701	CH 2 CF 3	Me	F	1	CH 2 Ph(4-OCHF 2 )
A-0702	CH 2 CF 3	Me	F	1	CH 2 Ph(2-OCF 3 )
A-0703	CH 2 CF 3	Me	F	1	CH 2 Ph(3-OCF 3 )
A-0704	CH 2 CF 3	Me	F	1	CH 2 Ph(4-OCF 3 )
A-0705	CH 2 CF 3	Me	F	1	CH 2 Ph(4-SCHF 2 )
A-0706	CH 2 CF 3	Me	F	1	CH 2 Ph(2-SCF 3 )
A-0707	CH 2 CF 3	Me	F	0	CH 2 Ph(3-SCF 3 )
A-0708	CH 2 CF 3	Me	F	1	CH 2 Ph(3-SCF 3 )
A-0709	CH 2 CF 3	Cl	F	0	CH 2 Ph(4-SCF 3 )
A-0710	CH 2 CF 3	Cl	F	1	CH 2 Ph(4-SCF 3 )

TABLE 19

Compound No.	R 1	R 2	R 3	n	R 4
A-0711	CH 2 CF 3	Me	F	0	CH 2 Ph(4-SCF 3 )
A-0712	CH 2 CF 3	Me	F	1	CH 2 Ph(4-SCF 3 )
A-0713	CH 2 CF 3	Me	F	1	CH 2 Ph(3-CH 2 SCF 3 )
A-0714	CH 2 CF 3	Me	F	1	CH 2 Ph(4-CH 2 SCF 3 )
A-0715	CH 2 CF 3	Me	F	0	CH 2 Ph(4-F)
A-0716	CH 2 CF 3	Me	F	0	CH 2 Ph(4-Cl)
A-0717	CH 2 CF 3	Me	F	1	CH 2 Ph(4-Cl)
A-0718	CH 2 CF 3	Me	F	0	CH 2 Ph(4-Br)
A-0719	CH 2 CF 3	Me	F	1	CH 2 Ph(4-Br)
A-0720	CH 2 CF 3	Me	F	0	CH 2 Ph(4-Me)
A-0721	CH 2 CF 3	Me	F	1	CH 2 Ph(4-Me)
A-0722	CH 2 CF 3	Me	F	0	CH 2 Ph(4-tBu)
A-0723	CH 2 CF 3	Me	F	1	CH 2 Ph(4-tBu)
A-0724	CH 2 CF 3	Me	F	0	CH 2 Ph(4-CN)
A-0725	CH 2 CF 3	Me	F	1	CH 2 Ph(4-CN)
A-0726	CH 2 CF 3	Me	F	0	CH 2 Ph(4-NO 2 )
A-0727	CH 2 CF 3	Me	F	1	CH 2 Ph(4-NO 2 )
A-0728	CH 2 CF 3	Me	F	0	CH 2 Ph(2,4-Cl 2 )
A-0729	CH 2 CF 3	Me	F	1	CH 2 Ph(2,4-Cl 2 )
A-0730	CH 2 CF 3	Me	F	0	CH 2 Ph(3,4-Cl 2 )
A-0731	CH 2 CF 3	Me	F	1	CH 2 Ph(3,4-Cl 2 )
A-0732	CH 2 CF 3	Me	F	0	CH 2 Ph(2,4,6-F 3 )
A-0733	CH 2 CF 3	Me	F	1	CH 2 Ph(2,4,6-F 3 )
A-0734	CH 2 CF 3	Me	F	0	CH 2 Ph(3,4,5-F 3 )
A-0735	CH 2 CF 3	Me	F	1	CH 2 Ph(3,4,5-F 3 )
A-0736	CH 2 CF 3	Me	F	1	CH 2 Ph(2,3,4-F 3 )
A-0737	CH 2 CF 3	Me	F	0	CH 2 Ph(2,3,4-Cl 3 )
A-0738	CH 2 CF 3	Me	F	0	CH 2 Ph(3,4,5-Cl 3 )
A-0739	CH 2 CF 3	Me	F	0	CH 2 Ph(3,4,5-Cl 3 )
A-0740	CH 2 CF 3	Me	F	1	CH 2 Ph(3,4,5-Cl 3 )
A-0741	CH 2 CF 3	Me	F	0	CH 2 Ph(3-CF 3 , 4-Cl)
A-0742	CH 2 CF 3	Me	F	1	CH 2 Ph(3-CF 3 , 4-Cl)
A-0743	CH 2 CF 3	Me	F	0	CH 2 Ph(3-CF 3 , 4-F)
A-0744	CH 2 CF 3	Me	F	1	CH 2 Ph(3-CF 3 , 4-F)
A-0745	CH 2 CF 3	Me	F	0	CH 2 Ph(3-F, 4-CF 3 )
A-0746	CH 2 CF 3	Me	F	1	CH 2 Ph(3-F, 4-CF 3 )
A-0747	CH 2 CF 3	Me	F	0	CH 2 Ph(4-CF(CF 3 ) 2 )
A-0748	CH 2 CF 3	Me	F	1	CH 2 Ph(4-CF(CF 3 ) 2 )
A-0749	CH 2 CF 3	Me	F	1	CH 2 Ph(4-CH 2 SCF 3 )
A-0750	CH 2 CF 3	Me	F	0	CH 2 Ph(4-Ph(4-CF 3 ))

TABLE 20

Compound No.	R 1	R 2	R 3	n	R 4
A-0751	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph
A-0752	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph
A-0753	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(4-F)
A-0754	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(4-F)
A-0755	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(4-Cl)
A-0756	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(4-Cl)
A-0757	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(4-Br)
A-0758	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(4-Br)
A-0759	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(2-CF 3 )
A-0760	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(2-CF 3 )
A-0761	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(3-CF 3 )
A-0762	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(3-CF 3 )
A-0763	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(4-CF 3 )
A-0764	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(4-CF 3 )
A-0765	CH 2 CF 3	Cl	F	0	CH 2 CH 2 Ph(4-CF 3 )
A-0766	CH 2 CF 3	Cl	F	1	CH 2 CH 2 Ph(4-CF 3 )
A-0767	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 Ph(4-CF 3 )
A-0768	CH 2 CF 3	Me	Me	1	CH 2 CH 2 Ph(4-CF 3 )
A-0769	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 Ph(4-CF 3 )
A-0770	tBu	CN	F	0	CH 2 CH 2 Ph(4-CF 3 )
A-0771	tBu	CN	F	1	CH 2 CH 2 Ph(4-CF 3 )
A-0772	CH 2 CF 3	Cl	F	0	CH 2 CH 2 Ph(4-OCHF 2 )
A-0773	CH 2 CF 3	Cl	F	1	CH 2 CH 2 Ph(4-OCHF 2 )
A-0774	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(4-OCHF 2 )
A-0775	CH 2 CF 3	Me	Me	1	CH 2 CH 2 Ph(4-OCHF 2 )
A-0776	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 Ph(4-OCHF 2 )
A-0777	CH 2 CF 3	Me	F	0	CH 2 Ph(3-OCF 3 )
A-0778	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(4-OCF 3 )
A-0779	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(4-OCF 3 )
A-0780	CH 2 CF 3	Cl	F	0	CH 2 CH 2 Ph(4-OCF 3 )
A-0781	CH 2 CF 3	Cl	F	1	CH 2 CH 2 Ph(4-OCF 3 )
A-0782	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 Ph(4-OCF 3 )
A-0783	CH 2 CF 3	Me	Me	1	CH 2 CH 2 Ph(4-OCF 3 )
A-0784	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 Ph(4-OCF 3 )
A-0785	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(4-SCHF 2 )
A-0786	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(4-SCF 3 )
A-0787	CH 2 CF 3	Cl	F	0	CH 2 CH 2 Ph(4-SCF 3 )
A-0788	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(4-SCF 3 )
A-0789	CH 2 CF 3	Cl	F	1	CH 2 CH 2 Ph(4-SCF 3 )
A-0790	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 Ph(4-SCF 3 )

TABLE 21

Compound No.	R 1	R 2	R 3	n	R 4
A-0791	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 Ph(4-SCF 3 )
A-0792	CH 2 CF 3	Me	Me	1	CH 2 CH 2 Ph(4-SCF 3 )
A-0793	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 Ph(4-SCF 3 )
A-0794	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(4-CF(CF 3 ) 2 )
A-0795	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(4-NO 2 )
A-0796	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(4-NO 2 )
A-0797	CH 2 CF 3	Cl	F	0	CH 2 CH 2 Ph(4-OS(═O) 2 CF 3 )
A-0798	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(4-OS(═O) 2 CF 3 )
A-0799	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(4-OS(═O) 2 CF 3 )
A-0800	CH 2 CF 3	Cl	F	1	CH 2 CH 2 Ph(4-OS(═O) 2 CF 3 )
A-0801	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(2,4-Cl 2 )
A-0802	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(3,4-Cl 2 )
A-0803	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(3,4-Cl 2 )
A-0804	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(3,4,5-Cl 3 )
A-0805	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(2,3,4-F 3 )
A-0806	CH 2 CF 3	Cl	F	1	CH 2 CH 2 Ph(2,3,4-F 3 )
A-0807	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(2,4,5-F 3 )
A-0808	CH 2 CF 3	Cl	F	1	CH 2 CH 2 Ph(2,4,5-F 3 )
A-0809	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(3,4,5-F 3 )
A-0810	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(3,4,5-F 3 )
A-0811	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(2,4,6-F 3 )
A-0812	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(2,4,6-F 3 )
A-0813	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(3-CF 3 , 4-F)
A-0814	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(3-CF 3 , 4-F)
A-0815	CH 2 CF 3	Cl	F	0	CH 2 CH 2 Ph(3-CF 3 , 4-F)
A-0816	CH 2 CF 3	Cl	F	1	CH 2 CH 2 Ph(3-CF 3 , 4-F)
A-0817	CH 2 CF 3	Cl	F	1	CH 2 CH 2 Ph(2-F, 4-CF 3 )
A-0818	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 Ph(2-F, 4-CF 3 )
A-0819	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 Ph(2-F, 4-CF 3 )
A-0820	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 Ph(2-F, 4-CF 3 )
A-0821	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(3-F, 4-CF 3 )
A-0822	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(3-F, 4-CF 3 )
A-0823	CH 2 CF 3	Cl	F	1	CH 2 CH 2 Ph(3-F, 4-CF 3 )
A-0824	CH 2 CF 3	Cl	F	0	CH 2 CH 2 Ph(3-F, 4-CF 3 )
A-0825	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(2-F, 4-CF 3 )
A-0826	CH 2 CF 3	Cl	F	0	CH 2 CH 2 Ph(3-Cl, 4-OCHF 2 )
A-0827	CH 2 CF 3	Cl	F	1	CH 2 CH 2 Ph(3-Cl, 4-OCHF 2 )
A-0828	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(4-Ph(4-CF 3 ))
A-0829	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(4-Ph(4-CF 3 ))
A-0830	CH 2 CF 3	Me	F	0	CH 2 CH 2 Ph(4-OCH 2 Ph)

TABLE 22

Compound No.	R 1	R 2	R 3	n	R 4
A-0831	CH 2 CF 3	Me	F	1	CH 2 CH 2 Ph(4-OCH 2 Ph)
A-0832	CH 2 CF 3	Cl	F	0	CH 2 C(Me) 2 Ph(4-Cl)
A-0833	CH 2 CF 3	Cl	F	1	CH 2 C(Me) 2 Ph(4-Cl)
A-0834	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 Ph
A-0835	CH 2 CF 3	Me	F	0	CH 2 CH(CH 3 )Ph
A-0836	CH 2 CF 3	Me	F	0	CH(CH 3 )CH 2 Ph
A-0837	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 Ph
A-0838	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 Ph(4-CF 3 )
A-0839	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 Ph(4-CF 3 )
A-0840	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 Ph(4-CF 3 )
A-0841	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 Ph(4-CF 3 )
A-0842	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 Ph(4-CF 3 )
A-0843	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 Ph(4-CF 3 )
A-0844	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 Ph(3-CF 3 )
A-0845	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 Ph(3-CF 3 )
A-0846	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 Ph(4-tBu)
A-0847	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 Ph(4-tBu)
A-0848	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 Ph(4-CN)
A-0849	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 Ph(4-CN)
A-0850	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 Ph(4-OCHF 2 )
A-0851	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 Ph(4-OCF 3 )
A-0852	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 Ph(4-SCHF 2 )
A-0853	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 Ph(4-SCF 3 )
A-0854	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 Ph(4-SCF 3 )
A-0855	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 Ph(3,4,5-F 3 )
A-0856	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 Ph(3,4,5-F 3 )
A-0857	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 Ph(2,4,6-F 3 )
A-0858	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 Ph(2,4,6-F 3 )
A-0859	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 Ph(4-CF(CF 3 ) 2 )
A-0860	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 Ph
A-0861	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH(CH 3 )Ph
A-0862	CH 2 CF 3	Me	F	0	CH 2 CH(CH 3 )CH 2 Ph
A-0863	CH 2 CF 3	Me	F	0	CH(CH 3 )CH 2 CH 2 Ph
A-0864	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 Ph
A-0865	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 Ph(4-F)
A-0866	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 Ph(4-CF 3 )
A-0867	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 Ph(4-OCF 3 )
A-0868	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 Ph(4-SCF 3 )
A-0869	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 Ph
A-0870	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 Ph

TABLE 23

Compound No.	R 1	R 2	R 3	n	R 4
A-0871	CH 2 CF 3	Me	F	0	CH 2 CH 2 SPh
A-0872	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SPh
A-0873	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SPh
A-0874	CH 2 CF 3	Me	F	0	CH 2 CH(CH 3 )SPh
A-0875	CH 2 CF 3	Me	F	0	CH(CH 3 )CH 2 SPh
A-0876	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SPh(4-Cl)
A-0877	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SPh(4-tBu)
A-0878	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SPh(4-F)
A-0879	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SPh(4-Br)
A-0880	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SPh(4-CF 3 )
A-0881	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SPh(4-CF 3 )
A-0882	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 SPh(4-CF 3 )
A-0883	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 SPh(4-CF 3 )
A-0884	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SPh(3-CF 3 )
A-0885	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SPh(3-CF 3 )
A-0886	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SPh(3-SCF 3 )
A-0887	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SPh(4-SCF 3 )
A-0888	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SPh
A-0889	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SPh(4-Cl)
A-0890	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SPh(4-F)
A-0891	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SPh(4-tBu)
A-0892	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SPh(3-CF 3 )
A-0893	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SPh
A-0894	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SPh(4-CF 3 )
A-0895	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SPh(4-Cl)
A-0896	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SPh(4-F)
A-0897	CH 2 CF 3	Me	F	0	CH 2 CH 2 S(═O)Ph
A-0898	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 S(═O)Ph
A-0899	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O)Ph
A-0900	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 S(═O)Ph(4-CF 3 )
A-0901	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O)Ph(4-CF 3 )
A-0902	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O)Ph(4-F)
A-0903	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O)Ph(4-tBu)
A-0904	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O) 2 Ph(4-CF 3 )
A-0905	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O) 2 Ph(4-Cl)
A-0906	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O) 2 Ph(4-F)
A-0907	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 S(═O) 2 Ph
A-0908	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 S(═O) 2 Ph
A-0909	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 S(═O) 2 Ph
A-0910	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 S(═O) 2 Ph(4-CF 3 )

TABLE 24

Compound No.	R 1	R 2	R 3	n	R 4
A-0911	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 S(═O) 2 Ph(4-Cl)
A-0912	CH 2 CF 3	Me	F	0	CH 2 CH 2 SCH 2 Ph
A-0913	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SCH 2 Ph
A-0914	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 SCH 2 Ph
A-0915	CH 2 CF 3	Me	Cl	0	CH 2 CH 2 CH 2 SCH 2 Ph
A-0916	CH 2 CF 3	CN	F	0	CH 2 CH 2 CH 2 SCH 2 Ph
A-0917	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 SCH 2 Ph
A-0918	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SCH 2 Ph
A-0919	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SCH 2 Ph(2-Cl)
A-0920	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SCH 2 Ph(3-Cl)
A-0921	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SCH 2 Ph(4-Cl)
A-0922	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SCH 2 Ph(4-Cl)
A-0923	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SCH 2 Ph(4-CF 3 )
A-0924	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SCH 2 Ph(4-CF 3 )
A-0925	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SCH 2 Ph(3-CF 3 )
A-0926	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SCH 2 Ph(4-NO 2 )
A-0927	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SCH 2 Ph(2-SCF 3 )
A-0928	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SCH 2 Ph
A-0929	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SCH 2 Ph(4-CF 3 )
A-0930	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SCH 2 Ph(4-Cl)
A-0931	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SCH 2 Ph(4-CN)
A-0932	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 SCH 2 Ph
A-0933	CH 2 CF 3	Me	F	0	CH 2 CH 2 SCH 2 CH 2 Ph
A-0934	CH 2 CF 3	Me	F	0	CH 2 CH 2 SCH(Me)Ph
A-0935	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SCH 2 CH 2 Ph
A-0936	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SCH(Me)Ph
A-0937	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SCH 2 CH 2 Ph
A-0938	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SCH(Me)Ph
A-0939	CH 2 CF 3	Me	F	0	CH 2 CH 2 S(═O)CH 2 Ph(4-CF 3 )
A-0940	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 S(═O)CH 2 Ph
A-0941	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 S(═O)CH 2 Ph(4-CF 3 )
A-0942	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O)CH 2 Ph(4-Cl)
A-0943	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O) CH 2 Ph(2-SCF 3 )
A-0944	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 S(═O) CH 2 Ph(4-SCF 3 )
A-0945	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 S(═O)CH 2 Ph(4-CF 3 )
A-0946	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O)CH 2 Ph(4-CF 3 )
A-0947	CH 2 CF 3	Me	F	0	CH 2 CH 2 S(═O) 2 CH 2 Ph(4-CF 3 )
A-0948	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 S(═O) 2 CH 2 Ph
A-0949	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 S(═O) 2 CH 2 Ph(4-CF 3 )
A-0950	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 S(═O) 2 CH 2 Ph(4-Cl)

TABLE 25

Compound No.	R 1	R 2	R 3	n	R 4
A-0951	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 S(═O) 2 CH 2 Ph(4-CF 3 )
A-0952	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 S(═O) 2 CH 2 Ph(4-CF 3 )
A-0953	CH 2 CF 3	Me	F	0	CH 2 CH 2 OPh(4-CF 3 )
A-0954	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 OPh
A-0955	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 OPh(4-Cl)
A-0956	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 OPh(4-CF 3 )
A-0957	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 OPh(4-CF 3 )
A-0958	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 OPh(4-CF 3 )
A-0959	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 OPh(4-OCF 3 )
A-0960	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 OPh(4-OCF 3 )
A-0961	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 OPh(4-CF 3 )
A-0962	CH 2 CF 3	Me	H	0	CH 2 CH 2 OCH 2 Ph
A-0963	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 OCH 2 Ph
A-0964	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 OCH 2 Ph
A-0965	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 OCH 2 Ph
A-0966	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 OCH 2 Ph
A-0967	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 OCH 2 Ph
A-0968	CH 2 CF 3	Me	F	0	CH 2 CH 2 ON═C(Me)CF 3
A-0969	CH 2 CF 3	Me	F	1	CH 2 CH 2 ON═C(Me)CF 3
A-0970	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 ON═CHtBu
A-0971	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 ON═CHtBu
A-0972	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 ON═C(Me)CF 3
A-0973	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 ON═C(Me)CF 3
A-0974	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )ON═C(Me)CF 3
A-0975	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 ON═CHCF 3
A-0976	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 ON═CHCF 3
A-0977	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 ON═C(Me)CF 3
A-0978	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 ON═C(Me)CF 3
A-0979	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 ON═C(Me)CCl 3
A-0980	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 ON═C(Me)CCl 3
A-0981	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 ON═CHCF 3
A-0982	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 ON═CHCF 3
A-0983	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 ON═C(Me)CF 3
A-0984	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 ON═C(Me)CF 3
A-0985	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 ON═C(Me)CF 3
A-0986	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )ON═C(Me)CF 3
A-0987	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 ON═C(Me)CF 3
A-0988	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 ON═C(Me)CF 3
A-0989	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 ON═C(Me)cPr
A-0990	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 ON═C(Me)cPr

TABLE 26

Compound No.	R 1	R 2	R 3	n	R 4
A-0991	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 ON═C(Me)CF 3
A-0992	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 ON═C(Me)CF 3
A-0993	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH(CH 3 )ON═C(Me)CF 3
A-0994	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH(CH 3 )CH 2 ON═C(Me)CF 3
A-0995	CH 2 CF 3	Me	F	1	CH 2 CH(CH 3 )CH 2 CH 2 ON═C(Me)CF 3
A-0996	CH 2 CF 3	Me	F	0
A-0997	CH 2 CF 3	Me	F	1
A-0998	CH 2 CF 3	Me	F	0	CH 2 CH 2 ON═CHPh
A-0999	CH 2 CF 3	Me	F	0	CH 2 CH 2 ON═CHPh(4-CF 3 )
A-1000	CH 2 CF 3	Me	F	1	CH 2 CH 2 ON═CHPh(4-CF 3 )
A-1001	CH 2 CF 3	Me	F	0	CH 2 CH 2 ON═CHPh(4-SCF 3 )
A-1002	CH 2 CF 3	Me	F	1	CH 2 CH 2 ON═CHPh(4-SCF 3 )
A-1003	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 ON═CHPh(4-CF 3 )
A-1004	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 ON═CHPh(3-CF 3 )
A-1005	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 ON═CHPh(4-CF 3 )
A-1006	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 ON═CHPh(3-CF 3 )
A-1007	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 ON═CHPh(4-SCF 3 )
A-1008	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 ON═CHPh(4-SCF 3 )
A-1009	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 ON═C(Me)Ph(4-CF 3 )
A-1010	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 ON═C(Me)Ph(4-CF 3 )
A-1011	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 ON═CHPh(4-SCF 3 )
A-1012	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 ON═CHPh(4-SCF 3 )
A-1013	CH 2 CF 3	Me	F	1	CH 2 CH 2 SC(═O)NMe 2
A-1014	CH 2 CF 3	Me	F	1	CH 2 CH 2 SC(═O)NHCH 2 CF 3
A-1015	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SC(═O)NMe 2
A-1016	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SC(═O)NMe 2
A-1017	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SC(═O)NHtBu
A-1018	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 SC(═O)NHCH 2 CF 3
A-1019	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 SC(═O)NHtBu
A-1020	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 NHC(═O)OtBu
A-1021	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 NHC(═O)OtBu
A-1022	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 NHC(═O)OCH 2 CF 3
A-1023	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 NHC(═O)OCH 2 CH 2 CF 3
A-1024	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 OC(═O)Me
A-1025	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 OC(═O)Me
A-1026	CH 2 CF 3	Me	H	0	CH 2 CH 2 OC(═O)Ph
A-1027	CH 2 CF 3	Me	H	1	CH 2 CH 2 OC(═O)Ph
A-1028	CH 2 CF 3	Me	F	0	CH 2 CH 2 OC(═O)Ph(4-CF 3 )

TABLE 27

Compound No.	R 1	R 2	R 3	n	R 4
A-1029	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 OC(═O)Ph(4-CF 3 )
A-1030	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 OC(═O)Ph(4-CF 3 )
A-1031	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 OC(═O)Ph(4-CF 3 )
A-1032	CH 2 CF 3	Me	F	0	CH 2 CH 2 OS(═O) 2 Me
A-1033	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 OS(═O) 2 Me
A-1034	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 OS(═O) 2 CF 3
A-1035	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 OS(═O) 2 CF 3
A-1036	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 OS(═O) 2 CF 3
A-1037	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 OS(═O) 2 CF 2 CF 2 CF 2 CF 3
A-1038	CH 2 CF 3	Me	F	1	CH 2 CH 2 OS(═O)CF 3
A-1039	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 OS(═O)CF 3
A-1040	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 OS(═O)CF 3
A-1041	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 OS(═O)CF 3
A-1042	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 OS(═O)CF 3
A-1043	CH 2 CF 3	Me	F	0	CH 2 CH 2 ONH 2
A-1044	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 ONH 2
A-1045	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 ONH 2
A-1046	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 ONH 2
A-1047	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 ONH 2
A-1048	CH 2 CF 3	Me	F	0	CH 2 C(═O)OEt
A-1049	CH 2 CF 3	Me	F	1	CH 2 CH 2 C(═O)OtBu
A-1050	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 C(═O)OEt
A-1051	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 C(═O)OtBu
A-1052	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 C(═O)OtBu
A-1053	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 C(═O)OtBu
A-1054	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 C(═O)OtBu
A-1055	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 C(═O)OtBu
A-1056	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 C(═O)OtBu
A-1057	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 C(═O)OEt
A-1058	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 C(═O)OEt
A-1059	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 C(═O)OH
A-1060	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 CH 2 CH 2 C(═O)OH
A-1061	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 C(═O)OH
A-1062	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 C(═O)NH(tert-pentyl)
A-1063	CH 2 CF 3	Me	F	0	CH 2 CH 2 C(═O)NHtBu
A-1064	CH 2 CF 3	Me	F	0	CH 2 CH 2 C(═O)NHCH 2 CF 3
A-1065	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 C(═O)NHtBu
A-1066	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 C(═O)NHCH 2 CF 3
A-1067	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 C(═O)NHtBu
A-1068	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 C(═O)NHCH 2 CF 3

TABLE 28

Compound No.	R 1	R 2	R 3	n	R 4
A-1069	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 C(═O)CF 3
A-1070	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 C(═O)CF 3
A-1071	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 C(═O)CF 3
A-1072	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 C(═O)CF 3
A-1073	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 C(═O)CF 3
A-1074	CH 2 CF 3	Cl	Cl	0	CH 2 CH 2 CH 2 CH 2 C(═O)CF 3
A-1075	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 C(═O)CF 3
A-1076	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 C(═O)CF 3
A-1077	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 C(═O)CF 3
A-1078	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 C(═O)CF 3
A-1079	CH 2 CF 3	Me	F	0	CH 2 C(═O)Ph(4-Cl)
A-1080	CH 2 CF 3	Me	F	1	CH 2 C(═O)Ph(4-Cl)
A-1081	CH 2 CF 3	Me	F	0	CH 2 C(═O)Ph(4-CF 3 )
A-1082	CH 2 CF 3	Me	F	1	CH 2 C(═O)Ph(4-CF 3 )
A-1083	CH 2 CF 3	Me	F	0	CH 2 CH 2 C(═O)Ph(4-CF 3 )
A-1084	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 C(═O)Ph(4-CF 3 )
A-1085	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 C(═O)Ph(4-CF 3 )
A-1086	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 C(═O)Ph(4-CF 3 )
A-1087	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CN
A-1088	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CN
A-1089	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CN
A-1090	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CN
A-1091	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CN
A-1092	CH 2 CF 3	Me	F	1	cPr
A-1093	CH 2 CF 3	Me	F	0	cPen
A-1094	CH 2 CF 3	Me	F	1	cPen
A-1095	CH 2 CF 3	Me	F	0	cHex
A-1096	CH 2 CF 3	Me	F	1	cHex
A-1097	CH 2 CF 3	CN	F	0	cHex
A-1098	CH 2 CF 3	CN	F	1	cHex
A-1099	CH 2 CF 3	Me	F	0	CH 2 CH 2 NH 2
A-1100	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 NH 2
A-1101	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 NH 2
A-1102	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 NH 2
A-1103	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 N(Me)tBu
A-1104	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 NHCH 2 CF 3
A-1105	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 N(Me)tBu
A-1106	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHCH 2 CF 3
A-1107	CH 2 CF 3	Cl	F	0	CH 2 CH 2 NHC(═O)C(Me)(CF 3 ) 2
A-1108	CH 2 CF 3	Cl	F	1	CH 2 CH 2 NHC(═O)C(Me)(CF 3 ) 2

TABLE 29

Compound No.	R 1	R 2	R 3	n	R 4
A-1109	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 N(Me)C(═O)tBu
A-1110	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 NHC(═O)CH 2 CF 3
A-1111	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 NHC(═O)CH(CH 3 ) 2
A-1112	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 NHC(═O)tBu
A-1113	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)tBu
A-1114	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)CH 2 tBu
A-1115	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 N(Me)C(═O)tBu
A-1116	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 NHC(═O)CF 3
A-1117	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)CF 3
A-1118	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)CH 2 CF 3
A-1119	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)CH 2 CF 3
A-1120	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)CCl 3
A-1121	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)CF(CF 3 ) 2
A-1122	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 NHC(═O)Ph
A-1123	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)Ph
A-1124	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)OCH(CH 3 ) 2
A-1125	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 NHC(═O)OtBu
A-1126	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)OtBu
A-1127	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 NHC(═O)OCH 2 CCl 3
A-1128	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)OCH 2 CCl 3
A-1129	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)OCH 2 CF 3
A-1130	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 NHC(═O)NHEt
A-1131	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 NHC(═O)NHtBu
A-1132	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)NHtBu
A-1133	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)NHCH 2 CCl 3
A-1134	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)NHCH 2 CH 2 F
A-1135	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHC(═O)NHCH 2 CF 3
A-1136	CH 2 CF 3	Me	F	0	CH 2 CH 2 NHS(═O) 2 CF 3
A-1137	CH 2 CF 3	Me	F	1	CH 2 CH 2 NHS(═O) 2 CF 3
A-1138	CH 2 CF 3	Cl	F	0	CH 2 CH 2 NHS(═O) 2 CF 3
A-1139	CH 2 CF 3	Cl	F	1	CH 2 CH 2 NHS(═O) 2 CF 3
A-1140	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1141	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1142	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1143	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1144	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1145	CH 2 CF 3	CN	F	1	CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1146	CH 2 CF 3	CN	F	1	CH 2 CH 2 CH 2 NHS(═O) 2 CHF 2
A-1147	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 NHS(═O) 2 CF(CF 3 ) 2
A-1148	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 NHS(═O) 2 CF(CF 3 ) 2

TABLE 30

Compound No.	R 1	R 2	R 3	n	R 4
A-1149	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CH 3
A-1150	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CH 3
A-1151	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CH 3
A-1152	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CH 3
A-1153	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CH(CH 3 ) 2
A-1154	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CHF 2
A-1155	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CHF 2
A-1156	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1157	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1158	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1159	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1160	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1161	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1162	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1163	CH 2 CF 3	Me	Me	1	CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1164	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CH 3
A-1165	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CH 3
A-1166	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CHF 2
A-1167	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1168	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1169	CH 2 CF 3	Me	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1170	CH 2 CF 3	Cl	Cl	1	CH 2 CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1171	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 Ph
A-1172	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 Ph
A-1173	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 Ph(4-CF 3 )
A-1174	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 Ph(4-CF 3 )
A-1175	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 NHS(═O) 2 CF 3
A-1176	CH 2 CF 3	Me	F	1	CH 2 CH 2 N(Me)S(═O) 2 CF 3
A-1177	CH 2 CF 3	Me	F	0	CH 2 CH 2 N(Ac)S(═O) 2 CF 3
A-1178	CH 2 CF 3	Me	F	1	CH 2 CH 2 N(Ac)S(═O) 2 CF 3
A-1179	CH 2 CF 3	Me	F	1	CH 2 CH 2 N(COtBu)S(═O) 2 CF 3
A-1180	CH 2 CF 3	Me	F	0	CH 2 CH 2 N(CO 2 CH 3 )S(═O) 2 CF 3
A-1181	CH 2 CF 3	Me	F	1	CH 2 CH 2 N(CO 2 CH 3 )S(═O) 2 CF 3
A-1182	CH 2 CF 3	Cl	F	0	CH 2 CH 2 N(CO 2 CH 3 )S(═O) 2 CF 3
A-1183	CH 2 CF 3	Cl	F	1	CH 2 CH 2 N(CO 2 CH 3 )S(═O) 2 CF 3
A-1184	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 N(Me)S(═O) 2 CF 3
A-1185	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 N(Ac)S(═O) 2 CF 3
A-1186	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 N(Ac)S(═O) 2 CF 3
A-1187	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 N(CO 2 CH 3 )S(═O) 2 CF 3
A-1188	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 N(CO 2 CH 3 )S(═O) 2 CF 3

TABLE 31

Compound No.	R 1	R 2	R 3	n	R 4
A-1189	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 N(CO 2 tBu)S(═O) 2 CF 3
A-1190	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 N(Me)S(═O) 2 CF 3
A-1191	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 N(Ac)S(═O) 2 CF 3
A-1192	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 N(Ac)S(═O) 2 CF 3
A-1193	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 N(propionyl)S(═O) 2 CF 3
A-1194	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 N(pivaloyl)S(═O) 2 CF 3
A-1195	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 N(CO 2 CH 3 )S(═O) 2 CF 3
A-1196	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 N(CO 2 CH 3 )S(═O) 2 CF 3
A-1197	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 N(CO 2 CH 3 )S(═O) 2 CF 3
A-1198	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 N(CO 2 tBu)S(═O) 2 CF 3
A-1199	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 N(CO 2 tBu)S(═O) 2 CF 3
A-1200	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 N(Ac)S(═O) 2 CF 3
A-1201	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 CH 2 N(CO 2 CH 3 )S(═O) 2 CF 3
A-1202	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 CH 2 N(CO 2 CH 3 )S(═O) 2 CF 3
A-1203	CH 2 CF 3	Me	F	1	CH 2 CH 2 SiMe 3
A-1204	CH 2 CF 3	Cl	F	1	CH 2 CH 2 SiMe 3
A-1205	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 SiMe 3
A-1206	CH 2 CF 3	Me	H	0	CH 2 CH 2 CH 2 SiMe 3
A-1207	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 SiMe 3
A-1208	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 SiMe 3
A-1209	CH 2 CF 3	Me	H	1	CH 2 CH 2 CH 2 SiMe 3
A-1210	CH 2 CF 3	Me	F	0	CH 2 CH 2 CH 2 CH 2 SiMe 3
A-1211	CH 2 CF 3	Me	F	1	CH 2 CH 2 CH 2 CH 2 SiMe 3
A-1212	CH 2 CF 3	Cl	F	0	CH 2 CH 2 CH 2 CH 2 SiMe 3
A-1213	CH 2 CF 3	Cl	F	1	CH 2 CH 2 CH 2 CH 2 SiMe 3
A-1214	CH 2 CF 3	Cl	F	1	SO 2 CH 2 Ph
A-1215	CH 2 CF 3	Me	F	1	C(═O)Ph
A-1216	CH 2 CF 3	Me	F	0	C(═O)Ph
A-1217	CH 2 CF 3	Cl	F	0	C(═O)Ph
A-1218	CH 2 CF 3	Cl	F	1	C(═O)Ph

TABLE 32 — [I]

Compound No.	R 1	R 2	R 3	n	R 4
B-0001	CH 2 CF 3	Me	F	0
B-0002	CH 2 CF 3	Me	F	1
B-0003	CH 2 CF 3	Me	F	0
B-0004	CH 2 CF 3	Me	F	1
B-0005	CH 2 CF 3	Me	F	0
B-0006	CH 2 CF 3	Me	F	1
B-0007	CH 2 CF 3	Me	F	0
B-0008	CH 2 CF 3	Me	F	1
B-0009	CH 2 CF 3	Me	F	1
B-0010	CH 2 CF 3	Me	F	0

TABLE 33

Compound No.	R 1	R 2	R 3	n	R 4
B-0011	CH 2 CF 3	Me	F	1
B-0012	CH 2 CF 3	Me	F	0
B-0013	CH 2 CF 3	Me	F	1
B-0014	CH 2 CF 3	Cl	F	0
B-0015	CH 2 CF 3	Cl	F	1
B-0016	CH 2 CF 3	Cl	F	0
B-0017	CH 2 CF 3	Me	F	0
B-0018	CH 2 CF 3	Me	F	1
B-0019	CH 2 CF 3	Me	F	1
B-0020	CH 2 CF 3	Me	F	0
B-0021	CH 2 CF 3	Me	F	1
B-0022	CH 2 CF 3	Me	F	0

TABLE 34

Compound No.	R 1	R 2	R 3	n	R 4
B-0023	CH 2 CF 3	Me	F	1
B-0024	CH 2 CF 3	Me	F	0
B-0025	CH 2 CF 3	Me	F	1
B-0026	CH 2 CF 3	Me	F	1
B-0027	CH 2 CF 3	Me	F	1
B-0028	CH 2 CF 3	Me	F	0
B-0029	CH 2 CF 3	Me	F	0
B-0030	CH 2 CF 3	Me	F	1
B-0031	CH 2 CF 3	Me	F	0
B-0032	CH 2 CF 3	Me	F	1
B-0033	CH 2 CF 3	Me	F	0

TABLE 35

Compound No.	R 1	R 2	R 3	n	R 4
B-0034	CH 2 CF 3	Me	F	1
B-0035	CH 2 CF 3	Me	F	0
B-0036	CH 2 CF 3	Me	H	0
B-0037	CH 2 CF 3	Me	H	1
B-0038	CH 2 CF 3	CHF 2	H	0
B-0039	CH 2 CF 3	CHF 2	H	1
B-0040	CH 2 CF 3	Me	F	2
B-0041	CH 2 CF 3	Me	F	1
B-0042	CH 2 CF 3	Me	F	0
B-0043	CH 2 CF 3	Cl	F	0
B-0044	CH 2 CF 3	Cl	F	1
B-0045	CH 2 CF 3	CN	F	0

TABLE 36 — Compound

No.	R 1	R 2	R 3	n	R 4
B-0046	CH 2 CF 3	CN	F	1
B-0047	CH 2 CF 3	Me	F	1
B-0048	CH 2 CF 3	Me	F	0
B-0049	CH 2 CF 3	Me	F	1
B-0050	CH 2 CF 3	Me	F	1
B-0051	CH 2 CF 3	Me	F	0
B-0052	CH 2 CF 3	Me	F	1
B-0053	CH 2 CF 3	Me	F	0
B-0054	CH 2 CF 3	Me	F	1
B-0055	CH 2 CF 3	Me	F	0
B-0056	CH 2 CF 3	Me	F	1
B-0057	CH 2 CF 3	Me	F	0

TABLE 37 — Compound

No.	R 1	R 2	R 3	n	R 4
B-0058	CH 2 CF 3	Me	F	1
B-0059	CH 2 CF 3	Me	F	1
B-0060	CH 2 CF 3	Me	F	0
B-0061	CH 2 CF 3	Me	F	1
B-0062	CH 2 CF 3	Me	F	1
B-0063	CH 2 CF 3	Me	F	0
B-0064	CH 2 CF 3	Me	F	0
B-0065	CH 2 CF 3	Me	F	1
B-0066	CH 2 CF 3	Me	F	0
B-0067	CH 2 CF 3	Me	F	1
B-0068	CH 2 CF 3	Cl	F	0
B-0069	CH 2 CF 3	Cl	F	1

TABLE 38

Compound No.	R 1	R 2	R 3	n	R 4
B-0070	CH 2 CF 3	Me	F	0
B-0071	CH 2 CF 3	Me	F	1
B-0072	CH 2 CF 3	Cl	F	0
B-0073	CH 2 CF 3	Cl	F	1
B-0074	CH 2 CF 3	Me	F	0
B-0075	CH 2 CF 3	Me	F	1
B-0076	CH 2 CF 3	Me	F	0
B-0077	CH 2 CF 3	Me	F	1
B-0078	CH 2 CF 3	Cl	F	0
B-0079	CH 2 CF 3	Cl	F	1
B-0080	CH 2 CF 3	Cl	F	0
B-0081	CH 2 CF 3	Cl	F	1

TABLE 39

Compound No.	R 1	R 2	R 3	n	R 4
B-0082	CH 2 CF 3	Me	F	0
B-0083	CH 2 CF 3	Me	F	1
B-0084	CH 2 CF 3	Cl	F	0
B-0085	CH 2 CF 3	Cl	F	1
B-0086	CH 2 CF 3	Me	F	0
B-0087	CH 2 CF 3	Me	F	1
B-0088	CH 2 CF 3	Me	F	0
B-0089	CH 2 CF 3	Me	F	1
B-0090	CH 2 CF 3	Cl	F	0
B-0091	CH 2 CF 3	Cl	F	1
B-0092	CH 2 CF 3	Cl	F	1
B-0093	CH 2 CF 3	Me	F	0

TABLE 40

Compound No.	R 1	R 2	R 3	n	R 4
B-0094	CH 2 CF 3	Cl	F	0
B-0095	CH 2 CF 3	Cl	F	1
B-0096	CH 2 CF 3	Me	F	0
B-0097	CH 2 CF 3	Me	F	0
B-0098	CH 2 CF 3	Me	F	1
B-0099	CH 2 CF 3	Me	F	0
B-0100	CH 2 CF 3	Me	F	1
B-0101	CH 2 CF 3	Me	F	0
B-0102	CH 2 CF 3	C	F	0
B-0103	CH 2 CF 3	Cl	F	1
B-0104	CH 2 CF 3	Me	F	0
B-0105	CH 2 CF 3	Me	F	1

TABLE 41

Compound No.	R 1	R 2	R 3	n	R 4
B-0106	CH 2 CF 3	Cl	F	0
B-0107	CH 2 CF 3	Cl	F	1
B-0108	CH 2 CF 3	Me	F	0
B-0109	CH 2 CF 3	Me	F	0
B-0110	CH 2 CF 3	Me	F	1
B-0111	CH 2 CF 3	Me	F	1
B-0112	CH 2 CF 3	Me	F	1
B-0113	CH 2 CF 3	Me	F	0
B-0114	CH 2 CF 3	Cl	F	0
B-0115	CH 2 CF 3	Me	F	0
B-0116	CH 2 CF 3	Cl	F	0
B-0117	CH 2 CF 3	Cl	F	0

TABLE 42 — [I′]

Compound No.	R 1	R 2	R 3	n
C-0001	CH 2 CF 3	Me	F	0
C-0002	CH 2 CF 3	Me	F	1
C-0003	CH 2 CF 3	Cl	F	0
C-0004	CH 2 CF 3	Cl	F	1
C-0005	CH 2 CF 3	Me	H	0
C-0006	CH 2 CF 3	Me	H	1
C-0007	CH 2 CF 3	Me	Cl	0
C-0008	CH 2 CF 3	Me	Cl	1
C-0009	CH 2 CF 3	Cl	H	0
C-0010	CH 2 CF 3	CI	H	1
C-0011	CH 2 CF 3	CN	F	0
C-0012	CH 2 CF 3	CN	F	1
C-0013	CH 2 CF 3	OMe	F	0
C-0014	CH 2 CF 3	Cl	Cl	0
C-0015	CH 2 CF 3	Cl	Cl	1
C-0016	CH 2 CF 3	Cl	F	2
C-0017	CH 2 CF 3	Me	Me	0
C-0018	CH 2 CF 3	Me	Me	1

TABLE 43

	Compound No.	Physical Property
A-0001	Reflactive Index (n D 20 )	1.4922
A-0004	Reflactive Index (n D 20 )	1.5072
A-0005	Melting Point (° C.)	140-141
A-0006	Reflactive Index (n D 20 )	1.4819
A-0007	Melting Point (° C.)	89-92
A-0012	Reflactive Index (n D 20 )	1.5055
A-0013	Melting Point (° C.)	87-89
A-0014	Reflactive Index (n D 20 )	1.4827
A-0015	Melting Point (° C.)	58-60
A-0017	Reflactive Index (n D 20 )	1.5016
A-0018	Melting Point (° C.)	87-88
A-0022	Reflactive Index (n D 20 )	1.4893
A-0023	Melting Point (° C.)	53-54
A-0024	Reflactive Index (n D 20 )	1.5008
A-0025	Melting Point (° C.)	97-99
A-0027	Reflactive Index (n D 20 )	1.4952
A-0028	Melting Point (° C.)	74-76
A-0030	Reflactive Index (n D 20 )	1.4800
A-0031	Melting Point (° C.)	64-67
A-0032	Reflactive Index (n D 20 )	1.4819
A-0033	Melting Point (° C.)	117-118
A-0035	Reflactive Index (n D 20 )	1.5032
A-0036	Melting Point (° C.)	125-127
A-0037	Reflactive Index (n D 20 )	1.4810
A-0038	Melting Point (° C.)	77-80
A-0039	Reflactive Index (n D 20 )	1.5032
A-0040	Melting Point (° C.)	105-107
A-0043	Reflactive Index (n D 20 )	1.4809
A-0044	Melting Point (° C.)	68-70
A-0046	Reflactive Index (n D 20 )	1.5004
A-0047	Melting Point (° C.)	97-98
A-0051	Reflactive Index (n D 20 )	1.4769
A-0052	Melting Point (° C.)	78-79
A-0055	Reflactive Index (n D 20 )	1.4987
A-0056	Melting Point (° C.)	77-79
A-0061	Reflactive Index (n D 20 )	1.4900
A-0064	Reflactive Index (n D 20 )	1.4989
A-0065	Melting Point (° C.)	106-109
A-0066	Melting Point (° C.)	113-114

TABLE 44

	Compound No.	Physical Property
A-0068	Reflactive Index (n D 20 )	1.5011
A-0069	Melting Point (° C.)	138-139
A-0070	Reflactive Index (n D 20 )	1.4760
A-0071	Melting Point (° C.)	98-100
A-0074	Reflactive Index (n D 20 )	1.4748
A-0075	Melting Point (° C.)	74-75
A-0076	Reflactive Index (n D 20 )	1.4830
A-0077	Melting Point (° C.)	65-66
A-0078	Reflactive Index (n D 20 )	1.4961
A-0079	Melting Point (° C.)	81-83
A-0081	Reflactive Index (n D 20 )	1.4820
A-0085	Reflactive Index (n D 20 )	1.4780
A-0086	Melting Point (° C.)	84-85
A-0087	Reflactive Index (n D 20 )	1.4915
A-0088	Melting Point (° C.)	62-64
A-0089	Reflactive Index (n D 20 )	1.4933
A-0090	Melting Point (° C.)	83-84
A-0091	Reflactive Index (n D 20 )	1.4865
A-0092	Melting Point (° C.)	51-52
A-0094	Melting Point (° C.)	108-110
A-0108	Melting Point (° C.)	50-51
A-0109	Melting Point (° C.)	56-57
A-0110	Melting Point (° C.)	76-77
A-0111	Melting Point (° C.)	105-107
A-0112	Reflactive Index (n D 20 )	1.5032
A-0113	Melting Point (° C.)	74-75
A-0114	Melting Point (° C.)	76-77
A-0115	Reflactive Index (n D 20 )	1.5160
A-0116	Reflactive Index (n D 20 )	1.4834
A-0117	Melting Point (° C.)	52-54
A-0118	Reflactive Index (n D 20 )	1.4899
A-0119	Melting Point (° C.)	104-105
A-0120	Reflactive Index (n D 20 )	1.4790
A-0122	Reflactive Index (n D 20 )	1.4790
A-0123	Melting Point (° C.)	58-60
A-0125	Reflactive Index (n D 20 )	1.4949
A-0126	Melting Point (° C.)	46-48
A-0130	Melting Point (° C.)	59-60
A-0132	Reflactive Index (n D 20 )	1.4842

TABLE 45

	Compound No.	Physical Property
A-0133	Melting Point (° C.)	48-50
A-0141	Melting Point (° C.)	60-61
A-0143	Reflactive Index (n D 20 )	1.4871
A-0144	Melting Point (° C.)	47-48
A-0145	Melting Point (° C.)	78-81
A-0147	Reflactive Index (n D 20 )	1.4870
A-0157	Melting Point (° C.)	86-88
A-0159	Reflactive Index (n D 20 )	1.4542
A-0160	Melting Point (° C.)	100-103
A-0163	Reflactive Index (n D 20 )	1.4549
A-0164	Melting Point (° C.)	79-81
A-0167	Reflactive Index (n D 20 )	1.4562
A-0168	Melting Point (° C.)	33-35
A-0169	Reflactive Index (n D 20 )	1.4631
A-0170	Melting Point (° C.)	44-47
A-0172	Reflactive Index (n D 20 )	1.4303
A-0173	Melting Point (° C.)	72-74
A-0174	Reflactive Index (n D 20 )	1.4365
A-0175	Melting Point (° C.)	57-59
A-0180	Reflactive Index (n D 20 )	1.4429
A-0181	Melting Point (° C.)	94-96
A-0184	Reflactive Index (n D 20 )	1.4200
A-0185	Melting Point (° C.)	47-48
A-0186	Reflactive Index (n D 20 )	1.4184
A-0187	Melting Point (° C.)	56-58
A-0188	Reflactive Index (n D 20 )	1.4445
A-0199	Reflactive Index (n D 20 )	1.4554
A-0200	Reflactive Index (n D 20 )	1.4613
A-0203	Reflactive Index (n D 20 )	1.4562
A-0204	Reflactive Index (n D 20 )	1.4644
A-0205	Reflactive Index (n D 20 )	1.4678
A-0206	Melting Point (° C.)	39-42
A-0207	Reflactive Index (n D 20 )	1.4725
A-0208	Reflactive Index (n D 20 )	1.4802
A-0211	Reflactive Index (n D 20 )	1.419
A-0212	Reflactive Index (n D 20 )	1.4273
A-0213	Reflactive Index (n D 20 )	1.4382
A-0214	Reflactive Index (n D 20 )	1.4378
A-0215	Reflactive Index (n D 20 )	1.4309

TABLE 46

	Compound No.	Physical Property
A-0216	Reflactive Index (n D 20 )	1.4341
A-0217	Reflactive Index (n D 20 )	1.4341
A-0218	Reflactive Index (n D 20 )	1.4359
A-0219	Reflactive Index (n D 20 )	1.4200
A-0220	Reflactive Index (n D 20 )	1.4321
A-0221	Reflactive Index (n D 20 )	1.4368
A-0222	Reflactive Index (n D 20 )	1.4401
A-0223	Reflactive Index (n D 20 )	1.4328
A-0224	Melting Point (° C.)	45-47
A-0225	Reflactive Index (n D 20 )	1.4163
A-0226	Reflactive Index (n D 20 )	1.4115
A-0227	Reflactive Index (n D 20 )	1.3980
A-0228	Reflactive Index (n D 20 )	1.4079
A-0229	Reflactive Index (n D 20 )	1.4018
A-0230	Melting Point (° C.)	43-44
A-0232	Reflactive Index (n D 20 )	1.3759
A-0243	Reflactive Index (n D 20 )	1.4961
A-0244	Melting Point (° C.)	79-80
A-0249	Reflactive Index (n D 20 )	1.4947
A-0250	Reflactive Index (n D 20 )	1.4929
A-0253	Reflactive Index (n D 20 )	1.4751
A-0254	Melting Point (° C.)	116-118
A-0260	Reflactive Index (n D 20 )	1.4963
A-0261	Reflactive Index (n D 20 )	1.5132
A-0262	Melting Point (° C.)	89-92
A-0263	Reflactive Index (n D 20 )	1.5241
A-0264	Reflactive Index (n D 20 )	1.5102
A-0266	Reflactive Index (n D 20 )	1.5260
A-0269	Reflactive Index (n D 20 )	1.5092
A-0270	Melting Point (° C.)	53-55
A-0271	Reflactive Index (n D 20 )	1.5078
A-0273	Reflactive Index (n D 20 )	1.5211
A-0275	Reflactive Index (n D 20 )	1.5133
A-0277	Reflactive Index (n D 20 )	1.5195
A-0279	Reflactive Index (n D 20 )	1.5160
A-0281	Reflactive Index (n D 20 )	1.5071
A-0285	Reflactive Index (n D 20 )	1.4981
A-0287	Reflactive Index (n D 20 )	1.5206
A-0289	Reflactive Index (n D 20 )	1.4943

TABLE 47

	Compound No.	Physical Property
A-0290	Reflactive Index (n D 20 )	1.4940
A-0291	Reflactive Index (n D 20 )	1.5089
A-0294	Reflactive Index (n D 20 )	1.5199
A-0299	Reflactive Index (n D 20 )	1.5102
A-0301	Reflactive Index (n D 20 )	1.4960
A-0303	Reflactive Index (n D 20 )	1.5094
A-0307	Reflactive Index (n D 20 )	1.4761
A-0308	Melting Point (° C.)	54-56
A-0311	Reflactive Index (n D 20 )	1.4741
A-0313	Melting Point (° C.)	75-78
A-0314	Melting Point (° C.)	93-96
A-0315	Reflactive Index (n D 20 )	1.4912
A-0316	Melting Point (° C.)	85-88
A-0318	Melting Point (° C.)	77-80
A-0319	Reflactive Index (n D 20 )	1.4851
A-0320	Melting Point (° C.)	116-117
A-0321	Reflactive Index (n D 20 )	1.4969
A-0322	Melting Point (° C.)	117-118
A-0324	Reflactive Index (n D 20 )	1.4752
A-0325	Reflactive Index (n D 20 )	1.4832
A-0326	Melting Point (° C.)	119-122
A-0327	Melting Point (° C.)	92-95
A-0330	Melting Point (° C.)	115-118
A-0331	Melting Point (° C.)	120-121
A-0338	Reflactive Index (n D 20 )	1.4751
A-0339	Reflactive Index (n D 20 )	1.4798
A-0340	Reflactive Index (n D 20 )	1.4831
A-0341	Reflactive Index (n D 20 )	1.4859
A-0342	Reflactive Index (n D 20 )	1.4968
A-0343	Melting Point (° C.)	66-67
A-0346	Reflactive Index (n D 20 )	1.4950
A-0347	Melting Point (° C.)	89-90
A-0349	Reflactive Index (n D 20 )	1.5321
A-0350	Melting Point (° C.)	117-118
A-0352	Melting Point (° C.)	83-84
A-0353	Melting Point (° C.)	51-52
A-0354	Melting Point (° C.)	88-90
A-0356	Melting Point (° C.)	54-56
A-0359	Melting Point (° C.)	74-77

TABLE 48

	Compound No.	Physical Property
A-0360	Reflactive Index (n D 20 )	1.5079
A-0363	Reflactive Index (n D 20 )	1.5012
A-0364	Melting Point (° C.)	46-47
A-0365	Reflactive Index (n D 20 )	1.5104
A-0366	Melting Point (° C.)	42-43
A-0368	Melting Point (° C.)	69-71
A-0369	Reflactive Index (n D 20 )	1.5089
A-0374	Reflactive Index (n D 20 )	1.4990
A-0375	Melting Point (° C.)	48-50
A-0379	Reflactive Index (n D 20 )	1.5217
A-0387	Melting Point (° C.)	68-70
A-0388	Melting Point (° C.)	111-112
A-0391	Melting Point (° C.)	88-89
A-0392	Melting Point (° C.)	95-98
A-0393	Melting Point (° C.)	98-99
A-0394	Melting Point (° C.)	109-110
A-0395	Melting Point (° C.)	93-94
A-0396	Melting Point (° C.)	108-109
A-0405	Reflactive Index (n D 20 )	1.4741
A-0406	Reflactive Index (n D 20 )	1.4800
A-0415	Reflactive Index (n D 20 )	1.4762
A-0417	Reflactive Index (n D 20 )	1.4882
A-0418	Melting Point (° C.)	57-59
A-0422	Reflactive Index (n D 20 )	1.4855
A-0423	Reflactive Index (n D 20 )	1.4869
A-0431	Reflactive Index (n D 20 )	1.4742
A-0433	Reflactive Index (n D 20 )	1.4932
A-0434	Melting Point (° C.)	49-50
A-0435	Melting Point (° C.)	51-52
A-0437	Reflactive Index (n D 20 )	1.5000
A-0438	Reflactive Index (n D 20 )	1.4878
A-0439	Reflactive Index (n D 20 )	1.4889
A-0441	Melting Point (° C.)	68-69
A-0443	Melting Point (° C.)	41-42
A-0444	Reflactive Index (n D 20 )	1.5006
A-0445	Melting Point (° C.)	63-66
A-0446	Reflactive Index (n D 20 )	1.4947
A-0447	Reflactive Index (n D 20 )	1.4931
A-0448	Reflactive Index (n D 20 )	1.4781

TABLE 49

	Compound No.	Physical Property
A-0449	Melting Point (° C.)	69-70
A-0470	Reflactive Index (n D 20 )	1.4770
A-0471	Melting Point (° C.)	42-44
A-0472	Reflactive Index (n D 20 )	1.4905
A-0473	Melting Point (° C.)	43-46
A-0474	Reflactive Index (n D 20 )	1.4886
A-0475	Reflactive Index (n D 20 )	1.4862
A-0476	Reflactive Index (n D 20 )	1.4951
A-0477	Melting Point (° C.)	45-48
A-0478	Reflactive Index (n D 20 )	1.5059
A-0479	Melting Point (° C.)	43-45
A-0481	Reflactive Index (n D 20 )	1.4859
A-0482	Reflactive Index (n D 20 )	1.4960
A-0483	Reflactive Index (n D 20 )	1.491
A-0484	Reflactive Index (n D 20 )	1.4759
A-0485	Reflactive Index (n D 20 )	1.4800
A-0486	Reflactive Index (n D 20 )	1.5086
A-0487	Reflactive Index (n D 20 )	1.5102
A-0488	Reflactive Index (n D 20 )	1.5005
A-0489	Reflactive Index (n D 20 )	1.4978
A-0490	Reflactive Index (n D 20 )	1.5181
A-0495	Reflactive Index (n D 20 )	1.4839
A-0496	Reflactive Index (n D 20 )	1.4782
A-0502	Reflactive Index (n D 20 )	1.4813
A-0503	Reflactive Index (n D 20 )	1.4773
A-0504	Reflactive Index (n D 20 )	1.4814
A-0505	Melting Point (° C.)	48-49
A-0507	Reflactive Index (n D 20 )	1.4932
A-0508	Melting Point (° C.)	43-44
A-0510	Melting Point (° C.)	44-45
A-0524	Melting Point (° C.)	82-83
A-0525	Melting Point (° C.)	50-51
A-0526	Reflactive Index (n D 20 )	1.4920
A-0533	Melting Point (° C.)	80-81
A-0534	Melting Point (° C.)	92-93
A-0535	Reflactive Index (n D 20 )	1.4709
A-0536	Melting Point (° C.)	73-74
A-0539	Melting Point (° C.)	74-77
A-0543	Reflactive Index (n D 20 )	1.4949

TABLE 50

	Compound No.	Physical Property
A-0553	Reflactive Index (n D 20 )	1.4914
A-0555	Reflactive Index (n D 20 )	1.5025
A-0556	Melting Point (° C.)	40-42
A-0558	Reflactive Index (n D 20 )	1.5052
A-0559	Reflactive Index (n D 20 )	1.5125
A-0560	Melting Point (° C.)	49-50
A-0561	Reflactive Index (n D 20 )	1.5201
A-0562	Melting Point (° C.)	57-59
A-0563	Reflactive Index (n D 20 )	1.5025
A-0571	Reflactive Index (n D 20 )	1.4957
A-0572	Reflactive Index (n D 20 )	1.5000
A-0573	Reflactive Index (n D 20 )	1.5023
A-0574	Reflactive Index (n D 20 )	1.4982
A-0575	Reflactive Index (n D 20 )	1.5098
A-0576	Reflactive Index (n D 20 )	1.5087
A-0577	Melting Point (° C.)	68-69
A-0578	Melting Point (° C.)	58-59
A-0587	Reflactive Index (n D 20 )	1.4941
A-0588	Reflactive Index (n D 20 )	1.4981
A-0589	Reflactive Index (n D 20 )	1.5010
A-0590	Melting Point (° C.)	41-42
A-0591	Melting Point (° C.)	50-51
A-0592	Reflactive Index (n D 20 )	1.5000
A-0594	Melting Point (° C.)	112-113
A-0599	Melting Point (° C.)	65-67
A-0605	Melting Point (° C.)	87-90
A-0606	Melting Point (° C.)	78-81
A-0610	Reflactive Index (n D 20 )	1.4909
A-0611	Melting Point (° C.)	96-99
A-0615	Melting Point (° C.)	60-61
A-0616	Melting Point CO	58-60
A-0617	Melting Point (° C.)	38-41
A-0618	Melting Point (° C.)	82-83
A-0622	Reflactive Index (n D 20 )	1.4864
A-0623	Melting Point (° C.)	86-88
A-0625	Reflactive Index (n D 20 )	1.4861
A-0626	Reflactive Index (n D 20 )	1.4899
A-0631	Reflactive Index (n D 20 )	1.4845
A-0632	Melting Point (° C.)	72-74

TABLE 51

	Compound No.	Physical Property
A-0638	Melting Point (° C.)	39-41
A-0640	Reflactive Index (n D 20 )	1.4902
A-0641	Melting Point (° C.)	68-69
A-0642	Melting Point (° C.)	43-44
A-0643	Melting Point (° C.)	61-63
A-0644	Reflactive Index (n D 20 )	1.5000
A-0662	Reflactive Index (n D 20 )	1.5353
A-0663	Reflactive Index (n D 20 )	1.5190
A-0665	Reflactive Index (n D 20 )	1.5309
A-0666	Reflactive Index (n D 20 )	1.5272
A-0667	Reflactive Index (n D 20 )	1.5509
A-0668	Reflactive Index (n D 20 )	1.5155
A-0670	Reflactive Index (n D 20 )	1.5281
A-0671	Reflactive Index (n D 20 )	1.5325
A-0672	Reflactive Index (n D 20 )	1.5299
A-0673	Reflactive Index (n D 20 )	1.5161
A-0674	Reflactive Index (n D 20 )	1.5130
A-0675	Reflactive Index (n D 20 )	1.5122
A-0676	Reflactive Index (n D 20 )	1.5210
A-0677	Reflactive Index (n D 20 )	1.5240
A-0680	Reflactive Index (n D 20 )	1.5085
A-0682	Reflactive Index (n D 20 )	1.5121
A-0683	Reflactive Index (n D 20 )	1.4769
A-0684	Reflactive Index (n D 20 )	1.5361
A-0686	Melting Point (° C.)	108-110
A-0688	Melting Point (° C.)	111-112
A-0690	Reflactive Index (n D 20 )	1.5016
A-0692	Melting Point (° C.)	81-83
A-0693	Reflactive Index (n D 20 )	1.5092
A-0694	Melting Point (° C.)	86-87
A-0695	Melting Point (° C.)	39-41
A-0696	Melting Point (° C.)	125-127
A-0697	Melting Point (° C.)	102-104
A-0698	Melting Point (° C.)	113-116
A-0699	Melting Point (° C.)	53-55
A-0700	Melting Point (° C.)	112-114
A-0703	Melting Point (° C.)	63-64
A-0709	Melting Point (° C.)	59-60
A-0710	Melting Point (° C.)	98-100

TABLE 52

	Compound No.	Physical Property
A-0711	Melting Point (° C.)	61-63
A-0712	Melting Point (° C.)	89-90
A-0713	Reflactive Index (n D 20 )	1.5188
A-0716	Melting Point (° C.)	66-68
A-0717	Melting Point (° C.)	80-81
A-0718	Melting Point (° C.)	79-82
A-0720	Reflactive Index (n D 20 )	1.5330
A-0721	Melting Point (° C.)	128-129
A-0722	Melting Point (° C.)	50-51
A-0723	Melting Point (° C.)	90-91
A-0724	Melting Point (° C.)	96-97
A-0725	Melting Point (° C.)	144-145
A-0726	Melting Point (° C.)	117-119
A-0727	Melting Point (° C.)	93-96
A-0728	Melting Point (° C.)	47-48.5
A-0729	Melting Point (° C.)	117-118
A-0730	Melting Point (° C.)	70-71
A-0731	Melting Point (° C.)	125-126
A-0732	Reflactive Index (n D 20 )	1.5021
A-0733	Melting Point (° C.)	144-145
A-0734	Reflactive Index (n D 20 )	1.5072
A-0735	Melting Point (° C.)	132-134
A-0736	Melting Point (° C.)	122-123
A-0739	Melting Point (° C.)	79-80
A-0740	Melting Point (° C.)	138-140
A-0741	Melting Point (° C.)	52-53
A-0742	Melting Point (° C.)	114-116
A-0743	Melting Point (° C.)	52-53
A-0744	Melting Point (° C.)	103-104
A-0746	Melting Point (° C.)	101-102
A-0748	Reflactive Index (n D 20 )	1.4766
A-0749	Melting Point (° C.)	96-98
A-0750	Melting Point (° C.)	85-87
A-0751	Reflactive Index (n D 20 )	1.5319
A-0752	Melting Point (° C.)	78-80
A-0753	Reflactive Index (n D 20 )	1.5224
A-0754	Melting Point (° C.)	92-94
A-0755	Reflactive Index (n D 20 )	1.5279
A-0756	Melting Point (° C.)	102-103

TABLE 53

	Compound No.	Physical Property
A-0757	Reflactive Index(n D 20 )	1.5500
A-0758	Melting Point (° C.)	104-105
A-0759	Reflactive Index (n D 20 )	1.5030
A-0760	Melting Point (° C.)	125-128
A-0761	Reflactive Index (n D 20 )	1.4979
A-0762	Reflactive Index (n D 20 )	1.5050
A-0763	Reflactive Index (n D 20 )	1.4991
A-0764	Melting Point (° C.)	95-96
A-0765	Reflactive Index (n D 20 )	1.5085
A-0766	Melting Point (° C.)	91-92
A-0767	Melting Point (° C.)	109-110
A-0768	Melting Point (° C.)	91-92
A-0769	Melting Point (° C.)	115-116
A-0771	Melting Point (° C.)	115-116
A-0772	Reflactive Index (n D 20 )	1.5190
A-0773	Melting Point (° C.)	89-90
A-0774	Melting Point (° C.)	75-76
A-0775	Melting Point (° C.)	81-82
A-0776	Melting Point (° C.)	118-120
A-0777	Melting Point (° C.)	40-41
A-0778	Reflactive Index (n D 20 )	1.4976
A-0779	Melting Point (° C.)	81-84
A-0780	Reflactive Index (n D 20 )	1.5009
A-0781	Melting Point (° C.)	94-95
A-0782	Melting Point (° C.)	111-112
A-0783	Melting Point (° C.)	80-81
A-0784	Melting Point (° C.)	120-122
A-0786	Reflactive Index (n D 20 )	1.5158
A-0787	Reflactive Index (n D 20 )	1.5247
A-0788	Melting Point (° C.)	89-90
A-0789	Melting Point (° C.)	114-115
A-0790	Melting Point (° C.)	51-54
A-0791	Melting Point (° C.)	131-134
A-0792	Melting Point (° C.)	110-111
A-0793	Melting Point (° C.)	126-127
A-0795	Melting Point (° C.)	117-118
A-0796	Melting Point (° C.)	133-136
A-0797	Reflactive Index (n D 20 )	1.5062
A-0798	Reflactive Index (n D 20 )	1.4980

TABLE 54

	Compound No.	Physical Property
A-0799	Melting Point (° C.)	79-81
A-0800	Melting Point (° C.)	83-84
A-0801	Melting Point (° C.)	109-110
A-0802	Reflactive Index (n D 20 )	1.5540
A-0803	Melting Point (° C.)	135-136
A-0805	Melting Point (° C.)	92-93
A-0806	Melting Point (° C.)	101-102
A-0807	Melting Point (° C.)	115-116
A-0808	Melting Point (° C.)	106-109
A-0809	Reflactive Index (n D 20 )	1.5051
A-0810	Melting Point (° C.)	88-90
A-0811	Reflactive Index (n D 20 )	1.5021
A-0812	Melting Point (° C.)	107-109
A-0813	Reflactive Index (n D 20 )	1.4896
A-0814	Melting Point (° C.)	104-106
A-0815	Reflactive Index (n D 20 )	1.4987
A-0816	Melting Point (° C.)	111-112
A-0817	Melting Point (° C.)	98-100
A-0818	Melting Point (° C.)	86-88
A-0819	Reflactive Index (n D 20 )	1.5210
A-0820	Melting Point (° C.)	99-100
A-0821	Melting Point (° C.)	90-91
A-0823	Melting Point (° C.)	93-95
A-0824	Reflactive Index (n D 20 )	1.5005
A-0825	Melting Point (° C.)	72-73
A-0826	Reflactive Index (n D 20 )	1.5282
A-0827	Melting Point (° C.)	76-78
A-0828	Reflactive Index (n D 20 )	1.5463
A-0829	Melting Point (° C.)	144-145
A-0830	Reflactive Index (n D 20 )	1.5589
A-0831	Reflactive Index (n D 20 )	1.5479
A-0832	Reflactive Index (n D 20 )	1.5406
A-0833	Melting Point (° C.)	49-52
A-0837	Melting Point (° C.)	96-97
A-0838	Reflactive Index (n D 20 )	1.4970
A-0839	Melting Point (° C.)	101-102
A-0844	Reflactive Index (n D 20 )	1.4962
A-0845	Reflactive Index (n D 20 )	1.5025
A-0846	Reflactive Index (n D 20 )	1.5270

TABLE 55

	Compound No.	Physical Property
A-0847	Melting Point (° C.)	58-60
A-0848	Reflactive Index (n D 20 )	1.5382
A-0849	Melting Point (° C.)	92-94
A-0853	Reflactive Index (n D 20 )	1.5140
A-0854	Melting Point (° C.)	100-103
A-0855	Reflactive Index (n D 20 )	1.5028
A-0856	Melting Point (° C.)	98-100
A-0857	Reflactive Index (n D 20 )	1.4969
A-0858	Melting Point (° C.)	101-102
A-0860	Reflactive Index (n D 20 )	1.5256
A-0864	Melting Point (° C.)	87-88
A-0869	Reflactive Index (n D 20 )	1.5241
A-0870	Reflactive Index (n D 20 )	1.5207
A-0876	Melting Point (° C.)	82-84
A-0877	Reflactive Index (n D 20 )	1.5442
A-0878	Melting Point (° C.)	44-46
A-0880	Reflactive Index (n D 20 )	1.5235
A-0881	Melting Point (° C.)	69-72
A-0884	Reflactive Index (n D 20 )	1.5201
A-0885	Melting Point (° C.)	49-50
A-0888	Reflactive Index (n D 20 )	1.5602
A-0902	Reflactive Index (n D 20 )	1.5450
A-0903	Melting Point (° C.)	83-85
A-0906	Melting Point (° C.)	140-143
A-0907	Reflactive Index (n D 20 )	1.5382
A-0908	Reflactive Index (n D 20 )	1.5508
A-0909	Melting Point (° C.)	103-105
A-0913	Reflactive Index (n D 20 )	1.5486
A-0914	Reflactive Index (n D 20 )	1.5580
A-0915	Reflactive Index (n D 20 )	1.5679
A-0916	Reflactive Index (n D 20 )	1.5649
A-0917	Reflactive Index (n D 20 )	1.5578
A-0918	Reflactive Index (n D 20 )	1.5500
A-0919	Reflactive Index (n D 20 )	1.5552
A-0920	Reflactive Index (n D 20 )	1.5539
A-0921	Reflactive Index (n D 20 )	1.5549
A-0922	Melting Point (° C.)	75-77
A-0923	Reflactive Index (n D 20 )	1.5171
A-0924	Melting Point (° C.)	83-86

TABLE 56

	Compound No.	Physical Property
A-0925	Melting Point (° C.)	75-76
A-0926	Reflactive Index (n D 20 )	1.5667
A-0927	Melting Point (° C.)	75-76
A-0933	Reflactive Index(n D 20 )	1.5471
A-0936	Reflactive Index (n D 20 )	1.5411
A-0940	Melting Point (° C.)	71-72
A-0941	Reflactive Index (n D 20 )	1.5259
A-0942	Melting Point (° C.)	112-114
A-0943	Melting Point (° C.)	93-96
A-0948	Melting Point (° C.)	57-58
A-0950	Melting Point (° C.)	136-138
A-0956	Reflactive Index (n D 20 )	1.5046
A-0957	Melting Point (° C.)	94-95
A-0958	Melting Point (° C.)	49-50
A-0959	Reflactive Index (n D 20 )	1.4908
A-0960	Melting Point (° C.)	91-92
A-0963	Reflactive Index (n D 20 )	1.5309
A-0964	Reflactive Index (n D 20 )	1.5341
A-0965	Reflactive Index (n D 20 )	1.5219
A-0966	Reflactive Index (n D 20 )	1.5269
A-0968	Reflactive Index (n D 20 )	1.5635
A-0969	Melting Point (° C.)	93-94
A-0972	Reflactive Index (n D 20 )	1.4600
A-0973	Melting Point (° C.)	71-74
A-0975	Reflactive Index (n D 20 )	1.5613
A-0976	Melting Point (° C.)	50-51
A-0977	Reflactive Index (n D 20 )	1.4741
A-0978	Melting Point (° C.)	85-87
A-0979	Reflactive Index (n D 20 )	1.5143
A-0980	Melting Point (° C.)	76-77
A-0981	Reflactive Index (n D 20 )	1.4626
A-0982	Melting Point (° C.)	50-53
A-0983	Reflactive Index (n D 20 )	1.5621
A-0984	Reflactive Index (n D 20 )	1.4711
A-0985	Melting Point (° C.)	66-69
A-0988	Melting Point (° C.)	76-77
A-0989	Reflactive Index (n D 20 )	1.5024
A-0990	Melting Point (° C.)	62-63
A-0991	Reflactive Index (n D 20 )	1.4639

TABLE 57

	Compound No.	Physical Property
A-0992	Melting Point (° C.)	35-37
A-0996	Melting Point (° C.)	48-51
A-0997	Melting Point (° C.)	55-58
A-0999	Melting Point (° C.)	87-88
A-1000	Melting Point (° C.)	104-105
A-1001	Melting Point (° C.)	91-92
A-1002	Melting Point (° C.)	70-73
A-1003	Reflactive Index (n D 20 )	1.5103
A-1004	Reflactive Index (n D 20 )	1.5094
A-1005	Melting Point (° C.)	86-88
A-1006	Melting Point (° C.)	72-75
A-1007	Reflactive Index (n D 20 )	1.5254
A-1008	Melting Point (° C.)	87-88
A-1009	Reflactive Index (n D 20 )	1.5101
A-1010	Melting Point (° C.)	78-80
A-1011	Reflactive Index (n D 20 )	1.5272
A-1012	Melting Point (° C.)	91-92
A-1015	Reflactive Index (n D 20 )	1.5226
A-1016	Melting Point (° C.)	92-94
A-1020	Reflactive Index (n D 20 )	1.4900
A-1021	Melting Point (° C.)	105-108
A-1024	Reflactive Index (n D 20 )	1.4931
A-1025	Reflactive Index (n D 20 )	1.4852
A-1026	Melting Point (° C.)	71-72
A-1027	Reflactive Index (n D 20 )	1.5430
A-1033	Reflactive Index (n D 20 )	1.4935
A-1037	Reflactive Index (n D 20 )	1.4792
A-1042	Reflactive Index (n D 20 )	1.4862
A-1048	Melting Point (° C.)	60-61
A-1050	Reflactive Index (n D 20 )	1.4850
A-1051	Reflactive Index (n D 20 )	1.4780
A-1052	Reflactive Index (n D 20 )	1.4802
A-1057	Reflactive Index (n D 20 )	1.4790
A-1058	Reflactive Index (n D 20 )	1.4859
A-1059	Melting Point (° C.)	63-64
A-1060	Melting Point (° C.)	75-76
A-1061	Reflactive Index (n D 20 )	1.4909
A-1062	Reflactive Index (n D 20 )	1.4942
A-1073	Melting Point (° C.)	67-70

TABLE 58

	Compound No.	Physical Property
A-1074	Reflactive Index (n D 20 )	1.4919
A-1075	Melting Point (° C.)	82-83
A-1079	Melting Point (° C.)	81-83
A-1080	Melting Point (° C.)	119-122
A-1081	Melting Point (° C.)	101-102
A-1082	Melting Point (° C.)	144-147
A-1087	Reflactive Index (n D 20 )	1.4991
A-1088	Melting Point (° C.)	89-92
A-1093	Reflactive Index (n D 20 )	1.5029
A-1094	Melting Point (° C.)	99-102
A-1097	Reflactive Index (n D 20 )	1.523
A-1098	Melting Point (° C.)	115-117
A-1099	Reflactive Index (n D 20 )	1.4985
A-1100	Reflactive Index (n D 20 )	1.5051
A-1102	Reflactive Index (n D 20 )	1.5152
A-1107	Melting Point (° C.)	92-93
A-1108	Melting Point (° C.)	142-143
A-1112	Reflactive Index (n D 20 )	1.4958
A-1113	Melting Point (° C.)	109-111
A-1117	Melting Point (° C.)	94-96
A-1119	Melting Point (° C.)	135-136
A-1122	Melting Point (° C.)	110-113
A-1123	Melting Point (° C.)	117-118
A-1125	Reflactive Index (n D 20 )	1.4881
A-1126	Melting Point (° C.)	70-72
A-1127	Reflactive Index (n D 20 )	1.5111
A-1128	Reflactive Index (n D 20 )	1.5049
A-1131	Melting Point (° C.)	70-73
A-1132	Melting Point (° C.)	70-73
A-1136	Reflactive Index (n D 20 )	1.4550
A-1137	Melting Point (° C.)	87-90
A-1138	Reflactive Index (n D 20 )	1.4826
A-1139	Melting Point (° C.)	98-101
A-1140	Reflactive Index (n D 20 )	1.4622
A-1141	Reflactive Index (n D 20 )	1.4682
A-1142	Reflactive Index (n D 20 )	1.4750
A-1143	Melting Point (° C.)	85-87
A-1150	Melting Point (° C.)	116-117
A-1151	Melting Point (° C.)	51-52

TABLE 59

	Compound No.	Physical Property
A-1152	Melting Point (° C.)	105-106
A-1153	Melting Point (° C.)	147-148
A-1154	Melting Point (° C.)	89-92
A-1155	Melting Point (° C.)	92-93
A-1157	Melting Point (° C.)	77-80
A-1158	Reflactive Index (n D 20 )	1.4679
A-1159	Reflactive Index (n D 20 )	1.4715
A-1164	Melting Point (° C.)	62-63
A-1165	Melting Point (° C.)	65-67
A-1166	Reflactive Index (n D 20 )	1.4919
A-1167	Melting Point (° C.)	67-68
A-1171	Reflactive Index (n D 20 )	1.5335
A-1172	Melting Point (° C.)	99-100
A-1174	Melting Point (° C.)	103-106
A-1175	Reflactive Index (n D 20 )	1.4721
A-1177	Reflactive Index (n D 20 )	1.4755
A-1178	Melting Point (° C.)	84-87
A-1180	Reflactive Index (n D 20 )	1.4729
A-1181	Reflactive Index (n D 20 )	1.4730
A-1183	Melting Point (° C.)	79-82
A-1185	Reflactive Index (n D 20 )	1.4685
A-1186	Melting Point (° C.)	107-108
A-1187	Melting Point (° C.)	105-107
A-1188	Melting Point (° C.)	84-85
A-1190	Reflactive Index (n D 20 )	1.4729
A-1191	Melting Point (° C.)	104-106
A-1192	Melting Point (° C.)	80-81
A-1195	Reflactive Index (n D 20 )	1.4720
A-1196	Melting Point (° C.)	90-91
A-1197	Reflactive Index (n D 20 )	1.4812
A-1200	Melting Point (° C.)	102-104
A-1202	Melting Point (° C.)	58-61
A-1203	Melting Point (° C.)	89-90
A-1205	Reflactive Index (n D 20 )	1.4801
A-1206	Reflactive Index (n D 20 )	1.4899
A-1207	Melting Point (° C.)	67-70
A-1209	Reflactive Index (n D 20 )	1.4925
A-1210	Reflactive Index (n D 20 )	1.4804
A-1211	Melting Point (° C.)	71-72

TABLE 60

	Compound No.	Physical Property
A-1212	Reflactive Index (n D 20 )	1.4880
A-1213	Melting Point (° C.)	46-48
A-1214	Melting Point (° C.)	99-100
A-1215	Reflactive Index (n D 20 )	1.5418
A-1216	Reflactive Index (n D 20 )	1.5391
A-1217	Melting Point (° C.)	69-70
A-1218	Melting Point (° C.)	80-82

TABLE 61

	Compound No.	Physical Property
B-0001	Reflactive Index (n D 20 )	1.4980
B-0002	Melting Point (° C.)	116-117
B-0003	Reflactive Index (n D 20 )	1.4599
B-0004	Reflactive Index (n D 20 )	1.4638
B-0005	Reflactive Index (n D 20 )	1.4830
B-0006	Reflactive Index (n D 20 )	1.4896
B-0007	Reflactive Index (n D 20 )	1.4839
B-0008	Reflactive Index (n D 20 )	1.4885
B-0009	Reflactive Index (n D 20 )	1.4880
B-0010	Reflactive Index (n D 20 )	1.4928
B-0011	Melting Point (° C.)	75-76
B-0012	Reflactive Index (n D 20 )	1.5291
B-0013	Melting Point (° C.)	102-103
B-0014	Reflactive Index (n D 20 )	1.5534
B-0015	Melting Point (° C.)	103-106
B-0016	Reflactive Index (n D 20 )	1.5528
B-0017	Reflactive Index (n D 20 )	1.5019
B-0018	Melting Point (° C.)	64-65
B-0019	Melting Point (° C.)	67-68
B-0020	Reflactive Index (n D 20 )	1.4952
B-0021	Melting Point (° C.)	124-126
B-0022	Reflactive Index (n D 20 )	1.4835
B-0023	Melting Point (° C.)	88-89
B-0024	Reflactive Index (n D 20 )	1.5051
B-0025	Melting Point (° C.)	85-86
B-0026	Melting Point (° C.)	57-59
B-0027	Melting Point (° C.)	53-54
B-0029	Reflactive Index (n D 20 )	1.5390
B-0030	Melting Point (° C.)	88-91
B-0032	Melting Point (° C.)	117-118
B-0033	Melting Point (° C.)	90-92
B-0034	Melting Point (° C.)	104-107
B-0035	Reflactive Index (n D 20 )	1.5013
B-0036	Reflactive Index (n D 20 )	1.5145
B-0037	Melting Point (° C.)	94-96
B-0038	Reflactive Index (n D 20 )	1.5028
B-0039	Melting Point (° C.)	73-74
B-0040	Melting Point (° C.)	93-95
B-0041	Melting Point (° C.)	85-87

TABLE 62

	Compound No.	Physical Property
B-0042	Reflactive Index (n D 20 )	1.5040
B-0043	Reflactive Index (n D 20 )	1.5220
B-0044	Melting Point (° C.)	87-89
B-0045	Reflactive Index (n D 20 )	1.5168
B-0046	Melting Point (° C.)	114-115
B-0047	Melting Point (° C.)	130-133
B-0048	Melting Point (° C.)	54-56
B-0049	Melting Point (° C.)	124-125
B-0050	Melting Point (° C.)	133-134
B-0051	Reflactive Index (n D 20 )	1.4976
B-0052	Melting Point (° C.)	147-149
B-0053	Melting Point (° C.)	54-55
B-0054	Melting Point (° C.)	117-118
B-0055	Reflactive Index (n D 20 )	1.5098
B-0056	Melting Point (° C.)	74-75
B-0058	Melting Point (° C.)	94-96
B-0059	Melting Point (° C.)	74-77
B-0061	Melting Point (° C.)	108-109
B-0062	Melting Point (° C.)	99-101
B-0064	Reflactive Index (n D 20 )	1.5210
B-0065	Melting Point (° C.)	142-144
B-0066	Reflactive Index (n D 20 )	1.5059
B-0067	Melting Point (° C.)	94-96
B-0068	Reflactive Index (n D 20 )	1.5085
B-0069	Melting Point (° C.)	126-127
B-0070	Reflactive Index (n D 20 )	1.4985
B-0071	Melting Point (° C.)	109-110
B-0072	Reflactive Index (n D 20 )	1.5031
B-0073	Melting Point (° C.)	78-79
B-0074	Reflactive Index (n D 20 )	1.4950
B-0075	Melting Point (° C.)	104-105
B-0076	Reflactive Index (n D 20 )	1.4970
B-0077	Melting Point (° C.)	77-78
B-0078	Reflactive Index (n D 20 )	1.4955
B-0079	Melting Point (° C.)	83-85
B-0080	Reflactive Index (n D 20 )	1.5051
B-0081	Melting Point (° C.)	68-69
B-0082	Reflactive Index (n D 20 )	1.4904
B-0083	Melting Point (° C.)	69-70

TABLE 63

	Compound No.	Physical Property
B-0084	Reflactive Index (n D 20 )	1.4713
B-0085	Melting Point (° C.)	92-94
B-0086	Reflactive Index (n D 20 )	1.4638
B-0087	Melting Point (° C.)	98-100
B-0088	Reflactive Index (n D 20 )	1.4912
B-0089	Melting Point (° C.)	115-117
B-0090	Reflactive Index (n D 20 )	1.5022
B-0091	Melting Point (° C.)	106-108
B-0092	Reflactive Index (n D 20 )	1.5005
B-0093	Reflactive Index (n D 20 )	1.4921
B-0094	Reflactive Index (n D 20 )	1.5022
B-0095	Melting Point (° C.)	106-108
B-0096	Melting Point (° C.)	57-58
B-0097	Reflactive Index (n D 20 )	1.5038
B-0098	Melting Point (° C.)	63-65
B-0099	Reflactive Index (n D 20 )	1.5042
B-0100	Melting Point (° C.)	110-111
B-0101	Reflactive Index (n D 20 )	1.5440
B-0102	Reflactive Index (n D 20 )	1.5120
B-0103	Melting Point (° C.)	117-118
B-0104	Reflactive Index (n D 20 )	1.5057
B-0105	Melting Point (° C.)	104-106
B-0106	Reflactive Index (n D 20 )	1.5441
B-0107	Reflactive Index (n D 20 )	1.5428
B-0108	Reflactive Index (n D 20 )	1.4988
B-0109	Reflactive Index (n D 20 )	1.5384
B-0113	Reflactive Index (n D 20 )	1.5578
B-0114	Melting Point (° C.)	89-100
B-0115	Melting Point (° C.)	86-89
B-0116	Melting Point (° C.)	114-115
B-0117	Melting Point (° C.)	84-85

TABLE 64

	Compound No.	Physical Property
C-0001	Reflactive Index (n D 20 )	1.4915
C-0002	Melting Point (° C.)	174-177
C-0003	Reflactive Index (n D 20 )	1.5185
C-0004	Melting Point (° C.)	145-146
C-0007	Reflactive Index (n D 20 )	1.529
C-0008	Melting Point (° C.)	167-169
C-0009	Reflactive Index (n D 20 )	1.5245
C-0010	Melting Point (° C.)	173-174
C-0011	Melting Point (° C.)	117-120
C-0013	Reflactive Index (n D 20 )	1.4918
C-0014	Reflactive Index (n D 20 )	1.5275
C-0016	Melting Point (° C.)	149-150

TABLE 65 — Physical Property

Compound No.	( 1 H-NMR DATA, in CDCl 3 /TMS δ (ppm))
A-0231	400 MHz	2.48(3H, s), 3.32(2H, q), 6.11(1H, d), 7.08
		(1H, d), 7.43(1H, d)
A-0234	400 MHz	3.37-3.47(1H, m), 3.70-3.81(1H, m), 6.16
		(1H, d), 7.38(1H, d), 7.94(1H, d)
A-0256	300 MHz	1.70-1.91(4H, m), 2.27-2.46(5H, m), 3.29
		(2H, q), 4.03(2H, t), 6.96(1H, d), 7.13
		(1H, d)
A-0257	300 MHz	1.71-1.94(4H, m), 2.30-2.46(5H, m), 3.29-
		3.50(2H, m), 4.12(2H, t), 6.99(1H, d),
		7.54(1H, d)
A-0259	300 MHz	2.37(3H, s), 3.30-3.51(2H, m), 5.30(1H,
		dd), 5.59(1H, dd), 6.19-6.51(1H, m), 7.11
		(1H, d), 7.77(1H, d)
A-0267	400 MHz	1.96-2.15(4H, m), 3.45(2H, q), 3.52(2H,
		t), 4.06(2H, t), 7.14(1H, s), 7.46(1H, s)
A-0283	400 MHz	1.50-1.60(4H, m), 1.81-1.93(4H, m), 3.39-
		3.49(4H, m), 4.02(2H, t), 7.13(1H, s),
		7.45(1H, s)
A-0284	300 MHz	1.53(4H, m), 1.70-2.03(4H, m), 2.17(3H,
		s), 2.38(3H, s), 3.26-3.43(4H, m), 3.94
		(2H, t), 6.96(1H, s), 6.99(1H, s)
A-0292	300 MHz	2.49(3H, s), 3.29(2H, q), 3.97(2H, t),
		4.13(2H, t), 6.98(1H, d), 7.49(1H, d)
A-0317	300 MHz	1.54-1.81(8H, m), 2.07-2.10(2H, m), 2.41
		(3H, s), 3.30(2H, q), 3.94(2H, d), 6.96
		(1H, d), 7.16(1H, d)
A-0328	400 MHz	1.23-1.40(2H, m), 1.61-1.90(7H, m), 2.04-
		2.16(2H, m), 2.41(3H, s), 3.29(2H, q),
		4.05(2H, t), 6.97(1H, d), 7.15(1H, d)
A-0329	400 MHz	1.23-1.51(2H, m), 1.60-1.88(7H, m), 2.03-
		2.16(2H, m), 3.41(2H, q), 4.06(2H, t),
		7.21(1H, d), 7.23(1H, d)
A-0410	300 MHz	2.16-2.25(5H, m), 2.39(3H, s), 3.11(2H,
		t), 3.31(2H, q), 4.05(2H, t), 6.97(1H, s),
		7.01(1H, s)

TABLE 66 — Physical Property

Compound No.	( 1 H-NMR DATA, in CDCl 3 /TMS δ (ppm))
A-0411	300 MHz	2.22-2.31(8H, m), 3.12(2H, t), 3.27-3.50(2H,
		m), 4.16(2H, m), 7.03(1H, s), 7.38(1H, s)
A-0412	300 MHz	2.21-2.29(2H, m), 3.15(2H, t), 3.45(2H, q),
		4.11(2H, t), 7.15(1H, s), 7.47(1H, s)
A-0413	400 MHz	2.28(2H, quint), 3.15(2H, t), 3.32-3.44(1H,
		m), 3.69-3.81(1H, m), 4.25(2H, t), 7.48(1H,
		s), 7.50(1H, s)
A-0416	300 MHz	1.90-2.04(4H, m), 2.36(3H, s), 2.97(2H, t),
		3.24-3.50(2H, m), 4.13(2H, t), 7.03(1H, d),
		7.54(1H, d)
A-0424	400 MHz	1.90-2.02(4H, m), 3.01(2H, t), 3.45(2H, q),
		4.05(2H, t), 7.13(1H, s), 7.46(1H, s)
A-0425	400 MHz	1.94-2.03(4H, m), 3.01(2H, t), 3.31-3.43
		(1H, m), 3.68-3.81(1H, m), 4.17(2H, t), 7.18
		(2H, s)
A-0432	400 MHz	1.62(2H, m), 1.70-1.95(4H, m), 2.31(3H, s),
		2.92(2H, t), 3.32-3.48(2H, m), 4.11(2H, t),
		6.98(1H, d), 7.54(1H, d)
A-0436	400 MHz	1.55-1.70(2H, m), 1.75-1.93(4H, m), 2.92
		(2H, t), 3.51(2H, q), 4.10(2H, t), 7.25(1H,
		d), 7.41(1H, d)
A-0440	300 MHz	1.54-1.67(2H, m), 1.70-1.95(4H, m), 2.39
		(3H, s), 2.92(2H, t), 3.33(2H, q), 4.01(2H, t),
		7.06(1H, s), 7.24(1H, s)
A-0480	400 MHz	1.49-1.53(4H, m), 1.71-1.82(4H, m), 2.17
		(3H, s), 2.38(3H, s), 2.90(2H, t), 3.30(2H,
		q), 3.94(2H, t), 6.96(1H, s), 6.70(1H, s)
A-0511	300 MHz	1.40-1.56(6H, m), 1.66-1.83(4H, m), 2.17
		(3H, s), 2.38(3H, s), 2.88(1H, t), 3.31(2H,
		q), 3.93(2H, t), 6.96(1H, s), 7.00(1H, s)
A-0512	300 MHz	1.41-1.52(6H, m), 1.68-1.86(4H, m), 2.28
		(3H , s), 2.33(3H, s), 2.89(2H, t), 3.26-3.50
		(2H, m), 4.03(2H, t), 7.01(1H, s), 7.36(1H,
		s)
A-0544	300 MHz	1.81-2.01(4H, m), 2.31(3H, s), 2.90(2H, t),
		3.31-3.48(2H, m), 4.13(2H, t), 6.82(1H, t),
		6.99(1H, d), 7.54(1H, d)

TABLE 67 — Physical Property

Compound No.	( 1 H-NMR DATA, in CDCl 3 /TMS δ (ppm))
A-0554	400 MHz	1.57-1.63(2H, m), 1.75-1.89(4H, m), 2.31
		(3H, s), 2.84(2H, t), 3.36-3.42(2H, m), 4.10
		(2H, t), 6.81(1H, t), 7.00(1H, d), 7.54(1H,
		d)
A-0557	400 MHz	1.57-1.63(2H, m), 1.72-1.84(4H, m), 2.38
		(3H, s), 2.84(2H, t), 3.40(2H, q), 3.94(2H,
		t), 6.75(1H, dd), 6.81(1H, t), 7.00(1H, s),
		7.11(1H, d)
A-0570	400 MHz	1.49-1.56(4H, m), 1.70-1.81(4H, m), 2.41
		(3H, s), 2.81(2H, t), 3.29(2H, q), 4.00(2H,
		t), 6.80(1H, t), 6.96(1H, d), 7.14(1H, d)
A-0661	400 MHz	1.59-70(2H, m), 1.79-1.92(4H, m), 3.21
		(2H, t), 3.41(2H, q), 4.04(2H, t), 7.21(1H,
		d), 7.25(2H, d)
A-0664	300 MHz	2.17(3H, s), 2.34(2H, quint), 2.39(3H, s),
		3.19(2H, t), 3.32(2H, q), 4.09(2H, t), 6.98
		(1H, s), 7.01(1H, s)
A-0678	400 MHz	1.50-1.62(4H, m), 1.83-1.92(4H, m), 2.96
		(2H, t), 3.45(2H, q), 4.03(2H, t), 7.13(1H,
		s), 7.46(1H, s)
A-0679	300 MHz	1.53-1.54(4H, m), 1.82-1.87(4H, m), 2.17
		(3H, s), 2.38(3H, s), 2.96(2H, t), 3.31(2H,
		q), 3.94(2H, t), 6.96(1H, s), 6.70(1H, s)
A-0681	300 MHz	1.40-1.56(6H, m), 1.75-1.88(4H, m), 2.17
		(3H, s), 2.38(3H, s), 2.95(2H, t), 3.31(2H,
		q), 3.93(2H, t), 6.96(1H, s), 7.00(1H, s)
A-0687	300 MHz	2.40(3H, s), 3.23(2H, q), 5.31(2H, s), 6.99
		(1H, d), 7.12(1H, d), 7.46(1H, t), 7.57(1H,
		t), 7.63-7.80(2H, m)
A-0745	300 MHz	2.42(3H, s) 3.24(2H, q) 5.14(2H, s), 7.00
		(1H, d), 7.15(1H, d), 7.21-7.37(2H, m),
		7.62(1H, dd)
A-0747	300 MHz	2.41(3H, s), 3.21(2H, q), 5.17(2H, s), 7.00
		(1H, d), 7.15(1H, d), 7.57(2H, d), 7.64(2H,
		d)
A-0822	300 MHz	2.41(3H, s), 3.15(2H, t), 3.27(2H, q), 4.23
		(2H, t), 6.96(1H, d), 7.11(1H, d), 7.11-7.19
		(2H, m), 7.55(1H, t)
A-0834	400 MHz	2.12(2H, quint), 2.41(3H, s), 2.82(2H, t),
		3.27(2H, q), 4.01(2H, t), 6.96(1H, d), 7.11
		(1H, d), 7.19-7.32(5H, m)

TABLE 68 — Physical Property

Compound No.	( 1 H-NMR DATA, in CDCl 3 /TMS δ (ppm))
A-0970	300 MHz	1.10(9H, s), 2.16(2H, t), 2.41(3H, s), 3.29
		(2H, q), 4.11-4.20(4H, m), 6.95(1H, d), 7.14
		(1H, d), 7.32(1H, s)
A-0971	400 MHz	1.09(9H, s), 2.18(2H, t), 2.31(3H, s), 3.30-
		3.50(2H, m), 4.16-4.20(4H, m), 6.98(1H, d),
		7.32(1H, s), 7.57(1H, d)
A-0998	400 MHz	2.40(3H, s), 3.26(2H, q), 4.26(2H, t), 4.51
		(2H, t), 6.98(1H, d), 7.25(1H, dd), 7.33-7.40
		(1H, m), 7.47(1H, t), 7.55-7.65(2H, m), 7.65
		(1H, d), 8.13(1H, s)
A-1032	400 MHz	2.42(3H, s), 3.09(3H, s), 3.29(2H, q), 4.25-
		4.35(2H, m), 4.56-4.61(2H, m), 6.99(1H, d),
		7.18(1H, d)
A-1044	400 MHz	2.10(2H, quint), 2.01(3H, s), 3.29(2H, q),
		3.87(2H, t), 4.10(2H, t), 5.40(2H, bs), 6.96
		(1H, d), 7.18(1H, d)
A-1072	400 MHz	1.83-1.97(4H, m), 2.85(2H, t), 3.41(2H, q),
		4.05(2H, t), 7.20(1H, d), 7.23(1H, d)
A-1101	300 MHz	1.40(2H, bs), 1.59-1.70(2H, m), 1.79-1.89
		(2H, m), 2.41(3H, s), 2.78(2H, t), 3.29(2H,
		q), 4.03(2H, t), 6.95(1H, d), 7.15(1H, s)
A-1116	400 MHz	1.80-1.93(4H, m), 2.42(3H, s), 3.29(2H, q),
		3.43-3.54(2H, m), 4.06(2H, t), 6.62(1H, bs),
		6.98(1H, d), 7.15(1H, d)
A-1149	400 MHz	1.78-1.94(4H, m), 2.41(3H, s), 2.97(3H, s),
		3.24(2H, t), 3.30(2H, q), 4.05(2H, t), 4.44
		(1H, bs), 6.97(1H, d), 7.15(1H, d)
A-1156	300 MHz	1.80-1.99(4H, m), 3.36-3.47(4H, m), 4.07
		(2H, t), 5.15(1H, m), 7.23(1H, d), 7.25(1H,
		d)
A-1201	400 MHz	1.48-1.57(2H, m), 1.75-1.88(4H, m), 2.41
		(3H, s), 3.29(2H, q), 3.82(2H, t), 3.92(3H,
		s), 4.11(2H, t), 6.96(1H, s), 7.14(1H, s)

TABLE 69 — Physical Property

Compound No.	( 1 H-NMR DATA, in CDCl 3 /TMS δ (ppm))
B-0028	300 MHz	2.42(3H, s), 3.24(2H, q), 5.13(2H, s), 7.01
		(1H, d), 7.15(1H, d), 7.30-7.38(2H, m), 8.60-
		8.68(2H, m)
B-0031	300 MHz	2.41(3H, s), 3.19-3.37(2H, m), 5.30(2H, s),
		7.00(1H, d), 7.17(1H, d), 7.71(1H, d), 7.97
		(1H, d), 8.86(1H, s)
B-0057	300 MHz	2.15(2H, quint), 2.42(3H, s), 2.94(2H, t),
		3.31(2H, q), 4.03(2H, t), 6.98(1H, d), 7.13
		(1H, d), 7.62(1H, d), 7.72(1H, d), 8.60(1H, s)
B-0060	300 MHz	2.32(2H, quint), 2.41(3H, s), 3.22(2H, t),
		3.28(2H, q), 4.13(2H, t), 6.95(1H, d), 7.15
		(1H, d), 7.88(1H, s), 8.70(1H, s)
B-0063	300 MHz	2.44(3H, s), 3.29(2H, q), 5.33(2H, s), 7.04
		(1H, d), 7.22(1H, d), 9.26(1H, s), 9.35(1H, s)

TABLE 70 — Physical Property

Compound No.	( 1 H-NMR DATA, in CDCl 3 /TMS δ (ppm))
C-0005	400 MHz	2.36(3H, s), 3.38(2H, q), 5.61(1H, brs),
		6.69(1H, dd), 6.93(1H, s), 7.03(1H, d)
C-0006	400 MHz	2.28(3H, s), 3.37-3.56(2H, m), 6.96(1H,
		dd), 7.12(1H, d), 7.73(1H, d), 8.04(1H, bs)
C-0015	300 MHz	3.30-3.44(1H, m), 3.66-3.80(1H, m),
		7.40(1H, s), 7.61(1H, s)
C-0017	300 MHz	2.20(3H, s), 2.36(3H, s), 3.32(2H, q),
		4.59(1H, s), 6.93(1H, s), 6.98(1H, s)
C-0018	300 MHz	2.25(6H, s), 3.35-3.53(2H, m), 6.98
		(1H, s), 7.63(1H, s), 7.69(1H, s)

TABLE 71

Compound No.	Specific Rotation
(−)-A-0086	−104.4
(+)-A-0086	+103.6
(−)-A-0434	−120.3
(+)-A-0434	+119.3
(−)-A-0479	−120.6
(+)-A-0479	+115.2
(−)-A-0481	−93.2
(+)-A-0481	+96.5
(−)-A-0764	−86.4
(+)-A-0764	+88.5
(−)-A-0767	−117.0
(+)-A-0767	+122.8
(−)-A-1215	−99.2
(+)-A-1215	+98.1
(−)-A-1218	−120.4
(+)-A-1218	+121.6

A compound described in Table 1 to Table 41	10	parts
Cyclohexanone	30	parts
Polyoxyethylene alkyl aryl ether	11	parts
Calcium alkylbenzenesulfonate	4	parts
Methylnaphthalene	45	parts

A compound described in Table 1 to Table 41	10	parts
Sodium salt of naphthalenesulfonic acid-	0.5	part
formalin condensate
Polyoxyethylene alkyl aryl ether	0.5	part
Diatomaceous earth	24	parts
Clay	65	parts

A compound described in Table 1 to Table 41	2	parts
Diatomaceous earth	5	parts
Clay	93	parts

A compound described in Table 1 to table 41	5	parts
Sodium salt of lauryl alcohol sulfate	2	parts
Sodium ligninsulfonate	5	parts
Carboxymethyl cellulose	2	parts
Clay	86	parts

A compound described in Table 1 to Table 41	20	parts
Polyoxyethylene styrenated phenyl ether	4	parts
sulfate
Ethylene glycol	7	parts
Silicone AF-118N (produced by Asahi	0.02	part
Chemical Industry Co. , Ltd. )
Water	68.98	parts

Claims as granted

10 claims

Classifications

36 codes

IPC · International Patent Classification

Section A — Human necessities

A01N33/20
A01N37/10
A01N43/08
A01N41/10
A01N37/34
A01N43/50
A01N43/56
A01N43/54
A01N43/653
A01N43/40
A01N55/00
A01N37/38
A01N37/32
A01N47/02
A01N47/48
A01N31/16
A01N39/00
A01N43/78
A01N41/12

Section C — Chemistry; metallurgy

C07D233/64
C07C321/28
C07C323/18
C07C317/32
C07C317/22
C07D231/12
C07C317/14
C07C323/12
C07C323/25
C07D239/26
C07C323/20
C07C317/46
C07D213/34
C07C331/10
C07D277/26
C07D249/08
C07C323/62

Claim changes

Soon

Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoom

USPTOApplicanthover for detail · click to open

Pendency

2.3 y

833 days filing → grant

Office actions

after a restriction

Responses

no RCE

Examiner

John M Mauro

art unit 1625 · TC 1600

Law firm

Law firm · Log in to unlock

Citations: 36 back · 2 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Chain of title

⤢ drag to zoom

Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.